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ABSTRACT 
Activation of the innate immune system is a prerequisite for the induction of 
adaptive immune responses to both infectious and non-infectious agents. Toll-like 
receptors (TLRs) are a family of proteins important for recognizing pathogen 
associated molecular patterns. MyD88 is an adaptor molecule whose function is 
critical in TLR signaling. MyD88-deficient (MyD88
-/-
) mice exhibit heightened 
susceptibility to infections, even by attenuated strains of Salmonella enterica 
serovar Typhimurium. Paradoxically, despite their hypersusceptibility, infected 
MyD88
-/-
 mice produce elevated serum levels of anti-Salmonella antibodies 
regardless of the route of infection. This hypergammaglobulinemia was observed 
with both Th1-driven (IgG2c and IgG3) and Th2-driven (IgG1) antibody isotypes. 
The dysregulated antibody responses also led to the production of autoantibodies 
as demonstrated by reactivity to dsDNA and thyroglobulin, positive nuclear 
staining with HEp2 cells, and immune complex deposition in the kidneys of 
MyD88
-/-
 mice. Utilizing intracellular cytokine staining, real-time PCR and 6-
color flowcytometric analysis, we demonstrated that these autoimmune responses 
correlate with the activation of distinct populations of IFN-+/IL-4+ and IFN+/IL-
10
+
 T helper lymphocytes. Further analysis revealed that these most likely 
represent a specialized family of cells known as follicular helper T cells (TFH 
cells) which function to promote B cell activation and antibody production. The 
aberrant expansion of these TFH-like cells could underlie the activation of 
autoreactive B cells leading to humoral autoimmunity. Our findings highlight a 
critical role for TLR-MyD88 pathway in controlling reactivity to self-antigens and 
provide a potential mechanism for the inter-relationship between microbial 
infections and autoimmune disease development in humans.  
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 الملخص
معدية. الغير لتكيفي تجاه العوامل المعدية وتحفيز جهاز المناعة الفطري شرط أساسي لتنشيط جهاز المناعة ا
هي مستقبلات مهمة لاستشعار الأنماط الجزيئية المرافقة للكائنات  )sRLT( المستقبلات شبيهة التول
عند إجراء التجارب على  لنقل الإشارة  داخل الخلية. 88dyMالممرضة و التي تعتمد على الجزيء الناقل 
وجد أن لديهم قابلية عالية للموت لدى إصابتهم بالعدوى حتى  )-/-88DyM( 88DyMالفئران المفتقرة ل
بعد إصابة هذه  . muirumihpyT ravores aciretne allenomlaSفة من السالمونيلابأنواع مضع
الفئران بعدوى السالمونيلا، لوحظ أنهم أنتجوا كميات كبيرة من الأجسام المضادة ضد السالمونيلا من كلا 
بغض النظر عن طريقة العدوى و هذه الظاهرة تعرف بفرط جاما  2-hT و  1-hTنوعي الخلايا المساعدة
. فرط جاما جلوبين الدم ترافق مع نشاط بعض هذه الأجسام )aimenilubolgammagrepyh( جلوبين الدم
المضادة إلى مولد الضد الذاتي حيث تفاعلت مع الحمض النووي و الثايروجلوبين، كما وجدت ترسبات 
الكلية. باستخدام عدة تقنيات، تمكنا من تحديد علاقة بين الاستجابة الناعية الذاتية و  للمتراكبات المناعية في
كذلك تبين  ، +01-LI/+γNFIو  +4-LI/+γ-NFIوجود نشاط لمجموعة مميزة من الخلايا التائية المساعدة 
 HFT(لمساعدة لنا أن هذه الخلايا على الأغلب هي من عائلة متخصصة تسمى بالخلايا الجريبية التائية ا
جود قد يفسر وو و التي لها دور في تعزيز نشاط الخلايا البائية و دفعها لإنتاج الأجسام المضادة.   )sllec
الخلايا الجريبية التائية المساعدة نشاط الخلايا البائية النشطة ذاتيا المسببة شذوذ في توسع للخلايا شبيهة 
دراستنا توضح أهمية مسار المستقبلات الشبيهة بالتول و  لأعراض أمراض المناعة الذاتية. في الختام،
ع مولدات الضد الذاتية و تقترح آلية تربط الإصابة بالعدوى و نشئة أمراض مفي التفاعل  88DyMبروتين 
 المناعة الذاتية عند الإنسان. 
 كلمات دلالية:
عدوى السالمونيلا، الذئبة الحمراء  المناعة الفطرية، المستقبلات الشبيهة بالتول، فرط جاما جلوبين الدم،
 ، أمراض المناعة الذاتية.    )ELS( الجهازية
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1. INTRODUCTION  
        The two main elements of the host immune defense system include the innate 
and adaptive immunity whose components target infectious agents like microbes 
and non-infectious agents such as adjuvants. Effective host defense against 
microbial infections is dependent on prompt recognition of pathogens, rapid 
induction of immediate anti-microbial defense mechanisms and ultimately the 
activation of strong, antigen-specific, lymphocyte responses. The innate immune 
system is an evolutionary conserved system that recognizes and responds to a 
wide range of microbial pathogens. It plays a crucial role in the initial control of 
infections and is mediated by phagocytic cells and antigen presenting cells 
(APCs). These cells recognize evolutionary conserved components of the 
pathogen essential for their survival and pathogenicity known as pathogen 
associated molecular patterns (PAMPs) through the host germline encoded pattern 
recognition receptors (PRRs). Several families of PRRs have been identified 
which include TLRs (Toll like receptors), RIG (retinoic acid-inducible gene 1 like 
receptors) and NLRs (nucleotide-binding oligomerization domain like receptors) 
all of which play a central role in the host defense (Kumar et al., 2011). 
1.1. Toll like receptors  
        TLRs, a family of one of the most extensively studied PRRs, is a class of 
conserved type 1 transmembrane structures that identify PAMPs through the 
process of pattern recognition (Takeda et al., 2003). This in turn leads to the 
initiation of a series of signaling cascades, resulting in the transcriptional 
expression of genes that code for inflammatory cytokines, chemokines and co-
stimulatory molecules (Akira et al., 2006); (Kopp and Medzhitov, 2003); 
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(Medzhitov, 2007)  depending on the type of cells activated. Some examples 
include secretion of TNF-α by murine macrophages on activation of TLR4 and 
TLR2 (Jones et al., 2001) On recognition of viral associated patterns, TLR 
activation on NK cells leads to production of GM-CSF (granulocyte-monocyte 
colony stimulating factor) and IFN-γ (Adib-Conquy et al., 2013).  
        The first member of the TLR family was a protein identified in Drosophila 
melanogaster (fruit fly). Drosophila Toll was found to play a crucial role in host 
response to fungal infections as well as dorso-ventral patterning during 
embryogenesis in the fruit fly (Lemaitre et al., 1996). Several mammalian 
homologues of the Drosophila Toll protein have been identified and shown to 
induce the expression of genes involved in the inflammatory response. One such 
example is TLR1-5 that has been found to be more closely linked to the Toll 
homologs of Drosophila (Rock et al., 1998); (Medzhitov et al., 1997). 
        About 13 mammalian TLRs have been cloned in mammals of which TLR1-9 
are conserved between mouse and human. Each of them recognizes distinct 
molecular patterns derived from viruses, pathogenic bacteria, pathogenic fungus 
and parasitic-protozoa through their PRRs (Akira et al., 2006); (Janeway, 1989). 
They are expressed in many immune cells such as B cells, dendritic cells (DCs), 
macrophages (antigen presenting cells) and certain types of T-cells as well as non-
immune cells like fibroblast and epithelial cells (Iwasaki and Kelsall, 1999); 
(Iwasaki and Medzhitov, 2004); (Akira et al., 2006). Most TLRs are expressed on 
the cell surface, which include TLR 2, 4, 6, 8 and 10 while some like TLR3, 7 and 
9 are expressed intracellularly (Akira et al., 2006); (Kawai and Akira, 2010) 
(Table 1). Members of the TLRs subfamily within the cell are localized on the 
membrane of intracellular vesicles, such as endosomes and lysosomes where they 
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identify the nucleic acid components of pathogenic organisms (Medzhitov, 2007). 
TLRs are found as individual units or as pair as well as with a range of other 
signaling molecules. 
TLR Ligand Microbial source 
TLR1 triacyl lipopeptides bacteria 
TLR2 peptidoglycans, lipoproteins, 
atypical LPS, zymosan, 
phospholipomannan, GPI 
anchors, heat-shock proteins 
(e.g. HSP 70) 
bacterial, fungi, protozoa, 
host cells 
TLR3 poly I:C, dsRNA virus 
TLR4 LPS, mannan, 
glucuronoxylomannan, 
glycoinositolphospholipids, 
RSV fusion protein, heat-shock 
proteins (e.g. HSP 60) 
bacterial, fungi, protozoa, 
virus host cells 
TLR5 flagellin bacteria 
TLR6 diacyl lipopeptides bacteria 
TLR7 synthethetic imiazoquinoline-
like molecules, ssRNA 
virus 
TLR8 ssRNA virus 
TLR9 CpG DNA bacteria, protozoa, virus 
TLR10 function and ligand unknown - 
TLR11 (mouse only) components of uropathogenic 
bacteria, profillin like 
molecules 
bacteria, protozoa 
TLR12-13 (mouse 
only) 
function and ligand currently 
unknown 
- 
 
Table 1: Toll like receptors and pathogen recognition (Adapted from 
Chong D.L.W. Sriskandan S. Herwald H, Egesten A (eds): Sepsis – Pro-Inflammatory 
and Anti-Inflammatory Responses. Contrib Microbiol. Basel, Karger, 2011, vol 17, pp 
86–107) 
 
        These evolutionarily conserved proteins are characterized by an extracellular 
ligand binding N terminus domain made up of leucine rich repeats (LRRs) and an 
intracellular C terminus domain homologous to IL-1 receptor (Bowie and O'Neill, 
2000); (Medzhitov, 2007). The intracellular Toll IL-1 receptor (TIR) region 
consists of around 200 amino acids and is involved in signal transduction (Bauer 
et al., 2008); (Bowie and O'Neill, 2000). Protein–protein interaction is mediated 
by the TIR domain, one of the earliest motifs to be involved in signaling 
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(Kimbrell and Beutler, 2001). Binding of the TLR to its ligand reveals the 
presence of an infection which leads to the activation of the immune system and 
elimination of the pathogen.  
        Upon binding to their respective ligands, TLRs generate signals through the 
recruitment of adaptor molecules such as MyD88 (myeloid differentiation primary 
response 88), TRIF (TIR-domain-containing adapter-inducing interferon-β), 
TIRAP (TIR domain containing adaptor protein) and TRAM (TRIF related 
adaptor molecule) via the TIR cytoplasmic domain. This stimulates the production 
of reactive oxygen and nitrogen intermediates (ROI and RNI). TLR signaling 
induces the production of pro-inflammatory cytokines, type 1 interferons as well 
as enhances the expression of co-stimulatory molecules. This leads to the 
activation of APCs, subsequently initiating the adaptive immune response 
(Werling and Jungi, 2003).  
        The MyD88 (myeloid differentiation factor 88) is the central adaptor 
molecule used by all TLRs except TLR3. The pathway initiates the expression of 
NF-kB or interferon-regulatory transcription factor (IRF-1) that are involved in 
the regulation of inflammation and activation of pathogen specific adaptive 
immunity (Kumar et al., 2009); (Akira, 2003). MyD88 is also involved in the 
signaling pathway of IL-1 and IL-18 receptors. This adaptor molecule recruits IL-
1 receptor-associated kinase-4 (IRAK-4) to TLRs through the death domain 
interaction of both molecules. By phosphorylation, IRAK-1 is activated and 
induces the interaction of TNF-receptor associated factor (TRAF6). TRAF6 then 
activates TAK1 complex through ubiquitination. TAK1 in turn leads to the 
subsequent activation of IκB kinase (IKK) complex. This catalyzes IκB and its 
degradation results in the release of NF-κB. The transcription factor once liberated 
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translocates into the nucleus and induces gene expression of the target 
inflammatory cytokines to the infection (Akira, 2003). TAK1 also activates the 
mitogen activated protein (MAP) kinase pathway that eventually leads to the 
activation of activator-protein (AP-1) and NF-κB. Meanwhile, TLR4 possesses a 
MyD88 dependent and a TRIF dependent pathway, whereas TLR3 signal only 
through TRIF. Signaling through TRIF adaptor molecule leads to the recruitment 
of TBK1 together with IKKi that result in the phosphorylation of IRF3. Once 
phosphorylated, IRF3 dimerizes and translocates to the nucleus and binds to the 
DNA. TRIF can also bind to TRAF6 and receptor-interacting protein (RIP-1) that 
mediates the activation of NF-κB. For the induction of type1 interferons (IFNs), 
activation of IRF3 and NF-κB are required (Fig. 1). On stimulation through TLR 
ligands, DCs and macrophages are the major producers of inflammatory 
cytokines.  
 
Fig. a. Toll like receptor signaling. T Kawai and S Akira. Cell Death and 
Differentiation (2006) 13, 816–825. 
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1.1.1. Control of adaptive immune response by TLRs 
        Activation of the innate immune cells by TLR ligands initiates adaptive 
immune responses (Fig.2). On recognition of PAMPs through TLRs on dendritic 
cells and macrophages, costimulatory molecules and major histocompatibility 
complex (MHCII) molecules are upregulated. Signaling through the receptors 
induces the production of cytokines like IL-12, chemokines and nitric oxide. The 
increased expression of CD80/86 and CD40 on DCs along with the presence of 
IL-12 leads to the activation of CD4
+
  T cells and its differentiation to T helper-1 
(Th1) cells (Werling and Jungi, 2003). TLR4 ligand like LPS can direct dendritic 
cell maturation through enhanced expression of CD86 which is important for the 
development of Th2 responses (Dabbagh et al., 2002). TLR2 activation through 
peptidoglycan and zymosan ligands induce increased IL-10 production from DCs 
(Qi et al., 2003) that is involved in the differentiation of Th2 cells (Iwasaki and 
Kelsall, 1999). The differentiation of CD4
+
 T cells to effector T cells is controlled 
by transcription factors. A very recent study has shown that IRF4 transcription 
factor in DCs drives Th2 differentiation (Williams et al., 2013). GATA-3 is the 
master regulator for Th2 responses promoting IL-4 production (Zheng and Flavell, 
1997), while T-bet drives Th1 lineage and IFN-γ production (Szabo et al., 2000). 
Loss of T-bet impairs Th1 response and by default commits to Th2 cell lineage 
(Matsui et al., 2005). TLR2 signaling has been shown to be involved in expansion 
of Treg cells (Netea et al., 2004) and TLR2 and TLR4 in promoting Th17 
responses (Reynolds et al., 2010); (Higgins et al., 2006). Synergistic effect of 
TLR2 and TLR7/8 agonists on DCs drives T cell differentiation to Th2/Th17 cells 
(Matsui et al., 2005). This is due to the lack of production of IL-12p70 on 
activated DCs (Wenink et al., 2009). TLR7 activation on DCs reduced Foxp-3 
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levels and the suppressive function of regulatory T cells through IL-6 production 
(Hackl et al., 2011). Th1/Th2 differentiation is also determined by the amount of 
antigen involved in the TLR activation of DCs (Sun and Pearce, 2007). At high 
doses of Ova-peptide, splenic DCs induced Th1 development, while low doses 
induced Th2 responses (Boonstra et al., 2003).  In another study, high doses of 
LPS through TLR4 failed to induce Th2 cell responses but rather induced IL-12 
production resulting in Th1 response (Eisenbarth et al., 2002). Thus, the activation 
of T cell subset largely depends on the TLR signals on APCs, the cytokine milieu 
and the dose of antigen involved. 
 
Fig. b. Toll-like receptors and innate immunity. Ruslan Medzhitov. Nature Reviews 
Immunology 1, 135-145 (November 2001) 
        Some TLRs are expressed on T cells, though their level of expression is 
variable. They are found to behave as costimulatory molecules and have a direct 
effect on T cell responses (Rahman et al., 2009); (Komai-Koma et al., 2004). One 
such example is the engagement of TLR1/2 through Pam3CysSK4 ligand on 
activated CD8
+ 
T cells that leads to enhanced CD8
+ 
T cell proliferation and 
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survival (Cottalorda et al., 2006). Stimulation of TLR5 on Tregs with flagellin 
enhances the expression of Foxp-3 and Treg suppressive activity (Crellin et al., 
2005). The type of T cell differentiation generated largely depends on the category 
of molecular pattern/ligand that is recognized by its respective TLR (Tipping, 
2006). 
        Since APCs are involved in initiating the adaptive immune response, it is of 
relevance to investigate the role of TLRs in altering the adaptive immunity. A 
defect in one or more components of the pathway exhibited, increased 
susceptibility to a variety of pathogens examined in mice and humans which 
underlines the importance of TLR-MyD88 interaction in recognition of microbial 
pathogens (Campos et al., 2004); (Scanga et al., 2004). 
1.2. Autoimmunity 
        The concept of autoimmunity as a cause for the development of disease in 
humans has been accepted into the field of medical science since the 1950’s. It 
was first predicted in the beginning of the twentieth century by the Nobel Laureate 
Paul Ehrlich in his proposed idea of ‘horror autotoxicus’ wherein an immune 
response against one’s own body tissues does not occur in a ‘normal’ being. An 
autoimmune disease develops when the immune system starts attacking self-
tissues as a result of failure of self-tolerance, resulting in an aberrant immune 
response. There is no individual theory that can fully explain the phenomenon of 
autoimmunity or the development of autoimmune diseases. Several factors are 
implicated in autoimmunity which include environmental triggers, immunological 
and hormonal factors and genetic variants. Most autoimmune diseases can only be 
treated but not cured because their target of self-antigen cannot be eliminated. 
Self-tolerance can be broadly classified into central tolerance and peripheral 
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tolerance. In central tolerance the immature self-reactive lymphocytes are deleted 
by apoptosis in the primary lymphoid organs, like bone marrow and thymus. 
Apoptosis is driven by the high affinity of T cells to MHCII in combination with 
self peptides and high affinity of B cell receptor (BCR) to naïve antigen for B 
cells. Although the process of central tolerance is efficient, it cannot fully 
eliminate all self-reactive lymphocytes partly because not all self antigens are 
expressed in the central site of lymphocyte development. Autoimmune regulator 
gene (AIRE) mainly expressed on medullary thymic epithelial cells (Kyewski and 
Klein, 2006) induces the expression of tissue-specific antigens, necessary for the 
negative selection of autoreactive T cells. In peripheral tolerance, the self antigens 
that are encountered by the mature self-reactive B and T lymphocytes in 
peripheral organs are eliminated through anergy (intrinsic biochemical changes 
that reduce the activation of self-reactive receptors on cells), deletion or 
suppression by Treg cells (Rioux and Abbas, 2005); (Gregersen and Behrens, 
2006); (Xing and Hogquist, 2012). These cellular strategies act as checkpoints in 
the pathway for the differentiation of lymphocytes, production of antibodies and 
effector T cells. When self-reactive lymphocytes escape these mechanisms of 
tolerance and get activated, autoimmune disease develops.  
        In the lymphoid organs, the major B cell subsets are the transitional (newly 
emigrant) B cells, marginal zone and follicular B cells. The main mechanisms in 
regulating B cell tolerance during its development include deletion, receptor 
editing and anergy. Rag genes that catalyze VDJ recombination are persistently 
expressed, enabling BCR receptor editing (Jankovic et al., 2004) in the immature 
B cells. Rag expression is first induced during gene assembly of immunoglobulin 
heavy chain (Allman et al., 1999); (Alt et al., 1984) and second, when pre-B cells 
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stop their division during genetic recombination of Ig light chain (Li et al., 1993). 
As B cells mature, their level of Rag expression is lowered. The self-reactive BCR 
do not undergo prolonged receptor editing. Some reports have also highlighted the 
expression of Rag in the germinal centers of spleen and Peyer’s patches (Han et 
al., 1996) as well as in B cells activated in vitro and in vivo (Hikida et al., 1996). 
Through the process of receptor editing which is at a frequency of 30-35%, those 
cells with non self-reactive Ig L and H chain are positively selected. Mature BCR 
is expressed on immature B cells in the form of IgM. Those immature B cells with 
high avidity interactions with multivalent membrane bound self-antigens are 
arrested and undergo elimination through apoptosis within the bone marrow 
(Hartley et al., 1993a).  During B cell development in the bone marrow, the 
majority of antibodies from early immature B cells were autoreactive with anti-
nuclear affinity (Wardemann et al., 2003). Several studies have shown that about 
80% of the immature B cells are deleted before they reach the mature B cell 
compartment in the spleen, suggesting a large population of autoreactive B cells in 
the initial repertoire (Pieper et al., 2013); (Sidman and Unanue, 1975); (Norvell et 
al., 1995); (Pieper et al., 2013). In the process of central B cell tolerance, the 
immature B cell with prolonged and excessive levels of BCR cross linking to self 
antigens, promptly internalizes the BCR thereby arresting its maturation (Hartley 
et al., 1993b); (Nemazee and Hogquist, 2003). In the course of their halt, the 
acquisition of adhesion molecules, such as CD62L homing receptors, which are 
necessary to migrate to lymph nodes, is blocked (Hartley et al., 1993a). Nemazee 
and colleagues have shown that gene rearrangement can edit the specificity of 
autoreactive BCR, thus rescuing the cells from clonal deletion (Nemazee and 
Hogquist, 2003). Other mechanisms of B cells escaping the primary lymphoid 
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organ include intermediate BCR signals and the ignorant state of self-reactive B 
lymphocytes to antigens. The majority of the immature B cells undergo receptor 
editing. However, this process also selects B cells that express two or more Ig L 
and H chains that largely react to self-antigens. As a result, B cells that co express 
autoreactive and non autoreactive BCRs get in to the mature peripheral B cell 
populations (Li et al., 2002); (Liu et al., 2005). B cell activating factor (BAFF) is 
crucial for peripheral B cell survival and their maturation. The level of expression 
of BAFF-R on immature non self-reactive B cells is associated with their tonic 
BCR signaling. Unlike non autoreactive B cells, immature autoreactive B cells 
express low levels of BAFF-R that correlate with their insufficient BCR tonic 
signaling (Rowland et al., 2010). Enhanced BAFF expression that causes 
increased B cell expansion is known to be linked to autoimmunity. Elevated level 
of the cytokine is observed in the serum of autoimmune patients (Migita et al., 
2007); (Pers et al., 2005); (Mackay et al., 2003); (Mackay and Browning, 2002). 
        During thymic development, T cells are selected based on their interaction 
with the MHC protein-bound with the self peptide fragments of antigen. Those 
developing T cells that express TCR with intermediate affinity to self-peptide 
MHCII complex are positively selected and mature to CD4
+ 
T/CD8
+ 
T cells. 
Double positive thymocytes that express TCR that do not bind to the self-peptide 
MHC complex are unable to survive and die by apoptosis. Polyclonal thymocytes 
that bind to self antigens are deleted in the cortex but those tissue specific or 
circulating antigens are deleted in the thymic medullary region. The positively 
selected thymocytes in the cortex move to the medulla trigger signals that induce 
expression of homing receptors and TCRs. On moving to the medulla, the 
thymocytes are still tested for their self reactivity where the medullary epithelial 
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cells and dendritic cells express costimulatory molecules like CD80, CD86 and 
CD28L for T cells (Derbinski et al., 2005). In this stage, those cells that bind 
strongly to self-peptide MHC complexes under the control of autoimmune 
regulatory AIRE gene, undergo clonal deletion (Goodnow et al., 2005). It has 
been shown that AIRE-deficient mice possessed disordered medulla (Gillard et al., 
2007); (Dooley et al., 2008) with altered maturation of thymocytes and reduced 
accumulation of Treg cells (Lei et al., 2011). Another process of tolerance 
mechanism is through clonal diversion where self-reactive clone from T cell 
repertoire induce Treg differentiation thus attaining immunoregulatory function 
(Xing and Hogquist, 2012). 
        T cell differentiation and their effector functions require two signals, the first 
of which is the antigen and the secondary signal is provided through costimulatory 
molecules on APCs. Costimulatory signals largely determine the activation or 
deletion of T lymphocytes. Not all self-antigens are expressed in the primary 
lymphoid organs; some can be expressed from sequestered tissues or through 
developmental antigens. Thus, tolerance mechanisms of deletion and anergy of 
self-reactive clones take place in the periphery. In the process of peripheral 
tolerance as mentioned earlier, a state of unresponsiveness or anergy can be 
generated in self-reactive lymphocytes. This is mainly through the repression of 
IL-2 expression and TCR signaling, as a result of interaction with APCs that do 
not possess adequate levels of costimulatory molecules and through activation of 
CTLA-4 on Tregs.  Mice deficient in CTLA-4 develop spontaneous autoimmunity 
(Waterhouse et al., 1995); (Tivol et al., 1995). An increased degree of autoreactive 
T cells accumulate in lymphoid tissues in the absence of CTLA-4 (Walker and 
Abbas, 2002). Furthermore, several nutrient sensing pathways have been 
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identified in mediating T cell anergy. Some of these include activation of ATP-
deprivation sensor, adenosine signals and others. Tolerogenic DCs that arise from 
incomplete maturation also regulate tolerance. These peripheral tolerogenic DCs 
fail to provide effective signals for T cell activation and proliferation (Xing and 
Hogquist, 2012). Peripheral deletion of autoreactive lymphocytes is mediated 
through Fas (death-domain-containing receptor) and Bim (BCL-2-interacting 
mediator of cell death) apoptotic pathways. As T helper cells are required for the 
activation of B cells, T cell tolerance is the most crucial process to maintain 
peripheral B cell tolerance (Goodnow et al., 2005); (Xing and Hogquist, 2012), as 
the B cells remain functionally unresponsive or undergo death by apoptosis due to 
specific T helper cells that are either deleted or anaergic. Newly formed immature 
B cells on migration to the spleen can encounter self antigens that are absent in the 
bone marrow. Similarly these cells are rapidly deleted due to high avidity 
interaction with the peripheral self-antigens (Goodnow et al., 2005). Also, B cells 
that have low affinity for self antigens can be rendered unresponsive through 
inhibitory receptor engagement and lack of signaling through NF-ƘB. In a varied 
repertoire of B cell population, mature B cells that have escaped clonal deletion in 
the bone marrow have a greater requirement for BAFF for their survival and being 
weak competitors, they are unable to express high levels of BAFF-R and are thus 
deleted (Lesley et al., 2004). Within the germinal centers, somatic hypermutation 
and affinity maturation increases B cell specificity. These processes however, can 
result in the generation of self-reactive receptors from formerly productive ones. 
The survival of these cells is based on their affinity to self-antigens. They can be 
eliminated because of competition for DC antigen presentation or T cell help 
(Basten and Silveira, 2010).  
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        Genetic factors that lead to disease susceptibility are mainly caused by 
complex traits that involve multiple genotypes and environmental factors such as 
pathogen exposure, smoking etc. However, there are several single gene disorders 
that have led to experimental models for the study of autoimmune diseases. The 
genetic variants that lead to autoimmunity can be identified through various 
genetic resources and tools. Genomic and proteomic approaches have made it  
possible to understand the molecular basis of the diseases. Microarray analyses are 
useful in determining the expression of hundreds of genes at the same time, 
providing crucial information in the pathogenesis of the disease, its progression 
and treatment (Fathman et al., 2005). Use of protein microarrays and assays based 
on flow cytometry has been greatly adapted in proteomic studies in autoimmunity. 
Numerous studies in complex human traits have reported the mapping of 
susceptible loci. Some of these include identification of CTLA-4 locus in Grave’s 
disease and type1 diabetes, PTPN22 locus in SLE, RA (Rheumatoid arthritis) and 
type1 diabetes and Nod2 susceptible gene in Crohn’s disease (Rioux and Abbas, 
2005). Also, most autoimmune diseases have been strongly associated with the 
MHC region containing the HLA genes. Various animal models have been 
valuable in investigating the general mechanism involved in these diseases. One 
challenge in identifying genetic disorders is the product combination of   genetic 
repertoire and environmental factors. The versatility of the techniques in the study 
of autoimmunity is limited and a multidisciplinary approach is required.  
1.2.1. TLR signaling in B cell development 
        TLRs are expressed on early hematopoietic progenitor cells that help in 
distinguishing between the self and non-self in the course of their development. 
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TLR signaling commits the differentiation of myeloid progenitors to monocytes or 
macrophages. MyD88-dependent signaling commits lymphoid biased progenitors 
to potential DCs through cytokine production that influence differentiation 
patterns (Nagai et al., 2006). An earlier study has implicated that signaling 
through TLR7/9/ MyD88 is not essential for the positive and negative selection of 
the B cell repertoire. They are however necessary for germinal center reaction and 
antigen induced activation of B cells (Silver et al., 2006). On the other hand, study 
by Isnardi et al. has identified the involvement of TLR signaling pathway during 
B cell development where expression of TLR7, TLR10, IRAK and MyD88 was 
detected in B cell fractions. They found that IRAK and MyD88 deficient B cells 
had altered receptor editing leading to B cell precursor expressing ANA. 
Moreover IRAK/MyD88/UNC93B1 deficient patients possess increased 
frequency of naïve mature autoreactive B cells in the periphery (Isnardi et al., 
2008). These data suggest the role of TLR signaling in the removal of autoreactive 
B cell lymphocytes and in maintenance of central and peripheral B cell tolerance. 
1.2.2. Autoimmune mouse models 
        Autoimmune diseases can be classified into organ specific, that target 
individual organs/tissues and systemic autoimmune diseases, characterized by 
autoantibodies against wide variety of autoantigens. The development of several 
inbred strains of mouse models, as a result of genetic and immunological 
manipulation, have contributed significantly in understanding the pathogenesis 
involved in autoimmune diseases. In spontaneous mice models, the autoimmune 
disorder develops in a given mouse strain or as a result of crosses between 
different strains, e.g non obese diabetic (NOD) mouse. In an induced model from 
physical, chemical or biological factors, the animals generally develop 
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autoimmunity, as a result of exposure to high concentrations of the self antigens 
activating an immune response. Some examples of this model are experimental 
autoimmune encephalomyelitis (EAE) for study of multiple sclerosis  and 
collagen induced arthritis to study RA (Morel, 2004).  
1.2.2.1. Systemic lupus erythematosus (SLE) 
        SLE is a complex multifactorial chronic autoimmune disease involving a 
combination factor of genetic and environmental variants. The disease is 
characterized by a systemic inflammation as a result of loss of B and T cell 
tolerance. The exact mechanism in the occurrence of the disorder is challenging to 
elucidate because of the combination of several susceptible gene loci. SLE 
presents itself depending on the humoral and cellular responses established. The 
distinct features of the disorder involve swollen joints, glomerulonephritis, 
proteinuria, skin rash and respiratory disorders. Females are more susceptible to 
the disease in both humans and mouse models of SLE. In order to understand the 
genetic and pathological features of the disease, induced and spontaneous mouse 
models of SLE have been studied. The spontaneous mouse strain models include 
the New Zealand Black and New Zealand White (NZB/W) mice, MRL/lpr mice, 
and BXSB/Yaa mice (Perry et al., 2010). Immunological manifestations in these 
mice include B cell and T cell hyper activation, production of ANAs (anti-nuclear 
autoantibodies), immune complex deposition and glomerulonephritis. Among the 
three strains BXSB/Yaa mice exhibit a more severe glomerulonephritis. The 
disease development in NZB/W mice is dependent on several susceptible genes on 
both MHC and non-MHC loci (Kotzin and Palmer, 1987); (Kono et al., 1994); 
(Rahman et al., 2002). The other two strains of the SLE model possess single gene 
mutation. The MRL/lpr mice are developed from numerous crosses of inbred 
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strains of mice. Its phenotype was characteristic to an lpr mutation of the fas gene 
located on chromosome 19. As a result, these mice show defective lymphocyte 
apoptosis leading to massive lymphadenopathy and high amounts of circulating 
immunoglobulins, including autoantibodies. The enlarged lymph nodes include 
accumulation of double negative CD4
-
CD8
-
 B220
+
 T cells. FasL gene mutation 
located on chromosome 1 also called generalized lymphoproliferative disease 
(gld) has shown to cause autoimmunity similar to that of an lpr mutation 
(Takahashi et al., 1994). Overexpression of cytokines like IL-12 and NO has been 
associated with pathogenesis in lpr syndrome (Huang et al., 1996). Also IL-4 and 
IFN γ though play opposing roles in antibody production; their isotype switching 
is indispensable in the development of autoimmunity in this spontaneous model. 
Knockout mice on either of these cytokines produce significantly reduced titers of 
their respective antibody isotypes along with decreased lymphadenopathy,end 
organ disease and early mortality (Peng et al., 1997). IFN-γ dependent 
autoimmune pathology has also been based on the hyper responsiveness of lpr/lpr 
cells to IL-18 (Neumann et al., 2001). In BXSB mice, the disease is accelerated in 
males due to mutation in the Yaa (Y linked autoimmune accelerator locus) - 
containing Y chromosome. The genetic cause for Yaa involves the translocation 
of TLR7 from the X chromosome onto the Yaa-containing Y chromosome. Along 
with abnormal B and T cell activation, these mice display monocytosis and 
lymphoid hyperplasia. Furthermore, it is the only model among the three that 
develop antibodies to nuclear components of Smith (Sm) and ribonucleoprotein. 
As a result of the genomic duplication, TLR7 ligand induced hyper responsiveness 
has been reported. However, since multiple other genes are also being duplicated, 
the exact role of this allele in accelerating the disease remains uncertain (Rottman 
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and Willis, 2010). Through TLR7 transgenic mice, TLR7 overexpression leads to 
spontaneous autoimmunity characterized by glomerulonephritis, autoantibodies to 
RNA components and dendritic cell expansion. Moreover, a reduction in the 
TLR7 gene dosage in the Yaa strain of mice abolishes their phenotype (Deane et 
al., 2007). BXSB male mice deficient in IL-21R lacks the abnormal characteristics 
of the Yaa mutant strain and seem highly resistant to the disease. This suggests the 
IL-12 signaling pathway in playing an essential role in the pathogenesis of the 
autoimmune disease in this SLE model (Bubier et al., 2009). Quantitative analyses 
have revealed the susceptibility loci of BXSB on chromosomes 1, 3, and 13 
(Bxs1-6) (Haywood et al., 2000). Some induced models of lupus include pristane 
induced model and induced graft versus host disease. Intraperitoneal injections of 
pristane into Balb/C mice generate autoantibodies and immune complex 
deposition similar to that found in MRL/lpr mice (Satoh et al., 1995). Disease is 
accelerated when pristane is administered to lupus-prone NZB/W F1 mice leading 
to enhanced IL-12 secretion and autoantibodies to nuclear components (Yoshida 
et al., 2002). The development of disease in this model is cytokine dependent as 
IL-6 or IFN-γ deficient mice abrogate the SLE phenotype but not IL-4 deficient 
mice (Richards et al., 1998); (Richards et al., 2001). Chronic graft versus host 
disease (cGVHD) is induced by the transfer of mature T cells into 
immunocompromised or semiallogenic recipient causing a cytokine storm ensuing 
a chronic GVHD (Reddy P, 2009). CD4
+  
T  knockout mice do not develop 
autoantibodies or renal disease on allogeneic splenocyte transfer highlighting the 
role of host endogenous T cells in cGVHD (Chen et al., 1998). Several potential 
targets have been identified in therapy for SLE mouse models. Some of these 
include the use of monoclonal antibodies against BAFF/BAFFR and cytokines 
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that are known to accelerate disease such as IL-6, IFN-γ and TNF-α. 
1.2.2.2. Multiple Sclerosis         
        Multiple Sclerosis is a complex inflammatory neurodegenerative disease of 
the central nervous system. Some of the major theories that explain the cause of 
MS include immunological as it is an immune mediated process, environmental 
variations, infectious agents as trigger factor and genetic predisposition. The most 
widely used and well known model of multiple sclerosis in humans is the 
experimental autoimmune encephalomyelitis (EAE) in mice or rats. The disease is 
induced in the animals by administration of myelin derived peptides in Freund’s 
complete adjuvant, such as myelin oligodendrocyte derived protein (MOG) in 
C57BL/6 mice (Farine, 1997); (Miller and Karpus, 2007). It can also be induced 
in naïve recipients by adoptive transfer of encephalitogenic T cell blasts. In the 
process, injection of the myelin antigens causes a breakdown of peripheral 
tolerance leading to myelin specific T cell activation (Perl et al., 2004).  The 
disease is
  
T cell mediated involving mononuclear cell infiltration of B cells, T 
cells and macrophages in the brain and spinal cord through the blood-brain barrier 
(Perl et al., 2004), by the help of expression of integrins (Yednock et al., 1992). 
These infiltrating cells produce inflammatory cytokines and reactive oxygen 
species that lead to the destruction of neuronal myelin sheath. The passive form of 
induction of EAE that involves adoptive transfer of T cells from immunized 
animals, helps in directly understanding the effector phase of the disease in the 
CNS (Katsnelson, 2012). Theiler’s Murine Encephalitis Virus-Induced 
Demyelinating Disease (TMEV-IDD) is another related murine model for MS. 
The principal mononuclear cells infected as a result of the virus are the 
macrophages or the oligodendrocytes (Clatch et al., 1990). Owing to the 
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complexity of the disease, EAE has its own limitations, however, these mouse 
models of demyelinating disease have played a significant role in better 
characterizing the T cell mediated demyelination and CNS tissue injury.  
1.2.2.3. Type1 diabetes (T1D) 
        Type1 diabetes mellitus also called juvenile diabetes (because of its early 
onset of age) is another chronic organ specific autoimmune disorder that occurs in 
genetically susceptible individuals through environmental factors. The disease is 
due to the lack of insulin as a result of damage to the pancreatic β cells. The 
inflammatory infiltrate in insulitis compromises mainly mononuclear cells, CD4
+
 
and CD8
+
 T cells. The cause of destruction of the β cells has been strongly linked 
to the highly polymorphic HLA class II molecules. Some of the autoantigens 
recognized by the islet cell antibodies are the glutamic acid decarboxylase 
(GAD65), protein tyrosine phosphatase–like molecule (IA-2) and thirdly insulin 
protein. This has made possible it to identify individuals who are at a high risk of 
developing T1D, before the clinical symptoms come in play. However, the 
contribution of these antibodies in the pathogenesis is not clearly understood 
(Notkins and Lernmark, 2001). The best known models of human type1 diabetes 
in rodents are the non-obese diabetic (NOD) mouse and the BioBreeding (BB) rat. 
The susceptibility to T1D in the NOD mice has been linked to the genetic loci of 
the insulin-dependent diabetes (Idd) region, compromising multiple genes, 
highlighting a large number of potential targets in the development of the disease 
(Driver et al., 2010). In the spleen and lymph nodes of the NOD mice, the reactive 
T cell clones to the islets has been known to be from both CD4
+ 
T and CD8
+ 
T 
cells (Van Belle et al., 2009). In the NOD mice IL-2 defective production leads to 
intra-islet Treg cell dysfunction, causing a breakdown of peripheral tolerance 
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establishing a loss of balance between Treg cells and Teffector cells (Tang et al., 
2008). Another susceptibility of the NOD mice to the disease, is the variation in 
the CTLA-4 gene that correlated with low mRNA levels of the CTLA-4 splicing, 
contributing to the tissue damage (Ueda et al., 2003). The effector functions of β 
cell autoreactive CD8
+
 T cells are MHCI dependent and can be negatively 
selected by interaction with MHCII variants (Serreze et al., 2004). 
Cyclophosphamide, when administered at high doses in NOD mice, leads to an 
aggravation of T1D and this has been associated with reduced CD4
+
CD25
+
Foxp3
+
 
Treg population (Brode et al., 2006). A pathogen induced model of diabetes is the 
lymphocytic choriomeningitis virus (LCMV) infection of the RIP-GP transgenic 
mice under the control of the rat insulin promoter that result in the LCMV 
glycoprotein expression in the pancreatic cells. As a result, the virus specific T 
cells recognize the infected cells as well as the glycoprotein from the β cells 
leading to an immune attack on these cells, causing an instant progress of the 
disease (Van Belle et al., 2009). The NOD is the best used model to understand 
the genetic causes of the human disease as well as to reverse the disease after 
hyperglycemia appears. The disease can be prevented by cytokine alteration or by 
activation of Treg suppressor cells so as to hinder effector cell functions (Farine, 
1997). 
1.2.2.4. Rheumatoid arthritis (RA) 
        RA is a heterogenous disease involving induced and spontaneous synovial 
inflammation. No single gene is responsible for the expression of the disease due 
to the polygenic genetic susceptibility, but genetics contributes to the overall 
disease. Several inflammatory cytokines, like TNF-α, IL-1 and IL-6, are expressed 
at high levels in the joints of individuals with RA (Lindqvist et al., 2002). 
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Genetically, RA is linked with MHCII molecule HLA-DR4. The MrL/l mice 
developed first by Murphy and Roths is a useful model for SLE, as mentioned 
earlier. These mice exhibited IgM and IgG related rheumatoid factors (RF) and 
polyarthritis, along with histological evidence of joint inflammation which are 
among the features of human RA. The synovial immune response is a result of 
interaction between T cells, B cells and macrophages and the joint disease was 
closely linked with increase amounts of IgM RF and joint pathology (Hang et al., 
1982). Other transgenic mouse models that develop RA spontaneously are 
(a) K/BxN mice in which immune response is elicited to enzyme G6P1 in a T cell 
dependent manner and (b) human-TNF transgenic mice that express excess TNF-α 
that is involved in the pathogenesis of arthritis (Bevaart et al., 2010). Some of the 
induced animal models that have proved to be efficient in the study of RA in 
humans are rat adjuvant arthritis, rat type II collagen arthritis and mouse type II 
collagen arthritis. Adjuvant arthritis is developed by injecting mycobacterium in a 
Freund’s adjuvant like mineral oil in the tail of the male Lewis rats (Farine, 1997). 
Though this model develops robust polyarticular inflammation, it also shows bone 
resorption and periosteal bone formation. The bone resorption can be inhibited by 
inhibition of IL-1 in this model. In rat type II collagen arthritis, an emulsion of 
bovine type II collagen in adjuvant is intradermally injected. This type of arthritis 
is characterized by cartilage damage, immune complex deposits, bone resorption 
and proliferation which are mediated by both B cells and T cells. Treatments with 
soluble TNFR and IL-1ra have been useful as combination therapies (Bendele, 
2001); (Bendele et al., 2000). This treatment is also useful for the other RA mouse 
model of mouse type II collagen arthritis. In this model, the susceptibility has 
been linked to the expression of MHCII haplotypes, particularly the H-2
q
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haplotype (Bevaart et al., 2010). Another joint specific antigen like cartilage 
proteoglycan is a candidate for inducing arthritis in mice in a Th1 cell mediated 
disease and it resembles RA both genetically and pathologically (Otto et al., 
2000). Several treatments for RA have been approved some of which are the use 
of cytokine inhibitors (against TNF-α, IL-6, IL-1) as well as T cell targeted 
therapies. 
1.2.3. Influence of infections in the development of autoimmunity 
        As we know, several environmental and genetic factors contribute to the 
development of immune response to self antigens in the host body. Among the 
environmental factors, infectious agents play a role as triggers of autoimmunity. 
Cells of innate immune system, like the antigen presenting cells and B cells 
possess receptors on the surface which can recognize or bind to the molecular 
patterns of the pathogen. For an adaptive immune response to occur, an antigen 
specific and a non-antigen specific signal is required. The antigen specific signal 
is through the concept of molecular mimicry in which the antigenic patterns of the 
invading pathogen resembles/mimics the antigenic determinants/self peptides of 
the host tissue (Rose and Mackay, 2000). Such an infection causes the activation 
of the local APCs, which in turn leads to the presentation of the self peptides. This 
presentation results in the activation and expansion of T cells that cross react to 
the self antigen, directly lyse the tissue cells and produce cytokines that activate 
cells like macrophages and further mediate tissue damage and activate pathogen 
specific B cells. This effect can also lead to the phenomenon of ‘epitope 
spreading’ in the case of chronic infection of target organs or in chronic 
autoimmune diseases. In this phenomenon an immune response that is initiated by 
the existing pathogen or direct lysis by the pathogen leads to tissue damage. These 
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antigens released from the injured tissue are engulfed by the APCs eliciting an 
expanded immune response to the protein, leading to an intramolecular or 
intermolecular epitope spreading of different self antigens. Acute phase proteins, 
such as complement proteins, opsonize the micro-organism and have the ability to 
bind to cellular debris of apoptotic cells, thus activating an antibody mediated 
effector response (Gregersen and Behrens, 2006). In bystander activation, 
pathogen specific T cells once activated, cause inflammation that injures the host 
tissue and activates autoreactive T cells in a non-host specific manner (Delogu et 
al., 2011). Another way that infections can lead to autoimmune response is 
through changes in protein (post translational modification, misfolding or 
mutations due to oxidative stress/free radical production) and exposure of cryptic 
antigens to T cells that have escaped central and peripheral tolerance which were 
invisible to the immune system and have now become immunogenic (Sfriso et al., 
2010). Proteins produced from microorganisms of bacteria, mycoplasma and virus 
infected cells, called superantigens can directly bind to the TCR, regardless of 
antigen specificities, resulting in the activation of a large number of T cells of 
different antigenic specificities and functioning as a strong immune stimulating 
molecule (Samarkos and Vaiopoulos, 2005). Overproduction of various 
inflammatory cytokines including type1 interferon enhances the adaptive immune 
responses. Viruses are known to initiate signaling through endogenous PRRs, 
eliciting type1 IFN cytokines that have been associated with various autoimmune 
diseases.  
        One of the well-known associations of autoimmunity in humans is infections 
with viruses and bacteria. The concept of molecular mimicry was first noted in the 
1980s where, by using monoclonal antibodies it was determined that the measles 
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virus phosphoprotein and a human simplex virus (HSV) protein cross reacted with 
different antigenic determinants of the intermediate filament protein in humans 
(Fujinami et al., 1983). Human cytomegalovirus (HCMV) is a common 
opportunistic pathogen with a long latency that targets several immune cells. This 
virus induces immunological abnormalities like RF, ANAs and cryoglobulins and 
lymphocytosis that has been linked to autoimmune diseases like RA, Sjodren’s 
syndrome, Crohn’s disease and others. Increase disease activity in SLE patients 
has also been associated with increase viral activity (Sfriso et al., 2010). In one 
finding, about 15% of patients with T1D showed  the presence of HCMVin the 
lymphocytes which induces islet cell-specific antibodies that react with the human 
islet cell protein (Pak et al., 1990). Through the mechanism of molecular mimicry 
the epitope derived from the HCMV once processed and presented by the DCs is 
recognized by GAD65 cross-reactive T cells (Hiemstra et al., 2001). A possible 
association of Coxsackie B virus (CVB) with T1D has been suggested due to T 
cell cross reactivity of GAD amino acid (enzyme expressed in the brain and β 
cells in the pancreas) and P2-C protein (involved in viral replication) of the virus 
due to their sequence similarity (stretch of 6 amino acid sequences) (Samarkos 
and Vaiopoulos, 2005); (Tian et al., 1994). In rheumatic fever, infection with 
Group A Streptococcus can lead to inflammation of the heart where myosin in the 
heart has been known to be the dominant autoantigen. In this disease peripheral T 
cell clones against the Streptococcal M protein were established to be cross 
reactive and hence, proliferate in response to human myosin and laminin (Ellis et 
al., 2005). Monoclonal antibodies that recognize the M protein and Streptococcus 
carbohydrate epitope GlcNAc (Adderson et al., 1998) also cross-react with 
myosin as well as DNA and keratin which was confirmed by the affinity of the 
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non-myosin specific purified Abs from rheumatic fever patients to the myosin 
proteins (Cunningham et al., 1988). Further supporting the concept of molecular 
mimicry, Lunardi and group in their study identified a sequence of peptide that 
shared homology with the VP1 protein of HCMV and human cytokeratin as well 
as transcription factor GATA1 (Lunardi et al., 2008). GATA1 plays a crucial role 
in megakaryopoiesis and erythropoiesis. The antiviral peptide antibodies were also 
specific to collagen type II, single-stranded DNA, and cardiolipin (Sfriso et al., 
2010). Significant homology has been revealed between the myelin basic protein 
and nucleoprotein of the hemagglutinin of influenza virus, hepatitis B virus 
polymerase and others (Oldstone, 1998). In a murine model of herpes simplex 
keratitis (HSK), local infection of HSV leads to inflammatory T mediated disease 
in the cornea. Similarly in a murine myocarditis model, induction of Chlamydial 
peptides that shared a similar sequence with the myosin peptide, caused 
inflammatory heart disease in BALB/c mice (Wucherpfennig, 2001); (Bachmaier 
et al., 1999). Another study revealed the neutralizing effects of monoclonal 
antibodies against myocardial CVB3. These antibodies can recognize 
discontinuous epitopes on the viral capsid proteins as well as human/mouse 
cardiac myosin and cardiac fibroblast, inducing chronic myocardial inflammation 
(Gauntt et al., 1995). 
        Superantigens are able to bind to a range of class II MHC molecules and 
TCR in a Vβ specific manner. Epstein Barr virus causes a lymphoproliferating 
disease that leads to vast T cell activation of human VI3
+ 
T cells due to possible 
induction of K18.3 that possess superantigenic properties (Sutkowski et al., 1996). 
Staphylococcal toxic shock syndrome toxin-1 and staphylococcal enterotoxin A 
are the most commonly secreted T cell superantigens of the bacteria which 
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additionally produce protein A, which is a B cell superantigen (Staphylococcus 
aureus nasal carriage in rheumatoid arthritis). In one study, chronic exposure to 
small amounts of superantigen-producing Staphylococcus aureus caused an 
inflammatory systemic disease similar to SLE, characterized by infiltration of 
mononuclear cells predominantly CD4
+ 
T cells bearing TCR Vβ8 accompanied by 
ANAs and glomerular deposits (Chowdhary et al., 2012). The enterotoxin A can 
also trigger encephalitogenic MBP-specific non-Vβ8+ T cells to cause 
experimental allergic EAE in PL/J mice (Soos et al., 1995). In chronic diseases 
like Crohn’s disease, the role of superantigens have been emphasized due to the 
increased percentages of Vβ8+ T cells in the mesenteric lymph nodes that drain the 
inflammatory lesions (Posnett et al., 1990). In one finding Crohn’s disease has 
been associated with I2 bacterial gene sequence that could be linked with disease 
pathogenesis in patients (Sutton et al., 2000). This was confirmed in mice where 
I2 was evidenced as a superantigenic stimulus that is a target of CD4
+  
Treg type 
cells (Dalwadi et al., 2001). Some superantigens are also virally encoded such as 
the protein coded by the open reading frame (ORF) gene of MMTV (Kay, 1995). 
        In other modes of development of autoimmunity from infections, Coxsackie 
virus B3 can infect and lyse the cardiac myocytes directly, causing myocardial 
destruction in SCID mice that can lead to autoimmunity through epitope 
spreading. TMEV virus, a natural mouse pathogen, has been known to induce 
CD4
+  
T cell mediated demyelinating autoimmune disease due to the release of 
sequestered self-antigens that activate T cells which initially react to an 
immunodominant peptide from PLP and later to peptides from myelin basic 
protein and myelin oligodendrocyte (Miller et al., 1997). 
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1.2.4. Influence of innate immunity in development of autoimmune diseases 
        An over activated response of the immune system to endogenous and 
exogenous ligands contribute to the development of autoimmunity. A large 
number of published data have established the involvement of the innate immune 
system, particularly the TLRs, in the pathophysiology of autoimmune diseases. 
Pattern recognition receptors like TLRs present on innate immune cells recognize 
PAMPs and signal through the common adaptor MyD88 molecule, except for 
TLR3 that signals in a MyD88 independent manner, leading to the downstream 
transcription of interferon inducible genes (Interferon α/β). TLR9 recognizes 
hypomethylated CpG motifs and TLR7 identifies viral ssRNA. Other intracellular 
non TLR associated cytoplasmic receptors, like MDA-5 and RIG-1, recognize 
viral components of dsDNA/dsRNA and activate the innate immune system. 
Damage associated molecular patterns (DAMPs) released from dying cells contain 
high mobility group box1, heat shock proteins, uric acid and other proteins which 
function as alarmins and signal through TLRs inducing an inflammatory response. 
Pathogen mediated cell damage or damage as a result of action of cytotoxic 
lymphocytes, can enhance the antigen processing of the self peptides and increase 
expression of costimulatory molecules that effectively activate the T cell 
responses. Peripheral tolerance and activation of autoreactive T cells strongly 
depend on the innate immune cell activation. 
        Some studies have highlighted the role of signaling through TLR3, TLR7 and 
TLR9 in the production of autoantibodies and development of autoimmunity in 
animal models of SLE. TLR3 expression was revealed in the glomerular 
mesangial cells of the MRL/lpr mice and on injection with viral dsRNA, the 
ligand was taken up by the mesangial cells and the infiltrating immune cells. This 
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leads to an increase in the serum cytokine levels of IL-6, IL-12p70, and            
IFN-α, eventually aggravating renal damage and proteinuria in the autoimmune 
mice (Patole et al., 2005). TLR7 and TLR9 have been closely associated with 
disease pathogenesis in SLE, one reason for this is their contribution to IFN-α 
production. In a model of AM14 B cell transgenic cell line, immune complex 
containing DNA/RNA gets internalized and the complex that triggers TLR7/9 
results in B cell activation and early autoantibody production. Dual TLR and BCR 
signaling have been implicated in the activation of auto-reactive B cells in AM14 
B cells activation through MyD88 dependent TLR9 signaling (Rawlings et al., 
2012). A class of immature dendritic cells, called plasmacytoid DCs expressing 
both TLR7 and TLR9 take up SLE-associated immune complex, leading to high 
levels of IFN-α production. The FcγR-mediated nucleic acid delivery to the 
TLR7/TLR9 of the DCs plays a vital role in the pathogenesis of SLE (Marshak-
Rothstein, 2006). The influence of TLR9 in autoimmune MRL/lpr mice has been 
conflicting in various published data. TLR9 deficient lpr mice display a different 
HEp-2 immunofluroscent staining pattern consisting of a nuclear speckled pattern 
(antibodies reactive to snRNPs), However, a homogenous one is observed in the 
TLR9-intact lpr mice (Marshak-Rothstein and Rifkin, 2007). TLR9
-/-
 MRL/lpr 
mice have increased autoantibody titers with massive lymphadenopathy, severe 
renal disease, proteinuria and mortality in comparison to the TLR9-sufficient mice 
suggesting a protective role in TLR9 signaling through a potential Treg cell 
function (Wu and Peng, 2006). A Yaa mutation results in expression of double the 
levels of TLR7 that drives the B6.Sle1.Yaa mice to produce high titers of IgG 
autoantibodies to RNA-associated autoantigens and increased numbers of 
activated T cells, mononuclear neutrophils and monocytes (Marshak-Rothstein 
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and Rifkin, 2007). In several lupus prone mouse models, deficiency of MyD88 
abrogates the disease. One of the examples is an SLE mouse model that involves a 
single mutation of the protein tyrosine Lyn gene (a negative regulator of BCR 
signaling). In this model, disrupting the MyD88 signaling completely abolished 
the IgG autoantibodies to nuclear antigens along with prevention of splenomegaly 
and glomerulonephritis. A reduction in these mice serum antibody titers of IgM 
and IgG2a similar to those of the wild-type mice, was reported with decreased 
expression of maturation markers in dendritic cells and CD4
+ 
 T cell populations 
when compared to the Lyn
-/-
 mice (Silver et al., 2007). Teichmann and colleagues, 
established the role of MyD88 in B cells but not in DCs in the progression of 
lupus using the MRL.Fas
lpr 
model. Moreover, the frequency of follicular T helper 
cells as well as IFN-γ producing CD4+ T cells were substantially reduced in 
MyD88 deficient B cell and DCs in the lupus mice (Teichmann et al., 2013).  
        Other biologically active autoantigens include heat shock proteins (hsp), 
glucosaminoglycans, high mobility group box 1 (HMGB1) and others. In one 
study generation of hsp, gp96 cell surface expressing transgenic mice develop 
hyper functional and over activated DCs in a MyD88 dependent manner leading to 
spontaneous development of SLE like autoimmune disease (Liu et al., 2003). 
Antibodies to Hsp60 and Hsp90 are commonly present in patients with SLE. High 
mobility group box1 is a DNA binding protein that facilitates transcription and its 
exposure to neutrophils/macrophages leads to increased production of 
inflammatory cytokines through increased nuclear translocation of NF-ƘB. 
HMGB induced activation of the myeloid cells has been demonstrated to involve 
the interaction with TLR2 and TLR4 that generates inflammatory responses (Park 
et al., 2004). 
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        In other autoimmune models such as autoimmune myocarditis, depletion of 
C3 leads to reduced production of IL-1 and TNF-α and prevents the development 
of the disease. The same model revealed a subset of CD44
high 
CD62L
low
 
expressing complement receptors (CR1 and CR2), that are involved in the 
activation of T cells through the upregulation of costimulatory molecules, 
highlighting the role of complement pathway in the induction of myocarditis 
(Zouali et al., 2005). In EAE mice models, complete resistance to the disease was 
observed in MyD88
-/-
 mice along with absence of proinflammatory cytokines and 
hence, no brain inflammation. Though TLR2 is dispensable for induction of EAE, 
absence of TLR4 aggravated the disease (Marta, 2009). Moreover, TLR4 and 
TLR9 have a regulatory role in this Th17 mediated autoimmune disease where 
TLR4
-/-
 and TLR9
-/-
 mice possess increased expression of IL-6 and IL-23, whereas 
absence of MyD88 exhibited reduced levels of these cytokines along with IL-17 
(Marta et al., 2008). Several in vitro and emerging in vivo research have 
highlighted the role of TLRs in disease progression and appropriate manipulation 
of these components in the treatment of chronic inflammatory conditions. 
1.3. TLRs and their role in microbial infections 
        TLRs can bind to multiple components of bacterial cell wall such as 
recognition of LPS of Gram-negative bacteria by TLR4, peptidoglycan from 
Gram-positive bacteria (detected by TLR2), lipoarabinomannan (LAM) from 
mycobacteria (detected by TLR2), diacyl or triacyl lipopeptides from bacteria, 
mycobacteria and mycoplasma (detected by TLR2/1 or TLR2/6), flagellin from 
flagellated bacteria (detected by TLR5) and genomic DNA rich in unmethylated 
CpG DNA (detected by TLR9) from bacteria (Kumar et al., 2009). Ligand binding                                                                                                                                                           
leads to activation of antigen presenting macrophages and DCs that can recognize 
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these ligands through the TLRs. This also directs their maturation to professional 
APCs which initiates the adaptive immune response.  
        TLR2 plays a potent role in detecting Gram-positive bacterial components 
particularly peptidoglycans and lipoproteins that are potent immunostimulants. 
Infections with Staphylococcus aureus or Streptococcus pneumoniae caused 
increased morbidity in TLR2
-/-
 mice (Takeuchi et al., 1999); (Echchannaoui et al., 
2002). TLR2 reportedly has also shown to detect LPS in non enterobacteria such 
as Porphyromonas gingivalis and Helicobacter pyroli but the LPS they detect is 
structurally different from the typical LPS of Gram-negative bacteria (Hirschfeld 
et al., 2001); (Smith et al., 2003). TLR2 identifies a large range of microbial 
components as they form heterophilic dimers with other structurally related TLRs 
like TLR1/ TLR6. Impaired TLR2 function in murine macrophages using gene 
knockouts or antibody blocking, on exposure to the bacterial cell wall components 
lead to diminished production of TNF-α and IL-6, in comparison to the normal 
cells (Takeuchi et al., 1999); (Takeuchi et al., 2000); (Torres et al., 2004). Thus 
several studies have demonstrated that TLR2-MyD88 dependent signaling 
contribute significantly to host resistance. 
        LPS endotoxin, a major constituent of the outer wall of Gram-negative 
bacteria interacts with CD14 (a soluble protein) and MD-2 (myeloid 
differentiating factor 2) to bind to TLR4 and activates signaling through MyD88, 
inducing a strong inflammatory response. TLR4 mutations have found to be 
associated with hyporesponsiveness to LPS (Hoshino et al., 1999). TLR4 mutant 
mice (C3H/HeJ mice) were highly susceptible to Mycobacterium tuberculosis 
infection due to impaired macrophage recruitment and proinflammatory cytokine 
response, leading to chronic infection of the bacteria (Abel et al., 2002). Impaired 
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phagosome maturation has been observed in the absence of signaling through 
MyD88 or TLR2/4 (Blander and Medzhitov, 2004). Infection with Candida 
albicans in TLR4 null mice exhibited reduced macrophage inflammatory protein-
2 (Mip-2) and chemokine secretion (Netea et al., 2002). Moreover, a vast number 
of gene expression in the lung as a result of Klebsiella pneumonia infection, is 
controlled by TLR signaling that provides host survival (Schurr et al., 2005). On 
the other hand, in response to LPS, MyD88 independent pathway has been found 
to be activated in MyD88 deficient cells. These cells activate IRF3 which induce 
production of IFN inducible genes. However, MyD88 dependent pathway is 
crucial for the production of inflammatory cytokines to LPS through TLR4 
signaling (Kawai et al., 2001). 
        Other TLRs, like TLR9 in co-operation with TLR2 have been found to 
provide effective resistance to M. tuberculosis infection, with inflammatory 
cytokine responses (IL-12p40, TNF, and IFN-α) and IFN-γ production (by CD4+ 
T cells) to be largely TLR9 dependent (Bafica et al., 2005). NF-ƘB activation and 
chemokine gene expression to Helicobacter pyroli infection requires expression of 
TLR2 and TLR5 (Smith et al., 2003). In some infections like Borrelia 
burgdorferi, MyD88 signaling is critical for control of pathogen burden (Liu et al., 
2004). Control of intracellular bacteria like Brucella, is also largely dependent on 
MyD88 for efficient pro-inflammatory cytokine production like TNF-α and        
IL-12p40 from DCs. This adaptor molecule is also crucial for DC maturation and 
activation that is essential for IFN-γ production by antigen specific T cells 
(Macedo et al., 2008). In Chlamydial muridarum infection, reduction in IFN-γ 
levels in natural killer cells has been associated with reduced inflammatory 
cytokines, as a result of lack of MyD88 (Nagarajan et al., 2011). Several in vitro 
34 
 
studies and in vivo studies have demonstrated the function of TLRs in recognition 
of Salmonella PAMPs and their response through the induction of pro-
inflammatory cytokine gene expression. Previously, we have confirmed the role of 
signaling through TLRs in the survival of MyD88 deficient mice to both oral and 
intraperitoneal infection with an attenuated strain of Salmonella Typhimurium 
(Issac et al., 2013).  
1.4. Salmonella infection 
        Salmonella of the family enterobacteriaceae are Gram-negative, flagellated, 
rod shaped, facultative intracellular bacteria first discovered in 1885 in pigs. 
About 2500 strains of the bacteria have been identified, most of which are 
pathogenic. The bacilli vary depending on their capsular antigen, flagellar 
antigens or envelope antigens. Salmonella species cause typhoid fever and 
gastroenteritis in humans and front a worldwide threat to human health.                
S. choleraesuis is associated with bacteremia, S. typhi and S. paratyphi which 
produce enteric fever and S. Typhimurium and S. entiriditis which produce 
gastroenteritis. Typhoid fever is the best studied enteric fever caused by S. typhi. 
S. typhi infects approximately 20 million people per year and is responsible for 
about 200,000 deaths per year (Broz et al., 2011). Infection is characterized by 
fever, abdominal pain and diarrhea within 6-72 hours that continues up to a week. 
Salmonella enteric species are generally contracted through contaminated poultry 
food or fruits and vegetables. With the increasing number of Salmonella strains, 
an emerging concern is their resistance to multiple antibiotics used to control or 
prevent it. So far multi-drug resistant Salmonella strains have been found to be 
resistant to fluroquinolones and third generation cephalosporins (World health 
organization 10-14). Infection of Salmonella enterica serotype Typhimurium in 
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mice results in a disease that resembles human enteric fever disease and is a 
widely used model for the study of systemic Salmonella infection in humans.  
        The first stage of the infection which lasts for a few hours, involves rapid 
clearance of the bacteria from the blood by phagocytic cells of the spleen and 
liver, where large number of organisms are killed due to the bactericidal activity 
of macrophages. In the second phase of infection, bacteria that have survived 
undergo intracellular multiplication in the target organs and an exponential growth 
phase occurs which is characterized by the production of inflammatory cytokines 
like TNFα and IFN-γ that is vital for the induction of macrophage bactericidal 
activity to suppress infection (Mittrucker and Kaufmann, 2000); (Sebastiani et al., 
2002). The host is then able to curb the bacterial growth and reach a plateau phase 
with high bacteria levels. Once the acquired immunity involving both B cells and 
T cells develop, particularly the activation and expansion of Th1 cells the bacterial 
infection is efficiently cleared. The main route of entry is through specialized 
epithelial cells of the Peyer’s patches called M cells. Salmonella then further 
propagates to the mesenteric lymph nodes and eventually through the blood 
stream to the spleen and liver causing disease. In the initial stages of bacterial 
infection after ingestion of contaminated food, bacteria adhere and cause 
subsequent invasion in the intestine. Bacterial adherence is mediated through 
type1 and type IV fimbriae, autotransporter adhesins as well as type 1 repetitive 
adhesins (Linke et al., 2011). Salmonella gain access into the macrophages 
through phagocytosis and receptor mediated uptake. Alongside, the injection of 
the secretory proteins by the bacteria enhances uptake and drives internalization 
(Finlay and Brumell, 2000). Virulence proteins called type3 secretion system 
(T3SS) encoded by Salmonella pathogenicity island (SPI) promote bacterial 
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uptake into the host cells and its survival. T3SS coded by SPI-1 in the intestinal 
lumen is involved in bacterial invasion into the epithelial cells and host cells, 
while T3SS encoded by SPI-2 is involved in the systemic phase of intracellular 
bacterial replication and survival as well as dissemination to the organs (Salcedo 
et al., 2001). Proteins coded by SPI-2 inhibit the fusion of Salmonella containing 
vacuoles in the macrophages with the lysosomes and endosomes (Uchiya et al., 
1999); (Tobar et al., 2006). This is facilitated by the ability of the SPI-2 TSS to 
thwart the NADPH oxidase assembly at the phagosomal membrane thus evading 
oxidative damage (Gallois et al., 2001). The effector proteins also counteract the 
localization of iNOS to the Salmonella containing vacuole thus, avoiding death by 
the combined microbicidal effect of reactive oxygen and nitrogen species 
(Chakravortty et al., 2002). The induction of these proteins plays a vital role in 
determining the virulence of Salmonella and its systemic spread into the host 
tissues. 
        Several mouse strains vary in their susceptibility to Salmonella infection 
depending upon their status of their Nramp1 (natural resistance-associated 
macrophage protein 1) gene expression. This macrophage specific transmembrane 
protein acts as a channel for divalent cations into the phagosome and controls 
intracellular microbial replication during the early phase of infection. A wild-type 
allele of the gene is present in the mouse strains of C3H and 129, while C57BL/6 
and BALB/c carry a mutant allele of the gene making them 1000 fold more 
susceptible to Salmonella infection (al-Ramadi et al., 2001); (al-Ramadi et al., 
2002); (al-Ramadi et al., 2004); (Gerold et al., 2007). The Nramp1 gene provides 
natural resistance to several intracellular infections and any mutation in the gene 
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reduces the efficacy to kill the pathogen and thus has been associated with 
increased susceptibility (Skamene et al., 1998). 
1.5. Role of TLRs in Salmonella infections and its association with 
autoimmunity 
        The main ligands of Salmonella that recognize and activate TLRs are the 
lipopolysaccharide, lipoproteins, CpG DNA and flagellin which are  recognized 
by TLR4, TLR2, TLR9 and TLR5 respectively (Hoshino et al., 1999); (Gewirtz et 
al., 2001); (Feuillet et al., 2006); (O'Brien et al., 1980); (Vazquez-Torres et al., 
2004). Csg component of the fimbriae that forms a structural characteristic of 
Salmonella Typhimurium is recognized by TLR2, eliciting an IL-8 host immune 
response (Tukel et al., 2005). LPS was postulated to being the major virulence 
factor since direct injection of LPS into the blood stream caused shock. Endotoxin 
containing LPS and BLP of Gram-negative bacteria can induce a strong 
inflammatory response. TLR4 responds to LPS-binding protein in association with 
CD14 and MD-2 proteins (Vazquez-Torres et al., 2004). A dominant missense 
mutation in TLR4 signaling in C3H/HeJ strain leads to impaired production of 
TNF-α, a cytokine that is crucial for protective function in response to Salmonella 
infection, when compared to wild-type mice (Li and Cherayil, 2003). TLR4
-/-
 mice 
were more susceptible to infection than TLR2
-/-
 mice which were similar to the 
WT mice, suggesting that TLR4 seems to a dominant role over TLR2, mainly due 
to its earlier expression in the immune response to Salmonella. However, MyD88
-
/-
 mice harbored the most bacterial burden due to defective macrophage killing and 
TNF-α production (Weiss et al., 2004). Moreover, TLR4 signaling through 
MyD88 and not TRIF, is essential for protection by establishing a plateau phase of 
bacterial growth in the typhoid model, as negligible levels of NO and TNF-α 
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production were observed in MyD88
-/- 
mice (Talbot et al., 2009). Activation of 
TLR9 enhances the antigen presentation by DCs and killing of Salmonella 
organisms in a ROS dependent manner (Lahiri et al., 2010). Furthermore, 
interaction of TLR5 of the lamina propria DCs with the Salmonella organisms, 
mediate migration of the bacteria across intestinal mucosa to the mesenteric 
lymph nodes (Uematsu et al., 2006). On the other hand, TLR11 blocks the entry of 
highly invasive Salmonella into the murine Peyer’s patch and the systemic spread, 
highlighting the potential of TLR11
-/-
 mice as S. Typhimurium murine model (Shi 
et al., 2012). Interestingly, a study has also shown that S. Typhimurium failed to 
form Salmonella containing vacuole and multiply in TLR2/4/9
-/-
 and MyD88
-/- 
bone marrow derived macrophages, suggesting a pre-requisite of TLR signaling in 
the induction of virulent gene expression for bacterial survival (Arpaia et al., 
2011b). Furthermore, inflammation in Salmonella colitis as a result of induction 
of T3SS by SPI-2, is solely dependent on MyD88 signaling while SPI-1 induced 
T3SS causes inflammation in a MyD88 independent manner (Hapfelmeier et al., 
2005).  
        MyD88 as an adaptor molecule, plays a crucial role in the acute phase of 
infection as MyD88
-/-
 mice are hyper-susceptible to even an infection with an 
attenuated strain of S. Typhimurium, due to increased bacterial burden in target 
organs, delayed recruitment of phagocytes and production of inflammatory 
cytokines (Issac et al., 2013). Several studies have confirmed the generation of 
antibody responses to S. Typhimurium, even in TLR mutant mice strains. 
Generally, Salmonella infection in wild-type mice is characterized by a Th1 
mediated IFN-γ response that drives B cells to the production of IgG3 and IgG2c 
humoral response. However, enhanced Salmonella specific IgG1 responses were 
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found to take place independently of signaling through MyD88 and TLR4 (Seibert 
et al., 2010). This was confirmed in another study where oral infection with 
recombinant attenuated S. Typhimurium (RASV) elicited dominant Th2 responses 
in MyD88
-/-
 mice, suggesting that signaling through the adaptor molecule may be 
dispensable for induction of LPS specific antibody responses (Ko et al., 2009). 
Moreover, in our previous study we verified dysregulated Salmonella specific 
antibody responses of all isotypes (both Th1 and Th2 responses) being produced 
in the MyD88 deficient mice in response to intraperitoneal infection of 
Salmonella, establishing a state of hypergammaglobulinemia. The memory T cells 
produced as a result of the bacterial dose, however failed to protect the MyD88 
knockout mice on a challenge to the virulent strain of the bacteria, further 
emphasizing the vitality of efficient signaling through the MyD88 for protection 
against Salmonella infection (Issac et al., 2013). 
        Several studies, as briefly described earlier, have confirmed TLRs to be 
actively involved in the pathogenesis of autoimmune diseases. Irrespective of the 
specificity of B cell receptor, TLR expression in B cells activates autoreactive B 
cells in autoantibody production (Soulas et al., 2005). A dramatic IgM 
hypergammaglobulinemia response, as a result of B cell hyper activation was 
observed in MyD88
-/-
 mice, in response to Borrelia burgdorferi infection. This 
contributed to autoreactivity of IgM antibodies to autoantigens at levels similar to 
those observed in a lupus prone MRL/lpr mouse strain (Woods et al., 2008). 
Similarly, oral administration of RASV in MyD88
-/-
 mice induces hyper-IgG 
autoimmune response in a T cell dependent manner, involving increased dsDNA 
autoantibody levels along with deposition of immune complex in the kidneys. 
Oral infection also leads to systemic inflammation characterized by increased 
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levels of inflammatory cytokines from enhanced inflammatory myeloid cell 
populations along with expansion of the B cell and T cell compartment 
compartment (Ko et al., 2011). 
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2. AIMS OF THE THESIS 
The overall aims of the thesis were to understand the potential mechanism 
involved in the observed phenomenon of hypergammaglobulinemia and to test the 
loss of immunological self-tolerance in MyD88-deficient mice following infection 
with Salmonella Typhimurium.  
The specific aims were: 
1. To define the underlying mechanisms involved in the induction of 
hypergammaglobulinemia in mice lacking MyD88 following infection with 
attenuated S. Typhimurium. 
2. To characterize the extent and specificities of autoantibody production in 
Salmonella-infected MyD88
-/-
 mice and define the parameters required for 
their synthesis.   
3. To uncover the cellular and molecular mechanisms responsible for the 
dysregulated antibody production.  
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3. MATERIALS AND METHODS 
3.1. Materials 
3.1.1. Summary of materials used and suppliers: 
Materials Company 
PBS (-CaCl2 – MgCl2) GIBCO 
10X PBS (-CaCl2 – MgCl2) GIBCO 
BSA Sigma 
SS Agar Mast Group 
Trypticase soy agar Mast Group 
Trypticase soy broth Oxoid 
RPMI 1640 medium (-L glutamine) HyClone 
Ethanol Carlo Erba 
H2SO4 Readel-de Haen 
Tryptan blue solution (0.4%) Sigma 
DPX Panreac 
Ampicillin Sigma 
Streptomycin Sigma 
NaCl Panreac 
NaH2PO4. H2O Panreac 
Na2HPO4 Panreac 
Na2CO3 AnalaR 
NaN3 AnalaR 
NaHCO3 GibcoBRL 
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NH4CL Sigma 
KHCO3 Sigma 
EDTA Sigma 
H3BO3 Sigma 
96 well Maxisorp nunc immuno plate Thermo Scientific 
24 well tissue culture plates Becton Dickenson 
96 well Microtest U bottom culture plates Becton Dickenson 
Microscope slides Fischer Scientific 
7-AAD Viability Staining Solution e-Bioscience 
Streptavidin HRP R&D 
TMB Becton Dickenson 
Xylene Panreac 
Heamotoxylin Panreac 
 
3.1.2. Standard solutions 
3.1.2.1. 10x Phosphate buffered saline (PBS) for antibody determination by 
ELISA 
87.66 g of NaCl, 2.56g of NaH2PO4, 11.94g of Na2HPO4 dissolved in 1L d.H2O, 
pH 7.2. 
3.1.2.2. Phosphate buffered saline (PBS) with 0.05% Tween-20 
1x PBS (made from home-made 10xPBS) with 0.05% tween-20, pH 7.2- 7.4 
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3.1.2.3. Trypticase soy broth (TSB) 
3.1.2.4. RBC lysis buffer 
8.3NH4Cl, 1g KHCO3 1.3ml of 5%EDTA dissolved in 1L distilled water and 
filtered through 0.2µm filter 
3.1.2.5. Blocking buffer for pathogen specific antibody detection by ELISA 
(1% BSA, 5% sucrose, 0.05% NaN3 in PBS) 
5g of BSA, 25g of sucrose, 0.25g NaN3 in 500ml 1xPBS (made from home-made 
10xPBS), pH 7.2-7.4 
3.1.2.6. Reagent diluent for antibody determination ELISA (1%BSA) 
1g Bovine serum Albumin dissolved in 100ml 1xPBS (made from home-made 
10xPBS), pH 7.2-7.4 
3.1.2.7. 0.05M Carbonate Buffer for autoantibodies detection by ELISA 
0.16g Na2CO3 and 0.3g NaHCO3 dissolved in 100ml PBS, pH 9.6 
3.1.2.8. Borate buffer saline (BBS) 
200mM of boric acid, 75mM NaCl in 1L d.H20, pH 8.4 
3.1.2.9. BBT 
0.5%BSA, 0.4%tween in BBS 
3.1.2.10. BBS: BBT 
0.5%BSA, 0.1% NaN3 and 0.4%tween in BBS 
3.1.2.11. 2N H2SO4 
6ml of conc.H2SO4 was dissolved in 100ml d.H20 
3.1.2.12. Staining Buffer for FACS (PBS/1% FCS/0.1% NaN3) 
1ml Fetal calf serum and 0.1g NaN3 was dissolved in 100ml PBS 
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3.1.2.13. 4% paraformaldehyde for fixation 
100ml 37% formaldehyde in 400ml d.H2O and 500ml 0.2M Phosphate buffer 
3.1.2.14. AutoMACS buffer for cell purification 
0.5% BSA, 2mM EDTA in 1xPBS, pH 7.2 
3.1.3. List of antibodies used in ELISA and cell culture: 
Antibody Catalogue 
# 
Company Concentration
/ Dilution used 
Rat anti-mouse IgG3 (Biotin) 1191-08 Southern Biotech 1:5000 
Goat anti-mouse IgG1 
(Biotin) 
1070-08 Southern Biotech 1:20,000 
Goat anti-mouse IgG2c 
(Biotin) 
1079-08 Southern Biotech 1:20,000 
Goat anti-mouse IgM 
(Biotin) 
115-066-
075 
Jackson 
Immunoresearch 
1:10,000 
Purified mouse IgG1 0102-01 Southern Biotech 50ng/ml 
Purified mouse IgG2c 0122-01 Southern Biotech 50ng/ml 
Goat anti-mouse 
IgM+IgG+IgA (H+L) 
1010-01 Southern Biotech 0.1µg/ml 
Goat anti-mouse IgG, F(ab´)2 
fragment-specific 
115-006-
006 
Jackson 
Immunoresearch 
1µg/ml 
Biotin labeled-goat anti-
mouse IgG (Fc-specific) 
115-066-
008 
Jackson 
Immunoresearch 
1:10,000 
FITC-labeled goat anti-
mouse IgG (Fc-specific) 
31547 Pierce 1:100 
Purified anti-mouse CD3 
(clone 2C11) 
8310 CJ Lab 1-5µg/ml 
Hamster anti-mouse CD28 
(clone 37.N.51) 
12.96 CJ Lab 10-20µg/ml 
Mouse IgG 115-000-
003 
Jackson 
Immunoresearch 
1µg/ml 
Mouse IFN-γ set  
 
555138 Becton 
Dickenson 
 
Mouse IL-4 set  
 
555232 Becton 
Dickenson 
 
Mouse IL-10 set  
 
555252 Becton 
Dickenson 
 
46 
 
 
3.1.4. Antibodies used for FACS staining 
Antibody Conjugate Company Catalogue Dilution 
used 
Rat anti-mouse CD3 FITC BDPharmingen 553063 1:200 
Rat anti-mouse CD4 PE-Cy7 Biolegend 100528 1:200 
Rat anti-mouse CD4 APC-Cy7 BDPharmingen 552051 1:100 
Rat anti-mouse CD4 APC e-Bioscience 17004182 1:200 
Rat anti-mouse CD8a APC-Cy7 BDPharmingen 557654 1:100 
Rat anti-mouse CD11b APC-
eFluor780 
e-Bioscience 47011282 1:500 
Rat anti-mouse CD19 PE-Cy7 BDPharmingen 552854 1:200 
Rat anti-mouse Sca-1 PE BDPharmingen 553336 1:100 
Rat anti-mouse Ly6G/C FITC e-Bioscience 11593182 1:200 
Hamster anti-mouse 
CD80 
APC BDPharmingen 560016 1:200 
Rat anti-mouse CD86 FITC e-Bioscience 11086282 1:100 
anti-mouse CD25 APC BDPharmingen 557192 1:100 
Armenian Hamster IgG1 
Isotype Control 
Alexa Fluor 
488 
e-Bioscience 12488883 1:200 
Rat IgG2a Isotype 
Control 
PE-Cy7 e-Bioscience 25432182 1:200 
Rat IgG2a Isotype 
Control 
PE e-Bioscience 12432182 1:200 
Rat IgG2a Isotype 
Control 
APC-
eFluor780 
e-Bioscience 47432182 1:200 
Rat IgG2b Isotype 
Control 
FITC e-Bioscience 11403182 1:200 
Rat IgG2b Isotype 
Control 
APC e-Bioscience 17403182 1:200 
Rat IgG2b Isotype 
Control 
APC-
eFluor780 
e-Bioscience 47403182 1:200 
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Rat IgG2a Isotype 
Control 
FITC e-Bioscience 11432182 1:200 
Rat IgG1 Isotype 
Control 
APC Biolegend 400412 1:200 
Rat anti-mouse IFN-γ 
(for intracellular 
staining) 
PE-Cy7 Biolegend 505826 1:100 
Rat anti-mouse IL-4 
(for intracellular 
staining) 
APC Biolegend 504106 1:100 
Rat anti-mouse IL-10 
(for intracellular 
staining) 
PE Biolegend 505008 1:100 
Rat IgG1 Isotype 
Control 
PE-Cy7 Biolegend 400416 1:200 
Rat IgG2b Isotype 
Control 
PE Biolegend 400608 1:200 
Anti-mouse CD16/32 - e-Bioscience 14016185 1:100 
 
3.1.5. Mice  
        C57BL/6 mice, obtained from Harlan Olac (Bicester U.K.) and MyD88-
deficient (MyD88
-/-
) mice provided by Dr. S. Akira (Osaka University, Japan) 
(Adachi et al., 1998a; Kawai et al., 1999) through Dr. Richard Flavell (Yale 
University School of Medicine, USA) were bred in our animal facility and 
maintained in filter-topped isolator cages on Bactrim-supplemented water (for 
MyD88
-/-
 mice only). CD154
-/-
 mice (CD40L
-/-
) mice on C57BL/6 background 
were provided by Dr Richard Flavell’s lab (al-Ramadi et al., 2006); (Xu et al., 
1998). Mice were taken off antibiotics for at least 7-10 days before use in any 
experiment. All animals were routinely used at 8-12 weeks of age. All studies 
involving animals were conducted in accordance with and after approval of the 
animal research ethics committee of the College of Medicine and Health Sciences, 
United Arab Emirates University.  
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3.2. Methods 
3.2.1. Bacterial strains used and preparation  
        For the current studies, we used an attenuated, double auxotrophic, strain of 
Salmonella enterica serovar Typhimurium (hereafter referred to as S. 
Typhimurium), with deletions in the aroA and aroD genes which are critical for 
the synthesis of essential prokaryotic aromatic compounds. The aroA
-
/aroD
-
 
mutant strain, designated BRD509, expressing the empty nirB plasmid vector was 
used throughout (al-Ramadi et al., 2001); (al-Ramadi et al., 2004). It acquired 
resistance to ampicillin, which is encoded by the nirB plasmid, and can therefore 
be easily selected. IFN-γ and IL-2 cytokine expressing strains of BRD509, 
designated GIDIFN and GIDIL2, have been previously described (Al-Ojali et al., 
2012a); (al-Ramadi et al., 2002); (al-Ramadi et al., 2001). The expression of IFN-
γ and IL-2 is under the control of the nirB promoter (Xu et al., 1998). In some 
studies, we also utilized a strain of Acinetobacter baumanii (designated NM97), 
which is a clinical isolate from Tawam hospital, and was kindly provided by Dr. 
Tibor Pal (Department of Microbiology & Immunology, CMHS). Aliquots of 
BRD509 (or its derivative strains) were grown on Salmonella Shigella (SS) agar 
[with ampicillin (100g/ml conc.)]. A.baumanii (NM97) strain was grown on 
trypticase soy agar (TSA). For the BRD509 (or its derivative strains) bacterial 
dosage preparation, about 4-5 CFUs were cultured in 10 ml trypticase soy broth 
(TSB) containing ampicillin (1µg/ml) overnight and then diluted 1:10 in fresh 
TSB [with ampicillin (1µg/ml)] and grown for 2 hours (shaking) at 37°C. At the 
end of this incubation, the OD600 nm optical density of the bacterial suspension 
was measured at 600nm. 1ml of the culture was read on a spectrophotometer 
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against TSB as blank. The bacterial concentration was estimated based on the 
formula of OD600 nm of 1=1.2x10
9
/ml bacterial CFUs. Log-phase bacterial 
suspensions were prepared in pyrogen-free saline and injected intraperitonealy 
(i.p) in 0.5ml volume at the indicated dose. For the NM97 bacterial dosage 
preparation, about 4-5 CFUs were cultured in 5ml TSB overnight. The next day, 5 
ml bacterial culture was poured into a conical flask containing 45ml fresh TSB 
and kept for shaking at 37°C for 4 hours. The bacterial culture was then 
transferred to a 50 ml tube, centrifuged at 3500 rpm for 15 minutes and re-
suspended in 1xPBS. The culture at 1:100 dilution was read on a 
spectrophotometer against 1xPBS as blank. Log-phase bacterial suspensions were 
prepared in pyrogen-free saline and injected intraperitonealy in 0.5 ml volume at 
the indicated dose. For all infections, the bacterial doses were verified by CFU 
plate counts. 
3.2.2. Enumeration of bacterial load and IgA extraction from fecal pellets  
        Procedures for determination of CFU have been described previously (al-
Ramadi et al., 2001). Groups of mice (5-10 mice per group) were sacrificed at 
different time points after i.p infection. Feces were freshly collected, weighed and 
suspended in 1xPBS. The suspension was vortexed and an aliquot at an 
appropriate dilution was streaked on SS agar plate containing both ampicillin 
(100g/ml) and streptomycin (200g/ml) and the CFU counts were determined 
after overnight incubation at 37°C. To determine the bacterial loads in spleen and 
liver, target organs were aseptically removed at the indicated time points and 
homogenized in 1 ml of cold sterile saline in an Ultra-terrax T25 tissue 
homogenizer (Janke & Kunkle, Staufenim Breisgau, Germany). An aliquot of 
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appropriate dilution was streaked on SS agar (with ampicillin) plates for BRD509 
and the CFU counts were determined after overnight incubation at 37°C. Spleen 
weights were also determined at the indicated time points post inoculation.  
        For secretory IgA extraction, fecal pellets were suspended at a concentration 
of 250 mg/ml of cold extraction buffer consisting of 1×PBS solution, 30 mM 
EDTA, 1% BSA, and 1/100 dilution of protease inhibitor cocktail stock 
(Calbiochem, Germany). The suspension was then vortexed and supernatants were 
collected after centrifugation at 10,000 rpm for 7 minutes at 4
o
C and stored at 
−20oC until assayed for IgA levels. 
3.2.3. Peritoneal exudate cell collection 
        Groups of mice (5–10 mice per group) were sacrificed at different time 
points after infection. To harvest peritoneal lavage, 10 ml of cold Ca2
+
-, Mg2
+
-
free saline was injected into the exposed peritoneal cavity and the fluid was 
withdrawn through the anterior abdominal wall with a 20-gauge needle. The fluid 
was then spun down at 2500 × g for 5 minutes and the cell pellet was resuspended 
in distilled water. 
3.2.4. Spleen cell preparation 
        Single cell suspensions were prepared by gently teasing the spleen between 
frosted ends of microscope slides. Cells were then spun down at 1200 rpm for 5 
minutes at 4°C. The spleen cell suspension was depleted of red blood cells by 
incubation in RBC Lysis buffer (10-12 ml/spleen sample) for 5 minutes, after 
which they were spun down at 1200 rpm for 5 minutes and suspended in 1xPBS. 
The erythrocyte-depleted spleen cells were counted on a hemocytometer and cell 
viability was determined by trypan blue dye exclusion. 
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3.2.5. Spleen cell purification 
        Purification of CD4
+
 and CD11b
+
 spleen cell subpopulations was done using 
magnetic bead separation on an autoMACS cell sorter (Miltenyi Biotec, 
Germany), following manufacturer’s procedure. For the purification of T 
lymphocytes, spleen cells (10 x 10
6
 cells per run) were centrifuged at 300 x g for 
10 minutes and cell pellets were re-suspended in 90µl of autoMACS buffer and 
10µl of anti-CD4 mAb-coated magnetic beads (GK 1.5 clone, Miltenyl Biotec). In 
case a higher cell number was needed for purification, the volume of buffer and 
magnetic beads were adjusted accordingly, while maintaining the cell: magnetic 
beads ratio. After incubation with mAb-coated magnetic beads for 15 minutes at 
4-8°C, spleen cells were washed with 1ml of buffer and centrifuged again at 300 x 
g for 10 minutes. Cells were then re-suspended in 500µl buffer and CD4-positive 
cell fraction was collected using the Possel program on the autoMACS cell sorter. 
The extent of cell purity was verified independently by staining with non-cross-
reactive CD4-specific mAb (RM 4-5) and analysis on a FACSCanto (BD). 
Routinely, purified cells were confirmed to be 90-95% CD4
+
 T cells. 
        The CD4
+
 T cell-negative fraction of the spleen cell suspension was also 
collected, and cell number was determined, for subsequent purification of CD11b
+
 
myeloid cells. For this purification, 10 x 10
6
 spleen cells were re-suspended in 
90µl of autoMACS buffer and incubated with 10µl of anti-CD11b mAb-coated 
magnetic beads (Miltenyl Biotec) for 15 minutes at 4-8°C. After incubation, the 
cells were washed with 1ml of the buffer and centrifuged again at 300 x g for 10 
minutes. Cells were then re-suspended in 500µl buffer and magnetic separation 
was carried out with the autoMACS separator. CD11b-positive cell fraction was 
collected using the Possel program on the magnetic cell sorter. Routinely, the cells 
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collected were composed of 75-85% CD11b
+
 cells as confirmed by staining with 
fluorochrome conjugated anti-CD11b antibodies.  
3.2.6. Flow cytometry 
        Spleen cell suspensions were prepared from animals infected intraperitonealy 
21 days previously with a dose of about 3000 BRD509/mouse. Processing of 
spleen cells for FACS analysis was conducted, as described previously (al-Ramadi 
et al., 2001). Whole spleen cells and PECs obtained from the peritoneal wash, as 
described above were re-suspended in staining buffer (SB) (PBS/1% FCS/0.1% 
NaN3) at a concentration of 0.5 x 10
6
 cells/well in U-bottom 96-well plate (BD) 
and incubated with 50µl/well of anti-mouse CD16/CD32-specific mAb (clone 
2.4G2) for 30 minutes at 4°C to block FcγRΙΙΙ/ΙΙ sites in order to avoid 
nonspecific binding. The plate was then centrifuged at 750 rpm for 3 minutes at 
4°C. After decanting the buffer, cells were stained with appropriate dilutions, of 
directly-conjugated monoclonal antibodies (mAbs; all purchased 
from eBioscience or BD or BioLegend, as previously mentioned and detailed in 
Table 3.1.4) in a total volume of 100µl/well and analyzed by 6-color FACS. In all 
staining groups, 7-AAD dye (e-Bioscience) was included in order to exclude non-
viable cells from the analysis. All antibodies were pre-titrated in preliminary 
experiments and used at saturating concentrations. Cells were incubated with a 
mixture of appropriately-diluted mAbs at 4°C for 30 minutes followed by two 
wash cycles with SB. The first wash was with 100 µl/well of SB where the cells 
were mixed well with the pipette and centrifuged. In the second wash, 200 µl/well 
of SB was added and mixed well followed by centrifugation. Cells were finally re-
suspended in 200µl/well of SB and fixed by adding 100µl of 4% 
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paraformaldehyde per well. Data were collected on 30,000 cells using BD 
FACSCantoII and analyzed using BD FACSDiva software.  
        For intracellular cytokine staining, 100µl of anti-mouse CD3 (clone 2C11) at 
5µg/well and 100µl of anti-mouse CD28 (clone 37.N.51) at 20µg/well in 1xPBS 
were added into 24-well tissue culture plates  and incubated at 37°C with 5% CO2 
for 2 hours after which the solution was aspirated from each well. Enriched CD4
+
 
T cells (1 x 10
6
 cells/ml/well) were suspended in RPMI supplemented with 
5%FCS, l-glutamine, sodium pyruvate, essential amino acids, non-essential amino 
acids, pen/strep, gentamicin, and 2-ME (all reagents from Gibco BRL) for 
stimulation at 37°C with 5%CO2 for 24 hours. Purified CD4
+
 T cells incubated in 
the absence of anti-CD3/CD28 mAb were also included and used as non-
stimulated control. Four hours before harvesting the cells, 1 µl of BD GolgiPlug 
(Brefeldin A) was added per well. Intracellular staining for cytokines was carried 
out following staining for cell surface antigens as described earlier, after which 
cells were permeabilized using permeabilization/fixation buffer (BD 
Cytofix/Cytoperm Plus #555028) for 20 minutes at 4°C. Cells were then incubated 
with 100µl/well of antibody conjugates of IFN-, IL-4 or IL-10 for 30 minutes at 
4°C and washed with 1x Perm/Wash solution. Isotype controls for the respective 
cell surface and intracellular antibodies were used to determine nonspecific 
binding. Data were collected on 30,000 cells and analyzed using BD FACSDiva 
software.  
3.2.7. Preparation of heat killed bacteria 
        Bacterial strains were grown to log-phase, as described above. After taking 
an aliqout for verification plate counting, bacterial suspension was washed in 
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pyrogen-free saline, centrifuged at 4000 rpm for 15 minutes at 4°C and finally re-
suspended in 5 ml PBS. The samples were then placed in a water bath at 65
0
C for 
1 hour, following which aliquots (100µl) were removed and streaked on SS agar 
or TSA plates for BRD509 or NM97 bacterial strains, respectively, to confirm that 
all bacteria were heat killed. The remainder of the heat-treated suspension was 
aliquoted in 0.5 ml volume and stored at -20°C until use. 
3.2.8. Measurement of pathogen specific antibodies in serum  
        Serum samples were obtained at the indicated time points post i.p infection 
with ~200 CFUs/mouse. Blood was collected on the day of sacrifice from the vena 
cava, left at room temperature to clot for 30-60 minutes, spun down at 2500 rpm 
for 5 minutes, following which sera (~200-300µl) were collected. Serum samples 
were stored at -20°C till further analysis. The presence of Salmonella-specific as 
well as Acinetobacter-specific antibodies of IgG1, IgG2b, IgG2c, IgG3, and IgM 
isotypes were determined by an established ELISA protocol (Issac et al., 2013). 
Maxisorp 96-well plates (Nunc, Roskilde, Denmark) were coated overnight with 
100 µl/well of heat-killed bacteria (1 x 10
6
 cells/well). Wells were then washed 3 
times with PBS-T and blocked for 2 hours at room temperature using 300µl/well 
of the blocking buffer (1%BSA, 5%Sucrose, 0.05%NaN3 in PBS). To generate a 
standard curve, wells were coated with 0.1µg/ml of goat anti-mouse Ig(H+L) 
(Southern Biotech), and blocked with 300µl/well of 2% BSA in 1xPBS (7.2 pH). 
After one wash cycle, serum samples from individual animals were serially 
titrated in the plate (range 1/100 to 1/3200 dilution, in duplicates). For the 
standard wells, mouse isotype-specific antibody (Southern Biotech) (starting at 
50ng/ml and titrated in 1:2 serial dilutions) was added in a final volume of 
100µl/well. The standards were prepared in separate tubes and added in 100µl 
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aliquots to appropriate wells. For the serum samples, dilutions were carried out 
directly in the plate. The test plates were then incubated at room temperature for 2 
hours. After extensive washing, secondary antibodies (biotin-conjugated, isotype-
specific antibodies; dilutions indicated in table 3.1.3) were added (100µl/well) and 
incubated for another 2 hours at room temperature. After another series of washes, 
streptavidin–HRP (100µl/well; R&D #DY998) was added at a final dilution of 
1/200 and incubated for 40 minutes. Wells were washed again and developed by 
adding 100µl/well of the substrate 3,3′,5,5′-tetramethylbenzidine (TMB; Becton 
Dickenson #555214) and incubated for 10-30 minutes. The reaction was stopped 
by adding 50µl/well of 2N H2SO4. Plates were read at 450 nm using a TECAN 
microplate reader (Maennedorf, Switzerland).  
3.2.9. Total IgG isotypes 
        Nunc MaxiSorp 96-well plates were coated with 100µl of 1µg/ml goat anti-
mouse IgG F(ab′)2 (Jackson Immunoresearch) in 0.5M sodium bicarbonate 
(pH=9.6)  and incubated at 4°C overnight. After washing, plates were blocked for 
2 hours with 200µl/well of 3% BSA in 1xPBS (pH 7.2). Plates were washed and 
serially diluted samples along with standard dilutions of mouse isotype specific 
antibody (Southern Biotech) in 1% BSA were added at a final volume of 
100µl/well. The standards were prepared in individual eppendorf tubes and 100µl 
aliquots were transferred to the wells. For the test samples, serial dilutions were 
carried out directly in the plate, followed by incubation for 2 hours at room 
temperature. After a series of washes, 100µl of biotin-labeled goat anti-mouse IgG 
(isotype specific) (Southern Biotech) antibody was added and incubated for an 
additional 2 hours followed by streptavidin-HRP, as mentioned earlier. TMB 
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substrate solution was added for color development and stopped with 2N H2SO4.  
The plates were then read at 450nm using TECAN reader. 
3.2.10. Cytokine determination  
        PECs obtained from the peritoneal wash, were also resuspended in 
supplemented RPMI medium and kept at 4 ◦C until placed in tissue culture plates. 
Cells were cultured, without further stimulation, at a concentration of 1.5 × 
106/ml (PECs) in 24-well plates and incubated for 24–48 hours at 37 ◦C with 5% 
CO2. Culture supernatants were then collected, spun free of any cells, and kept at 
−20 ◦C until assayed. Production of NO was measured by the accumulation of 
NO2
−
 in culture supernatants by the Griess reaction, following a procedure 
previously published (al-Ramadi et al. 1992). Production of IL-6 and IL-12 was 
quantitated in culture medium following in vitro culture of peritoneal, or spleen 
cell population after 2, 24 or 48 hours of infection. 
         Spleen cells were stimulated by plate-bound mAbs specific to murine CD3 
and CD28 molecules. For Ab immobilization, anti-mouse CD3 (clone: 2C11; 
50µl/well; 1µg/well) and anti-mouse CD28 (clone 37.N.51; 50µl/well; 10µg/well) 
mAbs were diluted in 1xPBS and added into 96-well U bottom plates (BD) and 
incubated at 37
0
C with 5% CO2 for 2 hours after which, the solution was aspirated 
from each well. Purified CD4
+
 splenic T cells (1 x 10
5
 cells/200µl), resuspended 
in complete medium (RPMI + 5%FCS + supplements), were then added and 
incubated at 37
o
C in a humidified incubator with 5% CO2 for 24 hours. As 
controls, purified CD4
+
 T cells were incubated without anti-CD3/CD28 mAb 
stimulation. Cells were spun down at 3,000 rpm for 7 minutes and supernatants 
were collected. Cell-free culture supernatants were analyzed for IFN-, IL-4 and 
57 
 
IL-10 cytokines using specific ELISA kits from BD Biosciences (as mentioned in 
table 3.1.3.) according to manufacturer’s instructions. For the IFN- ELISA, test 
supernatants were run at final dilutions of 1:10-1:20. For IL-4 detection, all 
samples were run undiluted. For IL-10 cytokine detection, test supernatants were 
run either undiluted (for C57BL/6 group) or 1:2 dilution (for the infected   
MyD88
-/-
 groups). Test supernatants from all non-infected control groups were run 
undiluted for all ELISA determinations. 
3.2.11. Measurement of autoantibodies in serum 
        The production of autoantibodies specific to dsDNA, thyroglobulin and 
mouse IgG (rheumatoid factor) was assessed by ELISA following a published 
method with modification (Chen et al., 1998). For the detection of anti-dsDNA 
antibodies, Maxisorp Nunc ELISA plates (Thermo Scientific) were coated with 
dsDNA at a final concentration of 1µg/ml (from calf thymus; Sigma #D4522) 
diluted in borate-buffered saline (BBS) and incubated overnight at 4°C. Following 
3 washes with BBS, wells were blocked with 200µl/well of BBS supplemented 
with Tween and BSA (BBT:BBS, 0.4%Tween 80, 0.5%BSA, and 0.1%NaN3) for 
1 hour at room temperature. Serum samples diluted to 1/1000 in BBT were added 
in duplicate, serially titrated on the plate (to a final volume of 100µl/well) and 
incubated for 2 hours at room temperature. After washing with BBS, the plates 
were incubated for 2 hours at room temperature with biotinylated goat anti mouse 
IgG (Fc-specific; Jackson Immunoresearch), diluted 1/10,000 in BBT 
(100µl/well). The plates were finally washed and incubated with streptavidin-HRP 
and developed using TMB, as mentioned above. Reaction was stopped with 2N 
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H2SO4 and read at 450 nm using a TECAN microplate reader (Maennedorf, 
Switzerland). 
        For the detection of RF and anti-thyroglobulin antibodies, Maxisorp plates 
were coated overnight at 4°C with 100µl of 1μg/ml of mouse IgG (Jackson 
Immunoresearch Laboratories) for RF assay or 100µl of 1μg/ml of thyroglobulin 
(from bovine thyroid; Sigma #T1001) diluted in 0.05M carbonate buffer 
(pH=9.6). Following 3 washes with PBS containing 0.05% Tween (PBS-T; pH 
=7.2), the plates were blocked with 200µl/well of 1% BSA in PBS-T at room 
temperature for 2 hours. Serum samples, diluted to 1/1000 in PBS-T containing 
0.5M NaCl, were added in duplicate, serially titrated on the plate (to a final 
volume of 100µl/well) and incubated for 2 hours at room temperature. The plates 
were then washed and developed using the same procedure described above. 
3.2.12. Detection of ANA by immunoflurosence using HEp-2 cells. 
        Serum ANA antibodies were detected by indirect immunofluorescence using 
HEp-2 ANA kit (INOVA Diagnostics, San Diego, CA, USA #708100), according 
to the manufacturer's protocol. 
        Diluted serum samples (1/80 dilution) and controls were added (25µl per 
reaction) and incubated for 30 minutes in a moist chamber at room temperature. 
After a gentle rinse with PBS, the slides were washed by immersing in a tray filled 
with PBS for 5 minutes. PBS was changed and the wash repeated. One drop of 
goat anti-mouse IgG-FITC (Pierce) was added into each well and incubated for 30 
minutes. Slides were washed similarly in PBS and dried, following which the 
mounting media was added and coverslip placed. The fluorescence was visualized 
at 400x magnification using an Olympus BX51fluorescence microscope (Olympus 
Corporation, Japan) 
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3.2.13. Histopathological kindney analysis.  
        Kidneys were fixed in 4% paraformaldehyde and embedded in paraffin. To 
assay for immune complex deposition, paraffin-embedded 5m tissue sections 
were dehydrated. The process of dehydration was done at room temperature by 
immersing the sections in xylene I solution for 5 minutes, xylene II for 5 minutes, 
absolute ethanol I for 3 minutes, absolute ethanol II for 3 minutes, 90% ethanol 
for 3 minutes, 80% ethanol for 3 minutes and finally, 70% ethanol for 3 minutes. 
Endogenous peroxidase activity was blocked using 1.5% H2O2 in PBS. After 3 
wash cycles with PBS-T (5 minutes each), the slides were further blocked with 
1%BSA in PBS for 45 minutes. The sections were then stained with biotin-goat 
anti-mouse IgG (Fcγ-specific; 1/2000 dilution) for 2 hours, followed by 
streptavidin-HRP (BD Pharmingen #550946) for 1 hour. Sections were washed 
again with PBS-T (3 times, 5 minutes each). The peroxidase activity was 
determined using DAB chromogen (BD #51-7549KC) for 5-10 minutes followed 
by washing with distilled water. Hematoxylin staining was done for 1 minute and 
sections were rehydrated. Rehydration was in the following order: 70% ethanol 
for 1 minute, 80% ethanol for 1 minute, 90% ethanol for 1 minute, absolute 
ethanol I for 1 minute, absolute ethanol II for 1 minute, xylene I for 2 minutes and 
xylene II for 2 minutes. The sections were mounted with DPX and viewed under 
200x and 400x light microscope.  
3.2.14. RNA extraction using Trizol 
        RNA was extracted from whole spleen cells, purified CD4
+
 T cells, or 
CD11b
+
 myeloid cells by the Trizol method. Cells (2-5 x 10
6 
per sample) were 
pelleted and resuspended in 1ml Trizol (Invitrogen #15596-018), following which 
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200µl of chlorophorm was added and mixed well. Once the cells were spun down 
at 14000 rpm for 10 minutes, 3 phases were obtained from which the top clear 
RNA layer (~500µl) was transferred to a new tube. Equal volume of 2-propanol 
(~500µl) was then added and mixed well to precipitate the RNA. Tubes were spun 
again, supernatant was discarded and 500µl of 70% ethanol added. On flicking the 
tubes, RNA was observed as a white pellet. Tubes were spun again, supernatant 
was removed and RNA was finally suspended in 20µl nuclease free water and 
stored at -80°C. 
        In studies involving whole spleen cells, the isolated RNA was further treated 
with RNase-free DNase (Promega #M6101) to eliminate genomic DNA 
contamination. In this process 2µg of RNA was treated with 2µl DNAase and 2 µl 
DNAase buffer. Volume was made up to 20µl with nuclease-free water and 
incubated at 37°C for 30 minutes in a theromomixer (Eppendorf). Stop solution 
(2µl) was then added and incubated at 65°C for 10 minutes to inactivate the 
DNase. The quality and quantity of the RNA was determined using the Nanodrop 
ND-1000 spectrophotometer (Thermo Scientific, Waltham, MA).   
3.2.15. Reverse Transcription Reaction 
        RNA was reverse transcribed using TaqMan reverse transcription reagent 
(Applied Biosystems #N8080234). Each master mix reaction contained 10x RT 
buffer, 25mM MgCl2, deoxy NTPs mixture (2.5mM), random hexamers (50µM), 
RNAase inhibitor (20U/µl) and MultiScribe RT enzyme. The master mix was 
aliquoted into separate PCR tubes. RNA was added (1µg/10µl per reaction) and 
total volume was made up to 50µl with nuclease-free water. The one step RT-PCR 
reaction was run on GeneAmp PCR System 2700 from Applied Biosystems, under 
the following conditions: hexamer incubation for 10 minutes at 25°C, reverse 
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transcription at 48°C for 30 minutes and reverse transcriptase inactivation at 95°C 
for 5 minutes. The samples were held at 4°C for a maximum of 1 hour until the 
samples could be removed and stored at -20°C 
3.2.16. Real time PCR reactions 
        The real time PCR was performed using TaqMan gene expression assay as 
specified below and amplified using the 7500 Real Time PCR System (Applied 
Biosystems). Each 20µl PCR reaction contained 10µl of 2xTaqMan Universal 
Master Mix (Applied Biosystems #4440047), 1µl of 20x TaqMan assay Mix 
(Applied Biosystems #4331182), 2µl cDNA and 7µl nuclease free water. A 
negative PCR reaction was also carried out using only the reaction mixture 
without cDNA in order to ensure that there was no DNA contamination .The 
thermal cycling conditions were as follows: 95°C for 10 minutes (Inactivation of 
Reverse Transcriptase and activation of TaqMan polymerase), 95°C for 15 
seconds (denaturation of dsDNA) and 60°C for 1 minute (annealing/extension- 
fluorescent data collected during this step) for a total of 40 cycles with the 
threshold set as 0.2. Data was analyzed using the Ct values for each sample that 
were in duplicates. Results were normalized to HPRT (Hypoxanthine-guanine 
phosphoribosyl transferase) and the mRNA fold change was determined using the 
following equation: 
Fold change= 2 [   
Ct (infected)
] / 2 [  
Ct (control)
], where    Ct(infected) = threshold cycle 
(Ct) for target gene after infection - Ct for HPRT after infection and   Ct(control) 
= Ct for target gene saline treated - Ct for HPRT saline treated. Control used was 
uninfected wild-type (C57BL/6). 
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The assay ID of the primers used are as follows:  
HPRT (Mm01545399_m1), IL-10 (Mm00484683_m1), BAFF 
(Mm00446347_m1),  APRIL (Mm03809849_s1), GATA-3 (Mm00484683_m1), 
IFN-γ (Mm01168134_m1), T-bet (Mm00450960_m1), RoRγ 
(Mm01261022_m1), IL-17A (Mm00439618_m1), IL-17F (Mm00521423_m1), 
IL-4 (Mm00445259_m1), Foxp3 (Mm00475162_m1), TGF-β 
(Mm01178820_m1), IL-21 (Mm 00517640_m1), CXCR5 (Mm00432086_m1), 
bcl-6 (Mm 00477633_m1) 
3.2.17. Statistical analysis  
        Statistical significance was analyzed using Student's t-test or Mann-whitney 
test, using the statistical program of GraphPad Prism software (San Diego, CA). 
Differences between experimental groups were considered significant when p 
values were <0.05. 
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4. RESULTS 
4.1. Susceptibility of MyD88
-/-
 mice to infection 
        The BRD509 strain of serovar Typhimurium is attenuated as a result of 
deletions in the aroA and aroD genes. It is very efficient in affording protection 
against virulent Salmonella challenge, with an immunizing dose of 10
5
 CFUs per 
mouse i.p., resulting in 100% protection against up to 10,000 LD50 dose of 
virulent Salmonella. In Salmonella-susceptible mouse strains of diverse genetic 
backgrounds, including C57BL/6 and BALB/c, the LD50 of the BRD509 strain is 
>2 x 10
6
 CFUs per mouse when given i.p. This contrasts with the virulent, 
parental, bacterial strain, designated SL1344, which has a LD50 of <10 CFUs per 
animal. In order to assess the effect of MyD88 deficiency on susceptibility to 
Salmonella infection, MyD88
-/-
 mice and their wild-type MyD88
+/+
 counterparts 
were inoculated with different doses of BRD509 (range of 4 x 10
2
 to 4 x 10
5
 
CFUs/mouse), following which animal survival was followed for up to 60 days. 
As shown in Fig.1A, MyD88
+/+
 mice exhibited 100% survival even at the highest 
inoculum dose used. In contrast, the survival rates of MyD88
-/-
 mice were ~6%, 
19%, 30% and 48% following inoculation with 4 x 10
5
, 4 x 10
4
, 4 x 10
3
 and 4 x 
10
2
 organisms per animal, respectively. Moreover, the median survival for the 
different groups was 20, 31, 36 and 59 days, respectively (Fig.1A). These findings 
demonstrate that MyD88
-/-
 mice are markedly more susceptible even to a highly 
attenuated strain of Salmonella at a dose approximately 10,000-fold lower than the 
LD50 dose in MyD88
+/+
 mice. The increased susceptibility of MyD88
-/-
 mice to 
Salmonella correlated with an inability to control bacterial proliferation in target 
organs. In response to inoculation with a moderate dose of ~5 x 10
4
 CFUs, 
MyD88
+/+
 mice kept bacterial proliferation under control with less than 10-fold 
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the inoculum being detectable in spleen or liver at any time after infection (Fig. 
1B-C).  
 
 
Fig. 1. MyD88-deficient mice are hypersusceptible to Salmonella infection. (A) Wild-
type C57BL/6 (MyD88
+/+
) and MyD88-deficient (MyD88
-/-
) mice were inoculated i.p. 
with an attenuated strain of S. Typhimurium, designated BRD509, at the indicated doses. 
Animal survival was followed for up to 60 days. The calculated median survival (in days) 
for each group is shown. The results are pooled from 6 independent experiments. (B-C) 
Mice were inoculated i.p. with 5 ×10
4
 CFUs of BRD509 strain. At the indicated days post 
inoculation, animals were sacrificed and the bacterial load in livers (B) and spleens (C) 
were enumerated. Each data point represents the mean ± SEM of 5 mice per group. 
Asterisks denote statistically significant differences between MyD88
-/-
 and MyD88
+/+
 
mice (*p < 0.05; **p < 0.01; ***p < 0.001). The results are representative of 3 
independent experiments. Data are based on Fig.1 of the paper Issac et al. 2013. 
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        In sharp contrast, proliferation of attenuated Salmonella organisms increased 
over the 3 week-observation period, reaching approximately 1000-fold increase in 
spleen and liver by day 21 post-infection. The extent of the susceptibility of 
MyD88
-/-
 mice was further examined by infecting the animals with a low dose of 
BRD509 (~200 CFUs/mouse) and following bacterial shedding in the feces over a 
4 week-period. As shown in Fig. 2A, a low level of detectable fecal shedding of 
Salmonella organisms (~0.01 CFUs/mg feces) was seen only in week 2 post-
infection in MyD88
+/+
 mice. By day 21 post-infection, as the infection had 
cleared, no further shedding was observed. In contrast, MyD88
-/-
 mice exhibited a 
progressively worsening, persistent, infection accompanied by increasing levels of 
bacterial shedding over the 4-week observation period (Fig. 2A). This also 
corresponded to increased bacterial burden in the spleen and liver of infected 
MyD88
-/-
 mice where the bacteria recovered was about 100-200 fold greater than 
in infected MyD88
+/+
 mice (Fig. 2B-C). Thus, there is a failure to control bacterial 
replication in MyD88
-/-
 mice even at a very low inoculum of an attenuated 
Salmonella strain. 
4.2. Defective recruitment of inflammatory cells and cytokine response 
        Given the critical role of MyD88 adaptor in TLR signaling and the innate 
immune response, we reasoned that the failure to control bacterial proliferation 
may be due to an early defect in the response to Salmonella infection. A critical 
step in the innate immune response to an intraperitoneal route infection with 
Salmonella is the recruitment of inflammatory cells into the peritoneal cavity 
within the first 48 hours of infection. Analysis of peritoneal cell exudates (PECs) 
in infected mice revealed a delayed cellular influx in MyD88
-/-
 mice (Fig. 3A).  At  
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Fig. 2. Increased fecal shedding of Salmonella in infected MyD88
-/-
 mice. Mice were 
inoculated i.p. with a low dose of BRD509 (~200 CFUs/mouse) and the extent of 
bacterial shedding in the feces (A) and bacterial load in spleen (B) and liver (C) were 
enumerated. Each data point represents the mean ± SEM of 6-10 mice per group. 
Asterisks denote statistically significant differences between MyD88
-/- 
and MyD88
+/+
 
mice (*, p<0.05; **, p<0.01). The results are representative of 3 independent experiments. 
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2 hours post-infection, the number of PECs in MyD88
+/+
 mice was 19% higher 
than that observed in MyD88
-/-
 mice. By 24 hours, the mean PECs count in 
MyD88
+/+
 mice was 5-fold higher than in MyD88
-/-
 mice (8 x 10
6
 vs 1.6 x 10
6
 
cells, respectively). Based on the kinetics of cell recruitment, the response peaked 
at 24 hours in wild-type mice, whereas it was minimal at 24 hours and was still 
rising at 48 hours in MyD88
-/-
 mice.   
        In addition to this quantitative delay in cell recruitment, flowcytometric 
analysis of PECs collected 48 hours post-infection demonstrated a significant 
defect in recruitment of inflammatory cells, exemplified by CD11b
+
Gr-1
+
 
neutrophils, in MyD88
-/-
 mice. In terms of absolute counts, these cells constituted 
up to 3 x 10
6
 (~55%) of total PECs in infected wild-type mice but only 0.5 x 10
6
 
(~8%) of PECs in MyD88
-/-
 mice (Fig. 3B). These results reveal quantitative as 
well as qualitative alterations in inflammatory cell recruitment between infected 
wild-type and MyD88
-/-
 mice.   
        Resistance to Salmonella infections is dependent on a robust Th1 response 
which leads to the activation of host macrophages and elimination of intracellular 
pathogens (Mastroeni et al., 1998). We therefore analyzed cytokine production in 
wild-type and MyD88
-/-
 mice during the innate immune phase of the infection. 
Production of IL-6, IL-12, and nitric oxide (NO) was undetectable in ex vivo-
cultured PECs from MyD88
-/-
 mice within the first 48 hours of Salmonella 
infection (Fig. 3C-E, respectively). This is in contrast to infected MyD88
+/+
 mice, 
in which production of IL-6, IL-12 and NO was readily detectable at 48 hours 
post-infection. These results are in agreement with previous studies that 
documented a defect in production of IL-1β, TNF-α and IL-6 in MyD88-/- mice 
(Kawai et al., 1999); (Weiss et al., 2004). 
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Fig. 3. Defective recruitment and activation of inflammatory cells in infected 
MyD88
-/-
 mice. Following inoculation of BRD509 (∼3 × 105/mouse), the number of total 
peritoneal exudate cells (PECs) were enumerated at 2, 24 and 48 hrs time points (A).  
After staining with mAbs to CD11b and Gr-1 and analysis by flow cytometry, the number 
of CD11b
+
Gr-1
+
 neutrophil population was determined at 48 hrs post-infection (B). Total 
PECs were collected from either saline-treated or Salmonella-infected mice at 24 and 48 
hrs and cultured overnight without additional stimulation. Cell-free culture supernatants 
were tested for IL-6 (C), IL-12p40 (D) and nitric oxide (E). Each data point represents the 
mean ± SEM of 3–5 mice per group, compiled from 2 independent experiments. Date are 
based on  Fig. 2A and 2D and Fig. 4 A-C from the paper Issac et al,2013. 
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4.3. MyD88
-/-
 mice exhibit dysregulated antibody responses following 
Salmonella infection 
        Systemic infection with Salmonella organisms typically leads to the 
induction of Th1-driven antibody production, characteristically of the IgG3 and 
IgG2c isotypes in C57BL/6 mice (al-Ramadi et al., 2006); (Harrison et al., 1997). 
Given the increased susceptibilty of MyD88
-/-
 mice to Salmonella infection, we 
reasoned that anti-Salmonella antibody responses would likely be also 
compromised in these animals. To test this hypothesis, mice were infected i.p. 
with a low dose of BRD509 (~200 CFUs/mouse) and sera collected 4-6 weeks 
later for the determination of isotype-specific, anti-Salmonella antibody levels. In 
C57BL/6 mice, BRD509 infection induced a predominantly Th1-driven antibody 
response, exemplified by IgG3 and IgG2c isotypes (Fig. 4B-C). Infection of 
MyD88
-/-
 mice induced the production of significantly higher levels of anti-
Salmonella antibodies of IgG3, IgG2c as well as IgM isotypes (Fig. 4A-C). Even 
more surprisingly, Salmonella-specific antibodies of the Th2-driven IgG1 isotype 
were detected in MyD88
-/-
 mice, an isotype not commonly associated with 
Salmonella infections in wild-type, MyD88
+/+
 mice (Fig. 4D). The absolute levels 
of Salmonella-specific IgG1 and IgG2c were also determined using known 
standards (shown in Fig. 5A-B) and the calculated concentrations in the various 
treatment groups were in agreement with the results shown in Fig. 4. Thus, despite 
their increased susceptibility to Salmonella, MyD88
-/-
 mice exhibit a state of 
infection-induced hypergammaglobulinemia which was evident in all of the tested 
antibody isotypes.   
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Fig. 4. Hypergammaglobulinemia in Salmonella-infected MyD88
-/-
 mice. Mice were 
inoculated i.p. with BRD509 (∼200 CFUs/mouse) and sera collected at 4-6 weeks and 
analyzed for the presence of Salmonella-specific IgM (A), IgG3 (B), IgG2c (C) and IgG1 
(D) isotypes. Asterisks denote statistically significant differences between the indicated 
experimental groups (*, p<0.05; **, p<0.01; ***, p<0.001). Data are pooled from 3 
independent experiments.  
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Fig. 5. Quantification of Salmonella-specific serum. IgG2c (A) and IgG1 (B) antibodies 
in non-infected (NI) and 3 week-infected (I) mice. Attenuated BRD509 strain was used 
for i.p. infection at a dose of (~200CFUs/m). Absolute antibody levels are expressed in 
ng/ml serum. Asterisks denote statistically significant differences between infected 
MyD88
-/- 
and MyD88
+/+
 mice (*, p<0.05). Data are pooled from 3 independent 
experiments. 
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        The kinetics of the early development of isotype specific antibodies to 
Salmonella organisms were evaluated at weekly intervals following inoculation. 
Wild-type mice developed anti-Salmonella antibodies of IgG2c and IgG3 isotypes 
of increasing concentrations over the 3 week-observation period (Fig. 6A-B). No 
significant Salmonella-specific antibodies of IgG1 isotype were observed in 
C57BL/6 mice (Fig. 6C). In contrast, starting at 14 days post-infection, MyD88
-/-
 
mice secreted Salmonella-specific antibodies of all three (IgG2c, IgG3 and IgG1) 
isotypes at higher levels than seen in C57BL/6 mice (Fig. 6A-C). Thus, the state 
of hypergammaglobulinemia in infected MyD88
-/-
 mice became evident as early 
as 14-21 days post Salmonella inoculation and was still significant up to 2 months 
later (the longest period of observation).  
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Fig. 6. Kinetics of development of anti-Salmonella antibodies. The development of 
antibodies to Salmonella infection was evaluated up to 3 weeks post i.p infection with a 
dose of 4000 CFUs/mouse. Salmonella specific IgG3 (A), IgG2c (B), and IgG1 (C) were 
determined. Data are compiled from 3 independent experiments. Asterisks denote 
statistically significant differences between MyD88
-/- 
and MyD88
+/+ 
mice (*, p<0.05).  
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        The effect of MyD88 deficiency on global antibody levels was evaluated by 
quantitating the concentrations of total serum IgG3, IgG2c, and IgG1 isotypes in 
both MyD88
+/+
 and MyD88
-/-
 mice before and after infection with Salmonella. In 
uninfected animals, relatively low levels of serum IgG3 and IgG2c were detected 
but they were equivalent in both MyD88
+/+
 and MyD88
-/-
 mouse strains (Fig. 7A-
B). Serum IgG3 concentrations were 45 ± 9 µg/ml (mean ± SEM) and 44 ± 27 
µg/ml for MyD88
+/+
 and MyD88
-/-
 mice, respectively (Fig. 7A). For IgG2c, serum 
concentrations were 554 ± 94 µg/ml and 307 ± 37 µg/ml for MyD88
+/+
 and 
MyD88
-/-
 mice, respectively (Fig. 7B). In infected mice, serum IgG3 and IgG2c 
concentrations were increased significantly by an average of 3-5 fold over those in 
uninfected mice. In contrast, baseline serum IgG1 concentrations in uninfected 
MyD88
-/-
 mice were significantly elevated compared to MyD88
+/+
 mice (2.3+ 0.7 
vs 0.63 + 0.1 mg/ml, respectively; Fig. 7C). However, no significant changes in 
serum IgG1 concentrations were observed upon infection with Salmonella in both 
mouse strains. These findings indicate that the humoral immune response in 
MyD88
-/-
 mice is constitutively skewed to Th2-induced IgG isotypes. 
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Fig. 7. Salmonella-induced dysregulation in total serum antibodies in  MyD88
-/-
 mice. 
Following infection with BRD509 (~200 CFUs/mouse), sera were collected 4-6 weeks 
later. Total serum IgG3 (A), IgG2c (B), and IgG1 (C) in both infected and non-infected 
mice were quantified by ELISA. Each data point represent mean ± SEM of 3–10 mice per 
group (*, p<0.05). 
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4.4. Oral Salmonella inoculation leads to persistent infection in MyD88
-/-
 mice  
        Since MyD88
-/-
 mice were hypersusceptible to systemic Salmonella 
infections, their response to an oral administration of BRD509 strain was 
investigated. Unlike systemic infections, mice inoculated orally with doses of up 
to 1 x 10
9
 CFUs/animal exhibited 100% survival and had no signs of morbidity for 
up to 60 days post-infection (data not shown). Long-term persistence of oral 
infections was followed by quantitating the extent of bacterial shedding in the 
feces for 6 months. In MyD88
+/+
 mice, fecal shedding of bacteria was evident up 
to 2 weeks post-infection with ~1 x 10
8
 CFUs/mouse (Fig. 8A). At later time 
points, no significant shedding was observed. In contrast, substantial shedding of 
Salmonella organisms was evident in infected MyD88
-/-
 mice for the entire 
observation period (up to day 191 post-infection).  
        Bacterial loads were also determined in mesenteric lymph nodes (MLNs), 
livers and spleens of infected mice at different time points post oral infection (Fig. 
8B-D). Consistent with the findings from systemic infection, MyD88
-/-
 mice 
harbor significantly increased loads (~10 to 100-fold) of BRD509 organisms in 
their tissues compared with wild-type mice over the first 3 weeks of infection. As 
expected, the highest concentration of bacteria was found in MLNs but even here 
differences between wild-type and MyD88-deficient mice were found throughout 
the observation period (Fig. 8B), suggesting that MyD88 is also important for 
immune defense along mucosal tissues. Assessment of spleen weights in orally 
infected mice also reflected a pattern previously observed with systemic infections 
(Fig. 8E). Thus, early on, spleen weights of infected MyD88
-/-
 mice lagged behind 
those of wild-type counterparts, perhaps reflecting the defective recruitment of 
inflammatory cells. By day 21 post-infection, as bacterial proliferation was 
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brought under control, splenomegaly in wild-type mice began to normalize.  
However, the degree of splenomegaly continued to increase in infected MyD88
-/-
 
mice most likely as a reflection of their failure to control the infection (Fig. 8E).  
Interestingly, while infected MyD88
-/-
 mice exhibited continuous shedding of 
bacteria in the feces (Fig. 8A), no Salmonella organisms were detectable in 
spleens and livers of these animals at day 191 after infection (data not shown). 
Therefore, in the absence of MyD88 protein, oral administration of an attenuated 
Salmonella strain leads to a long-term persistent infection that appears to be 
restricted to the mucosal tract.  
 
 
 
78 
 
 
 
 
Fig. 8. Oral infection with attenuated Salmonella leads to persistent infection. Mice 
were inoculated orally with BRD509 (~1 x 10
8
 CFUs/mouse). Shedding of Salmonella 
organisms in the feces was followed for up to 27 weeks (A). (B-D) Mice were inoculated 
orally with ~1 x 10
9
 CFUs/mouse of BRD509 strain and bacterial load in mesenteric 
lymph nodes (MLNs; B), liver (C) and spleen (D) was enumerated at the indicated time 
points. Degree of splenomegaly was also determined (E). Asterisks denote statistically 
significant differences between MyD88
-/- 
and MyD88
+/+
 mice (*, p<0.05; **, p<0.01; ***, 
p<0.001). The experiment was performed twice with similar results. 
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        Next, the systemic and mucosal Salmonella-specific antibody levels were 
evaluated after oral infection in normal and MyD88
-/-
 mice. Consistent with the 
findings of systemic infections, orally-infected MyD88
-/-
 mice had elevated levels 
of Salmonella-specific IgG3, IgG2c and IgG1 antibodies (Fig. 9A-C). In normal 
mice, the most significant rise in anti-Salmonella antibodies was in the IgG2c 
isotype (Fig. 9B). No significant differences in serum IgA levels were observed 
between the mouse strains following infection (Fig. 9D). However, a significantly 
stronger mucosal IgA response was observed in infected wild-type mice compared 
to MyD88
-/- 
counterparts, despite the higher levels of bacterial persistence seen in 
the latter mouse strain (Fig. 9E). These data demonstrate that the induced 
hypergammaglobulinemia in MyD88
-/-
 mice is not restricted to systemic 
infections. In contrast, MyD88 protein appears to be essential for the induction of 
a robust mucosal IgA response. Taken together, these findings suggest that the 
systemic antibody response is fundamentally dysregulated in MyD88
-/-
 mice. 
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Fig. 9. Elevated serum but not mucosal antibody levels following oral infection with 
BRD509 in MyD88
-/-
 mice. Animal sera were tested at 3-6 months after infection for the 
presence of Salmonella-specific IgG3 (A), IgG2c (B), IgG1 (C) and IgA (D) antibody 
isotypes. Mucosal IgA levels were also determined in fecal pellets at the same time (E). 
Data are compiled from 2 independent experiments. Asterisks denote statistically 
significant differences between MyD88
-/-
 and MyD88
+/+
 mice (***, p<0.001).  
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4.5. Breakdown of humoral self-tolerance in MyD88
-/-
 mice following systemic 
Salmonella infection 
        Given the observed dysregulation in antibody synthesis in Salmonella-
infected MyD88
-/-
 mice, the potential generation of autoantibodies was examined 
in these mice. Polyclonal B cell activation in response to infections has been 
shown to cause hyper antibody responses that could lead to autoimmunity (Woods 
et al., 2008); (Ko et al., 2011). Sera were collected 4-6 weeks following i.p 
infection and tested for reactivity against a panel of self antigens including 
dsDNA, thyroglobulin and IgG. To rule out non-specific cross-reactivity, all 
autoantibody ELISAs were determined at a serum dilution of 1/1000 or greater. 
The data illustrate the presence of significant titers of autoantibodies to dsDNA, 
thyroglobulin and IgG (RF) in Salmonella-infected MyD88
-/- 
mice (Fig. 10A-C). 
Importantly, sera from uninfected MyD88
-/-
 mice had no reactivity to any of the 
autoantigens. Similarly, no autoreactive antibodies were detectable in wild-type 
(MyD88
+/+
) mice before or after infection. These findings provide evidence for the 
secretion of autoantibodies in MyD88
-/-
 mice, but not for normal mice, following 
infection with Salmonella.  
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Fig. 10. Autoantibody reactivity of MyD88
-/-
 sera after systemic Salmonella infection. 
Sera were collected 4-6 weeks following i.p. infection with BRD509 (~200 CFUs/mouse) 
and tested for reactivity with dsDNA (A), thyroglobulin (B) and rheumatoid factor (RF; 
C) by specific ELISA. The cut-off for the detection of these autoantibodies was 
determined at 1/1000 dilution. Date compiled from 3 independent experiments. (*, 
p<0.05; **, p<0.01). 
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        Autoantibodies targeting dsDNA, histones and other nuclear antigens can 
also be determined by immunofluorescence using HEp-2 human epithelial cells. 
The presence of anti-nuclear antibodies (ANA) has been strongly associated with 
various autoimmune mouse models (Silver et al., 2007); (Sadanaga et al., 2007); 
(Bolland et al., 2002). To determine the overall levels of ANA, we assayed the 
reactivity of serially diluted sera to fixed HEp-2 cells by immunofluorescence. 
Approximately 53% of sera (8 out of 15) collected from Salmonella-infected 
MyD88
-/-
 mice showed strong reactivity with HEp-2 cells (Fig. 11G). Importantly, 
these sera exhibited different staining patterns, such as homogenous and 
fine/coarse speckled (Fig. 11D-F), reflecting the different nuclear antigens being 
recognized. In contrast, only about 8% of the sera from infected MyD88
+/+
 mice (1 
out of 12) were positive for HEp-2 staining (Fig. 11C, G). Non-infected mice of 
both strains were all negative (Fig. 11A-B). Positive ANA staining with HEp-2 
cells generally correlated with high anti-dsDNA antibody levels.  
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Fig. 11. Immunofluoresence detection of HEp-2 cell ANA reactivity of sera from 
Salmonella-infected MyD88
-/-
. ANA staining obtained with sera from non-infected (A-
B) and infected (C-F) MyD88
+/+
 (A, C) and MyD88
-/-
 (B, D-F) mice. Different staining 
patterns are detected, including homogenous (D), speckled (E), and cytoplasmic (F). 
Negative staining is depicted in panels A-C. The percentage of different experimental 
groups (5-15 mice/gp) that were positive for ANA is summarized in panel G. The 
fluorescence was visualised at 400x magnification using an Olympus fluorescent 
microscope. Data are compiled from 2 independent experiments.  
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        Given the state of hypergammaglobulinemia and the increased levels of 
serum IgG autoantibodies in infected MyD88
-/-
 mice, we next evaluated whether 
this was associated with more abundant deposits of immune complexes in kidney 
glomeruli. No evidence of staining was detected in the glomeruli of non-infected 
MyD88
-/-
 or MyD88
+/+
 mice (Fig. 12A, D). In comparison, about 20% of infected 
MyD88
+/+ 
mice showed positive staining of glomeruli but those were generally of 
low level of intensity (Fig. 12E-F). In sharp contrast, much brighter staining, 
indicating more deposits of immune complexes, was detected in ~69% of 
Salmonella-infected MyD88
-/-
 mice (Fig. 12B-C, G). Thus, the absence of MyD88 
predisposes animals to hypergammaglobulinemia, production of autoantibodies, 
and deposition of immune complexes in kidney glomeruli following infection with 
Salmonella. 
 
 
86 
 
 
 
Fig. 12. Immunoglobulin deposition in kidney sections of Salmonella infected 
MyD88
-/-
 mice. Kidney sections were prepared from non-infected (A, D) and infected (B, 
C, E, F) MyD88
-/-
 (A-C) and MyD88
+/+
 (D-F) mice and stained with anti-IgG antibody, 
as described in M&M. (G) The percentage of mice whose kidney sections scored positive 
for the presence of immune deposits by DAB staining. Images were taken at 400x 
magnification. Data are compiled from 2 independent experiments. 
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4.6. Requirements for infection-induced hypergammaglobulinemia and 
autoantibody production   
        The next series of experiments were designed to study the requirements for 
the observed hypergammaglobulinemia and autoantibody synthesis in MyD88
-/-
 
mice. We first evaluated whether infection with another Gram-negative bacterium, 
Acinetobacter baumanii, could lead to similarly dysregulated antibody production. 
Mice infected with a dose of ~1 x 10
5
 organisms of Acinetobacter baumanii 
(strain NM970) still harbored bacteria in spleen and liver 2 months following 
inoculation, with higher bacterial loads than those being observed in MyD88
-/-
 
mice (Fig. 13A-B). Infected wild-type mice were strongly positive for 
Acinetobacter-specific antibodies, predominantly of IgG3 isotype (Fig. 13C). 
Interestingly, infected MyD88
-/-
 mice also developed mainly IgG3 antibodies 
specific to Acinetobacter, but they were significantly lower than those observed in 
infected MyD88
+/+
 mice (Fig. 13C). No significant bacteria-specific IgG2c or 
IgG1 antibodies were detected (Fig. 13D-E). Thus, infection with a non-
intracellular Gram-negative pathogen failed to induce hypergammaglobulinemia 
in MyD88
-/-
 mice, as observed with Salmonella bacteria.  
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Fig. 13. No evidence for immunoglobulin dysregulation in MyD88
-/-
 mice following 
infection with Acinetobacter baumanii. Two months post i.p. infection with a dose of ~1 
x 10
5
 CFUs/mouse of A. baumanii, bacterial counts in spleen (A) and liver (B) were 
enumerated. Serum levels of anti-acinetobacter IgG3 (C), IgG2c (D) and IgG1 (E) 
isotypes were determined at 6-8 weeks post -infection.(*, p<0.05, ****, p<0.0001). Data 
are compiled from 2 independent experiments. 
 
 
 
 
M
yD
88
+/
+  N
I
M
yD
88
-/
-  N
I
M
yD
88
+/
+  (
N
M
97
)
M
yD
88
-/-
 (N
M
97
)
0.0
0.5
1.0
1.5
Ig
G
3
 O
.D
****
****
M
yD
88
+/
+  N
I
M
yD
88
-/
-  N
I
M
yD
88
+/
+  (
N
M
97
)
M
yD
88
-/-
 (N
M
97
)
0.0
0.5
1.0
1.5
Ig
G
2
c 
O
.D
M
yD
88
+/
+  N
I
M
yD
88
-/
-  N
I
M
yD
88
+/
+  (
N
M
97
)
M
yD
88
-/-
 (N
M
97
)
0.0
0.5
1.0
1.5
Ig
G
1
 O
.D
(C) 
(E) 
(D) 
M
yD
88
+/
+
M
yD
88
-/-
101
102
103
104
105
C
F
U
s/
S
p
le
en
*
M
yD
88
+/
+
M
yD
88
-/
-
102
103
104
105
C
F
U
s/
g
 L
iv
er
(A) 
(B) 
89 
 
        The presence of antibodies specific to dsDNA and thyroglobulin was also 
tested in these mice following Acinetobacter infection. However, no 
autoantibodies were detectable in any of the experimental groups (Fig. 14A-B). 
Furthermore, there was no evidence of antibody dysregulation or autoantibody 
production in MyD88
-/- 
mice infected with the Gram-positive bacteria, Group B 
Streptococcus (Streptococcus agalactiae), or another Gram-negative pathogen E. 
coli (data not shown).  
 
 
 
Fig. 14. Serum reactivity to dsDNA and thyroglobulin following A. baumanii 
infection. Serum reactivity to dsDNA (A) and thyroglobulin (B) were determined 6-8 
weeks post-infection with A. baumanii. The cut off for the detection of these 
autoantibodies was determined at 1/1000 dilution. Data are compiled from 2 independent 
experiments.  
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        The capacity of heat-killed (HK) Salmonella (strain BRD509) to induce a 
state of hypergammaglobulinemia was also tested. Following injection with          
2 x 10
5
 HK Salmonella organisms, low levels of IgG3 antibodies were detected in 
MyD88
+/+
 mice which were similar to the levels produced after live infection (Fig. 
15A). In contrast to infection with live bacteria, however, no IgG2c antibodies 
were detected in response to HK bacteria in MyD88
+/+
 mice (Fig. 15B). Another 
difference in isotype profile, was the induction of IgG1 antibodies seen in 
MyD88
+/+
 mice after injection of HK, but not live, Salmonella (Fig. 15C). In 
sharp contrast to live Salmonella infection, MyD88
-/-
 mice injected with HK 
BRD509 strain produced largely IgG1 but not any significant IgG3 or IgG2c 
isotype antibodies (Fig. 15A-C). Thus, injection with HK bacteria favors the 
induction of predominantly Salmonella-specific IgG1 antibodies in both mouse 
strains with no evidence of hypergammaglobulinemia being observed in MyD88
-/-
 
mice. 
        In line with these observations, sera collected from HK Salmonella-injected 
mice also failed to show any reactivity to dsDNA. This was true for both wild-
type and MyD88
-/-
 mice (Fig. 15D). Taken together, these results indicate that 
heat-killed Salmonella fail to induce dysregulated antibodies, suggesting the 
nature of the bacterial antigen is critical for the observed breakdown in self-
tolerance that is observed in MyD88
-/-
 mice.  
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Fig. 15. Absence of immunoglobulin dysregulation and autoantibodies in MyD88
-/-
 
mice following injection of heat-killed BRD509. Serum levels of Salmonella-specific 
IgG3 (A), IgG2c (B) and IgG1 (C) antibodies were determined at 8 weeks post i.p 
inoculation of 2 x 10
5 
heat-killed (HK) BRD509 in comparison to those observed in 
response to live BRD509 infection. (D) Serum reactivity to dsDNA in heat-killed vs live 
Salmonella infected mice. The cut-off for the detection of dsDNA was determined at 
1/1000 dilution. Data are compiled from 2 independent experiments (*, p<0.05; **, 
p<0.01; ***, p<0.001). 
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4.7. Regulation of hypergammaglobulinemia by cytokine-expressing 
Salmonella strains 
        It is clear from the data thus far, that infection of MyD88
-/-
 mice with an 
attenuated strain of Salmonella leads to dysregulated humoral immune responses 
in which pathogen-specific antibodies of all IgG isotypes are produced at high 
levels. Immunoglobulin class switching is largely regulated by T cell-derived 
cytokines such as IFN-γ and IL-4, which are produced by Th1 and Th2 cells, 
respectively. Our laboratory has previously demonstrated the potential of 
manipulating the anti-Salmonella immune response in wild-type mice by using 
recombinant Salmonella strains engineered to express specific murine cytokines 
(al-Ramadi et al., 2001); (Al-Ojali et al., 2012b). Two of these strains, GIDIL2 
and GIDIFN, which express IL-2 and IFN-γ respectively, were therefore used to 
study their effect on humoral immune responses in MyD88
-/-
 mice. These 
cytokines are important regulators of the Th1 response required for protection 
against intracellular bacterial infection in C57BL/6 mice. The bacterial load in the 
spleen and liver were determined at 4 weeks post-infection with a low dose of 
BRD509 (~200 CFUs/mouse) (as shown earlier) or GIDIFN. As described earlier, 
the bacterial loads in the spleen and liver of MyD88
-/-
 mice after BRD509 
infection were 100-200 fold greater than in the infected wild-type mice (Fig. 16A-
B). Similarly, using the GIDIFN strain, the bacterial load recovered in the target 
organs of the MyD88
−/−
 mice were 400-500 fold greater than in the wild-type 
mice (Fig. 16A-B). Notably, the bacterial loads in GIDIFN-infected MyD88
-/-
 
mice were 1.5-2.6 fold lower than those infected with BRD509. In MyD88
+/+
 
mice, the differences in bacterial loads between BRD509- and GIDIFN-infected 
mice approached 4-9 fold (Fig. 16A-B). This suggests that IFNγ-expressing 
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Salmonella strain is cleared more robustly by both mouse strains compared to 
BRD509. The observations in wild-type mice are consistent with previous data 
from our laboratory (Al-Ojali et al., 2012a). 
 
 
 
Fig. 16. Hypersusceptibility of MyD88
-/-
 mice to infection with an IFN-γ-expressing 
Salmonella strain, GIDIFN. Mice were inoculated i.p. with GIDIFN or its parental strain 
BRD509 (~200 CFUs/mouse) Bacterial loads in the spleen (A) and liver (B) were 
enumerated at 4 weeks post-infection (*, p<0.05; **, p<0.01). 
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        Salmonella-specific antibody responses were compared in normal or  
MyD88
-/-
 mice 4-6 weeks following a low dose (~200 CFUs/mouse) infection 
with GIDIFN, GIDIL2 or BRD509 strain. In C57BL/6 mice, significant titers of 
IgG3 and IgG2c isotypes were observed after infection, with the former being 
predominant in BRD509-infected mice and the latter in mice infected with either 
GIDIL2 or GIDIFN strain (Fig. 17A-B). Importantly, no IgG1 antibodies were 
detectable in wild-type mice following infection with any of the Salmonella 
strains (Fig. 17C). In contrast, compared to wild-type animals, MyD88
-/-
 mice 
consistently produced significantly higher levels of antibodies of all three isotypes 
to all Salmonella strains, with the sole exception of IgG2c isotype in GIDIL2-
infected mice (Fig. 17A-C). It is also interesting to note that infection with 
GIDIFN, but not GIDIL2, strain appeared to enhance Th1-driven isotypes (IgG2c 
and IgG3) and reduce Th2-driven IgG1 isotype in MyD88
-/-
 mice. Overall, a state 
of hypergammaglobulinemia was still evident in MyD88
-/-
 animals following 
infection with recombinant, cytokine-expressing, Salmonella strain.  
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Fig. 17. Induction of hypergammaglobulinemia in MyD88
-/-
 following infection with 
two different cytokine-expressing Salmonella strains. Mice were inoculated i.p. (~200 
CFUs/mouse) with BRD509 or its recombinant derivatives, the IFNγ-expressing 
(GIDIFN) or IL-2-expressing (GIDIL2) strain. Salmonella-specific antibodies of the IgG3 
(A), IgG2c (B) or IgG1 (C) isotypes were determined at 4-6 weeks post-infection. Data 
are compiled from 2 independent experiments for cytokine expressing strains and 3 
independent experiments for the BRD509 strain (*, p<0.05; **, p<0.01; ***, p<0.001). 
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        The presence of autoreactive antibodies specific to dsDNA and thyroglobulin 
was determined in sera of infected mice at 4-6 weeks post inoculation. As shown 
in Fig. 18A-B, significant reactivity to the two self antigens was observed in  
MyD88
-/-
 mice infected with the BRD509 strain. Sera of MyD88
-/-
 animals 
infected with either GIDIFN or GIDIL2 failed to exhibit any significant reactivity 
to self antigens. Sera of infected wild-type mice, regardless of the Salmonella 
strain used, were also negative. 
 
 
Fig. 18. No evidence for autoantibody induction in mice infected with cytokine-
expressing Salmonella strains. Serum reactivity to dsDNA (A) and thyroglobulin (B) 
following infection with BRD509, GIDIFN or GIDIL2 Salmonella strains in WT and 
MyD88
-/- 
mice. The cut off for the detection of autoantibodies was determined at 1/1000 
dilution. Data are compiled from 2 independent experiments for cytokine expressing 
strains and 3 independent experiments for the BRD509 strain (**, p<0.01). 
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4.8. Flowcytometric analysis of the cellular alterations following infection of 
MyD88
+/+
 and MyD88
-/-
 mice 
        In an effort to better understand the underlying mechanism for the observed 
hypergammaglobulinemia in MyD88
-/-
 mice, the cellular changes in the spleen 
following infection were characterized by flowcytometry. This analysis was 
carried out at 3 weeks post-infection since this is the time at which elevated serum 
antibodies began to be observed. Normal or MyD88
-/-
 mice were infected with 
~3000 CFUs/mouse of BRD509 strain and sacrificed at day 21 for analysis. As 
expected, inoculation of MyD88
-/-
 mice with this rather low dose of attenuated 
Salmonella results in bacterial persistence in target organs as evidenced by the 
significantly larger loads in liver and MLNs (Fig. 19C-D). This is accompanied by 
a protracted state of splenomegaly in MyD88
-/-
 mice characterized by significantly 
larger (~3.8-fold) spleens compared to infected MyD88
+/+
 mice (Fig. 19A-B).  
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Fig. 19. Splenomegaly elevated bacterial organ loads in infected MyD88
-/-
 mice. Mice 
infected with BRD509 (3000 CFUs/mouse) were sacrificed at day 21. Significantly 
enlarged spleens are observed, particularly in infected MyD88
-/-
 mice (panels A-B).  
Spleens of non-infected (NI) groups are shown for comparison (A-B). Bacterial loads in 
liver (C) and MLNs (D) were also determined. This data is a representative of 3 
independent experiments (*, p<0.05, ***, p<0.001). 
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        Flowcytometric analysis was carried out on spleen cell populations from non-
infected as well as infected animals using a panel of monoclonal antibodies 
(mAbs) specific to each major cell population as well as a series of activation 
markers for each cell subpopulation. Based on staining with a combination of 
mAbs to CD11b and Gr-1 cell surface molecules, three CD11b
+
 myeloid 
subpopulations could be discerned, Gr-1
H
, Gr-1
Int
 and Gr-1
L
 which represent 
granulocytes, activated macrophages and monocytes, respectively (Fig. 20). In the 
spleens of non-infected C57BL/6 mice, the mean percentages of each of these 
populations were 2.0 ± 0.5, 3.2 ± 0.7, and 6.2 ± 1.3, respectively (Fig. 20A and 
Fig. 21A). By day 21 post-infection with BRD509 strain, a time by which the 
infection has been largely resolved in wild-type mice, the respective percentages 
were 4.4 ± 0.4, 6 ± 0.7, and 5.2 ± 0.5 (Fig. 20C and Fig. 21A), representing about 
2-fold increase in percentage of Gr-1
H
 and Gr-1
Int
 myeloid cell populations. The 
cellular changes observed in the spleens of MyD88
-/-
 mice were more profound 
(Fig. 20B, D and Fig. 21A); the percentages of Gr-1
H
, Gr-1
Int
 and Gr-1
L
 cells 
increased from 0.7 ± 0.2, 1.8 ± 0.1, and 4.7 ± 0.4 in non-infected mice to 3.7 ± 0.5, 
14.2 ± 2.2, and 4.5 ± 0.3 in infected animals, respectively. These results represent 
~5-fold and ~8-fold increase in Gr-1
H
 and Gr-1
Int
 myeloid cells, largely as a 
consequence of the persistent infection in MyD88
-/-
 mice. No significant 
differences were observed in the CD11b
+
Gr-1
low 
myeloid subpopulation in either 
mouse strain (Fig. 21A).  
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Fig. 20. Flow cytometric analysis of inflammatory myeloid cell influx and activation 
status in the spleen. Splenocytes were prepared from non-infected (A-B) or Salmonella-
infected (C-D) MyD88
+/+
 (A, C) or MyD88
-/-
 (B, D) mice and analyzed for CD11b and 
Gr-1 positivity. Analysis was done on day 21 post-infection with the BRD509 strain. 
Based on level of expression of Gr-1 protein, three distinct CD11b
+
 myeloid populations 
could be discerned in each experimental mouse group, CD11b
+
Gr-1
high
 (top panel), 
CD11b
+
Gr-1
Inter
 (middle panel), and CD11b
+
Gr-1
−/low
 (bottom panel). Each of these sub-
populations was further analyzed for the expression of CD80 and Sca-1 activation 
markers, as indicated. Cell percentages are shown in each quadrant. Results of individual 
mice are shown and are representative of four independent experiments. 
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        The activation status of the various populations of myeloid cells was also 
assessed by co-staining with antibodies to Sca-1 and CD80 proteins. Salmonella 
infection induced a dramatic upregulation of Sca-1 expression on all myeloid cell 
populations in both mouse strains. Within the infected groups, the level of Sca-1 
expression was higher in MyD88
-/-
 than in MyD88
+/+
 mice (Fig. 21B). This 
suggests a robust IFNγ-driven up regulation following infection. Interestingly in 
the
 
Gr-1
L 
monocytic populations, the MyD88
-/-
 controls exhibited a higher level of 
Sca-1 expression than the wild-type control group (Fig. 21B). Regarding CD80 
expression, the majority of myeloid cells in non-infected mice showed substantial 
levels of CD80 (Fig. 21C) and there was no significant alteration in the expression 
of this costimulatory molecule in any of the myeloid populations after infection in 
either of the two mouse strains (Fig. 20C-D and 21C). Thus, by day 21 post 
inoculation, persistence of Salmonella infection in MyD88
-/-
 mice correlated with 
increased expansion of activated splenic macrophages and granulocytes which 
was more apparent than in MyD88
+/+
 counterparts in which the infection had 
largely been resolved by that time.  
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Fig. 21. Quantification of alterations in splenic myeloid cell sub-populations and 
their activation status following infection. (A). Percentages of CD11b
+
 myeloid cells 
expressing either high, intermediate or low levels of Gr-1 protein in non-infected or 
BRD509-infected MyD88
+/+
 or MyD88
-/-
 mice. (B-C) Alterations in expression of Sca-1 
(B) or CD80 (C) proteins in the different myeloid subpopulations. Graphs are compiled 
from 4 independent experiments (*, p<0.05, **, p<0.01). 
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4.9. Enhanced lymphocyte activation in the spleens of Salmonella-infected 
MyD88
-/-
 mice 
        We further assessed the splenic population of B lymphocytes (Fig. 22A) and 
their activation status after infection at day 21. In saline-treated MyD88
-/-
 mice, 
CD19
+
 B lymphocytes constituted ~55% of the splenic population which was 
slightly higher than those observed in the wild-type strain (~49.3%). After 
Salmonella infection, percentage of B lymphocytes decreased to 37% in MyD88
-/-
 
mice compared to 44% in MyD88
+/+ 
mice (Fig. 22B).  
 
 
Fig. 22. Flow cytometric analysis of splenic CD19
+
 B lymphocytes in various 
experimental animal groups. (A) representative dot blot of gated CD19
+
 cells. (B) 
Percentage of CD19
+
 B cells in infected and non-infected groups. Analysis was done on 
day 21 post-infection with the BRD509 strain. Data are compiled from 4 independent 
experiments (**, p<0.01). 
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        The activation status of B cells was determined by evaluating the expression 
of Sca-1, CD80 and CD86 markers. Representative dot plots of Sca-1 and CD80 
staining are shown in Fig. 23 and quantitative analysis for each marker is shown 
in Fig. 24A-C. The majority of B cells from both mouse strains (51% and 75% in 
MyD88
+/+
 and MyD88
-/-
, respectively) were positive for Sca-1 in normal animals. 
After infection, the percent positive cells increased to 92% and 99%, respectively 
(Fig. 23C-D and Fig. 24A). In contrast, CD80 expression was not induced upon 
infection on B cells of either mouse strain (Fig. 24B). However, the percentage of 
B cells expressing CD86 increased by 2-fold and 3-fold in infected MyD88
+/+
 and 
MyD88
-/-
 mice, respectively (Fig. 24C). Thus, B lymphocytes of MyD88
-/-
 mice 
appear to be at a heightened level of activation, especially after Salmonella 
infection. 
 
Fig. 23. Increased B lymphocyte activation in the spleens of MyD88
-/-
 mice following 
infection with Salmonella. Dot plots depicting the level of expression of Sca-1 and 
CD80 proteins on gated CD19
+
 B cells in non-infected (A-B) and Salmonella infected (C-
D) MyD88
+/+
 (A, C) or MyD88
-/-
 (B, D) mice. Numbers within quadrants represent 
percentage of positive cells in that population. Analysis was done on day 21 post-
infection with the BRD509 strain. Results of individual mice are shown and are 
representative of four independent experiments. 
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Fig. 24. Changes in expression level of activation markers on B lymphocytes. 
Percentages of CD19
+
 lymphocytes expressing Sca-1 (A), CD80 (B) or CD86 (C) proteins 
in non-infected or BRD509-infected MyD88
+/+
 or MyD88
-/-
 mice. . Analysis was done on 
day 21 post-infection with the BRD509 strain. Graphs are compiled from 4 independent 
experiments (*, p<0.05, **, p<0.01, ***, p<0.001). 
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        The splenic CD3
+
 T cell populations, their subsets and activation status were 
also evaluated at day 21 post-infection. A representative dot plot of the gated 
CD3
+
 T cells (Fig. 25A) and their CD4
+
 and CD8
+
 subsets (Fig. 25C) is shown. 
The CD3
+
 T cells constituted up to 33% of the splenic populations in wild-type 
mice which did not change significantly on infection (Fig. 25B). However, 
infected MyD88
-/-
 mice were observed to have significantly lower percentages 
(~26%) of CD3+ T cells (Fig. 25B). On evaluating the T cell subsets, the decrease 
of CD3
+
 T cells in the infected MyD88
-/-
 mice constituted mainly a reduction in 
the percentage of CD8
+
 T cells and not CD4
+
 T cells (Fig. 25D).  
 
Fig. 25. Changes in splenic T lymphocyte populations following infection. 
Representative dot plot of gated CD3
+ 
T lymphocytes (A) and CD4 and CD8 
subpopulations (C) within gated CD3
+
 cells. (B). Changes in the percent of CD3
+
 
lymphoid cells in the whole spleen. (D) Changes in the ratios of CD4
+
 and CD8
+
 cells 
within the T cell populations. Analysis was done on day 21 post-infection with the 
BRD509 strain. Graphs are compiled from 4 independent experiments for (B) and (D) 
(**, p<0.01). 
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        Using appropriate gates, the expression of activation markers CD25 and Sca-
1 was studied on CD4
+
 and CD8
+
 T cells (Fig. 26 and 27). Similar to previous 
observations with B cells, the great majority of CD4
+
 T cells in uninfected spleens 
(76% and 85% in MyD88
+/+
 and MyD88
-/-
 mice, respectively) were positive for 
Sca-1 antigen (Fig. 26A-B). These percentages were further increased to >94% in 
infected mice. A much more limited expression of CD25 was observed on CD4
+
 T 
cells (Fig. 26A, C). In non-infected mice, only 7-8% of CD4
+
 T cells were 
positive for CD25 (Fig. 26C). The only significant alteration to this ratio was 
observed in infected MyD88
-/-
 mice where the percentage of positive CD4
+
 CD25
+
 
T cells increased to ~12% (Fig. 26C). For CD8
+
 T cells, the percentage positive 
for Sca-1 antigen was 45% and 59% in uninfected MyD88
+/+
 and MyD88
-/-
 mice, 
respectively, which was increased to 84% and 98% in the corresponding infected 
groups (Fig. 27A-B). As for CD25 expression, the only significant alteration was 
the increase in ratio of positive cells to 5.4% in infected MyD88
-/-
 mice, most 
likely a response to an ongoing active infection (Fig. 27C).  
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Fig. 26. Increased CD4
+
 T cell activation in the spleens of MyD88
-/-
 mice following 
infection with Salmonella. (A) Expression of Sca-1 and CD25 proteins on gated CD4
+
 T 
cells. Changes in the percent of cells positive for Sca-1 (B) or CD25 (C) are shown. 
Analysis was done on day 21 post-infection with the BRD509 strain (A) Results of 
individual mice are shown and are representative of four independent experiments. (B-C) 
Data are compiled from 4 independent experiments (*, p<0.05, ***, p<0.001). 
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Fig. 27. Increased CD8
+
 T cell activation in the spleens of MyD88
-/-
 mice following 
infection with Salmonella. (A) Expression of Sca-1 and CD25 proteins on gated CD8
+
 T 
cells. Changes in the percent of cells positive for Sca-1 (B) or CD25 (C) are shown. 
Analysis was done on day 21 post-infection with the BRD509 strain. (A) Results of 
individual mice are shown and are representative of four independent experiments. (B-C) 
Data are compiled from 4 independent experiments (***, p<0.001). 
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        The absolute numbers of the myeloid and lymphoid cells were also 
determined per spleen. The most noticeable changes in cell number were observed 
in the CD11b
+
 myeloid cell populations. Compared to non-infected spleens, there 
were 3-fold and 6-fold increase in these cells in MyD88
+/+
 and MyD88
-/-
 mice, 
respectively (Fig. 28A). Correlating with the chronicity of infection in MyD88
-/-
 
mice, we observed a 40% increase in splenic myeloid cell number compared to 
infected MyD88
+/+
 counterparts (Fig. 28A). In general, infected spleens also had 
increased lymphocyte numbers but to a much lesser extent than the myeloid 
population. The increases in lymphocyte populations averaged 30-40% above 
those in non-infected spleens for B lymphocytes for both mouse strains (Fig. 
28B).  For T lymphocytes, the increases in absolute cell number were 44% and 
112% in infected MyD88
+/+
 and MyD88
-/-
 mice, respectively (Fig. 28C). 
Therefore, the changes in absolute cell number of myeloid cells are in agreement 
with the observed cell percentages calculated from the flow cytometry data. 
However, for the B and T lymphocyte populations, the changes in absolute cell 
numbers following infection were not as dramatic as for myeloid cells. These 
findings confirm the predominance of myeloid cells in the cellular influx into the 
spleen, as a result of Salmonella infection. 
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Fig. 28. Changes in spleen cellularity expressed in terms of absolute cell counts. 
Absolute counts of CD11b
+ 
myeloid cells (A), CD19
+
 B lymphocytes (B) and CD3
+
 T 
lymphocytes (C) per spleen. Analysis was done on day 21 post-infection with the 
BRD509 strain. Data are compiled from 3 independent experiments (*, p<0.05, **, 
p<0.01). 
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4.10. Dysregulated T helper cells responses in MyD88
-/-
 mice after Salmonella 
infection 
        Given the hyper antibody responsiveness and the dysregulated isotypes 
observed in MyD88
-/-
 mice, and the fact that these responses are T cell-dependent, 
we compared gene expression profiles of purified splenic CD4
+
 T (Fig. 29A) cells 
isolated from the different experimental groups at day 21 post-infection. The 
transcriptional level of IFN-γ was significantly elevated (27-32 fold) upon 
infection with Salmonella in both MyD88
+/+
 and MyD88
-/-
 mice (Fig. 29B). This 
was correlated with increased expression of t-bet, the transcriptional factor 
responsible for Th1 differentiation (Fig. 29C). Moreover, CD4
+
 T cells from 
infected MyD88
-/-
, but not wild-type, mice expressed significant levels of IL-4 and 
IL-21, signature cytokines of Th2 and TFH cells, respectively. The significant level 
of constitutive IL-4 expression in uninfected MyD88
-/-
 mice was noteworthy 
which further increased upon Salmonella infection to a level that was 10-fold 
higher than infected MyD88
+/+
 mice (Fig. 29B). Another intriguing difference in 
cytokine transcriptional activity was observed with IL-10 which was expressed at 
low levels in CD4
+
 T cells of infected wild-type mice (~2.5-fold over background) 
but was significantly elevated (~14-fold) in infected MyD88
-/-
 mice (Fig. 29B). 
Finally, no evidence for IL-17 or TGF-β production by CD4+ T cells of any of the 
groups was observed. Of all of the transcription factors analyzed, only t-bet was 
expressed at high levels by both MyD88
+/+
 and MyD88
-/-
 CD4
+
 T cells (Fig. 29C). 
No evidence for expression of GATA-3, RoR γ, or Bcl-6 was seen. Curiously, 
significant levels of Foxp3 were expressed by CD4
+
 T cells of non-infected 
MyD88
-/-
 mice, but this was curtailed following infection (Fig. 29C). This 
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suggests a reduced expansion of the Treg cells in the absence of MyD88 as a 
result of a persistent Salmonella infection. 
 
 
 
 
Fig. 29. Gene expression profiles in purified CD4
+
 T lymphocytes. (A). Representative 
dot plots of splenic CD4
+
 T cells before and after purification. Gene expression levels of 
key cytokines (B) and transcription factors (C) in CD4
+
 T cells of different experimental 
groups were analyzed by quantitative real-time PCR. Analysis was done on CD4
+
 T cells 
purified from non-infected or Salmonella-infected mice (~3000 CFUs/mouse) at day 21. 
Alterations in gene expression are depicted as fold-change compared to non-infected WT 
mice. Data are compiled from 2-3 independent experiments (*, p<0.05, **, p<0.01, ***, 
p<0.001). 
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        Given the increased infiltration of inflammatory myeloid cells into the 
spleens of MyD88
-/-
 mice at day 21 of infection, the capacity of purified myeloid 
cells (Fig. 30A) to produce inflammatory mediators was assessed. The highest 
transcriptional activity observed was for iNOS, which was expressed at >1000-
fold higher levels in both MyD88
+/+
 and MyD88
-/-
 myeloid cells compared to 
uninfected controls (Fig. 30B). Equivalent levels of induction of IL-6 and IL-
12p35 were also evident in both mouse strains. Interestingly, a small but 
significant level of expression was observed for BAFF, a cytokine associated with 
polyclonal B cell responses and autoimmune diseases, in MyD88
-/-
 mice (Fig. 
30A). Consistently, this induction was absent in infected wild-type mice.   
 
Fig. 30. Gene expression profiles in purified CD11b
+
 myeloid cells. (A). 
Representative dot plots of splenic CD11b
+
 cells before and after purification. Gene 
expression levels of BAFF, IL-12p35 and IL-6 (B) and iNOS (C) in myeloid cells of 
different experimental groups were analyzed by quantitative real-time PCR. Analysis was 
done on myeloid cells purified from non-infected or Salmonella-infected mice (~3000 
CFUs/mouse) at day 21. Alterations in gene expression are depicted as fold-change 
compared to non-infected WT group (*, p<0.05). 
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        In order to validate cytokine production by CD4
+
 T cells, purified cells were 
stimulated with a combination of plate-bound anti-CD3/CD28 mAbs for 24 hours 
after which culture supernatants were collected and assayed for IFN-γ, IL-4 and 
IL-10 content. In confirmation of gene expression data, CD4
+
 T cells of infected 
MyD88
+/+
 or MyD88
-/-
 mice secreted abundant levels of IFN-γ reaching up to 14.3 
ng/ml and 11.5 ng/ml, respectively (Fig. 31A). In sharp contrast, IL-4 secretion 
was detected only from MyD88
-/-
 CD4
+
 T cells, which is in agreement with the 
gene expression findings (Fig. 31C). Interestingly, CD4
+
 T cells from uninfected 
MyD88
-/-
, but not MyD88
+/+
, mice could also secrete IL-4 upon induction via the 
TCR, suggesting an endogenous predisposition to Th2 responses in these mice 
(Fig. 31C). Moreover, high levels of IL-10 (mean of 2174 pg/ml) were uniquely 
observed in Salmonella-infected MyD88
-/-
 mice (Fig. 31B). Overall, the data 
suggest the prevalence of CD4
+
 T cells producing both the proinflammatory 
cytokine IFN-γ and/or anti-inflammatory cytokines IL-4 and IL-10 in MyD88-/- 
mice, following infection with BRD509. This contrasts with wild-type mice that 
exhibit predominantly Th1-mediated immune responses against Salmonella 
infection. 
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Fig. 31. Evidence of IL-4 and IL-10 production by purified CD4
+
 T cells in infected 
MyD88
-/-
 mice. Secretion of IFN-γ (A), IL-10 (B) and IL-4 (C) by purified CD4+ T cells 
after stimulation with plate-bound anti-CD3/CD28 antibodies. CD4
+ 
T cells were purified 
from non-infected or Salmonella-infected spleens of WT and MyD88
-/- 
mice at day 21 
post-infection. Data are compiled from 2 independent experiments (*, p<0.05, **, p<0.01, 
***, p<0.001). 
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        An important question that was still unanswered by the above data was 
whether the proinflammatory (IFN-γ) and anti-inflammatory cytokines (IL-4 and 
IL-10) were produced by the same or distinct populations of CD4
+
 T cells. To 
address this issue, we carried out intracellular cytokine analysis by flowcytometry. 
Highly purified CD4
+
 T cells from infected or uninfected mice were stimulated 
overnight with anti-CD3/CD28 antibodies and assessed for the intracellular levels 
of IFN-γ, IL-4 and IL-10 cytokines. No evidence for any IL-10 production was 
observed when CD4
+
 T cells from any of the 4 experimental groups of animals 
were cultured without TCR stimulation (Fig. 32; Control groups). Similarly, less 
than 1% of CD4
+
 T cells in unstimulated cultures were positive for IFN-γ. The 
same was also true for IL-4 production (Fig. 33). After TCR ligation, the 
percentage of CD4
+
 T cells from uninfected mice that were positive for IFN-γ was 
~2.3% and 0.7% for MyD88
+/+
 and MyD88
-/-
 mice, respectively (Figs. 33). After 
infection, the percentage of cells positive for IFN-γ increased dramatically to 21% 
and 30%, respectively.  We focused our attention on defining populations of CD4
+
 
T cells that co-expressed both IFN-γ and IL-4 or IFN-γ and IL-10. In infected 
MyD88
-/-
 mice, approximately 4.2% of CD4
+
 T cells were IFN-γ+IL-10+ (Fig. 32 
and Fig. 34B). Importantly, there was no evidence for equivalent cells in infected 
MyD88
+/+
 mice. In terms of IL-4/IFN-γ co-expressers, approximately 2% of CD4+ 
T cells from infected MyD88
-/-
 mice were positive, which was significantly 
different from the case in infected wild-type mice (Fig. 33 and Fig. 34C).  
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Fig. 32. Co-production of IFN-γ and IL-10 by CD4+ T cells of MyD88-/- mice 
following Salmonella infection. Cytokine secretion by purified T cells was detected by 
intracellular staining for IFN-γ and IL-10. Purified CD4+ T cells were cultured with or 
without overnight stimulation with plate bound anti-CD3/CD28 antibodies and analyzed. 
CD4
+
 T cells were purified from non-infected or Salmonella-infected spleens of WT and 
MyD88
-/- 
mice at day 21 post-infection Percent of various cell populations is shown in 
each quadrant. The data are representative of three independent experiments. 
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Fig. 33. Co-production of IFN-γ and IL-4 by CD4+ T cells of MyD88-/- mice following 
Salmonella infection. Cytokine secretion by purified T cells was detected by intracellular 
staining for IFN-γ and IL-4. Purified CD4+ T cells were cultured with or without 
overnight stimulation with plate bound anti-CD3/CD28 antibodies and analyzed. CD4
+
 T 
cells were purified from non-infected or Salmonella-infected spleens of WT and MyD88
-/- 
mice at day 21 post-infection Percent of various cell populations is shown in each 
quadrant. The data are representative of three independent experiments. 
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Fig. 34. Graphical representation of intracellular cytokine data. (A) Percent of IFN-γ-
expressing
 
CD4
+
 T cells. Percent of IFN-γ+ IL-10+ (B) and IFN-γ+ IL-4+ double positive 
(C) cells in different experimental groups. Data points depict the mean ± SEM of 3 
(infected) or 2 (non-infected) mice per group. (**, p<0.01) 
 
(A) 
(B) 
(C) 
0
1
2
3
4
5
*
*
IF
N
-g
+
 I
L
-1
0
+
0
10
20
30
40
**
**
**
C
D
4
+
IF
N
-g
+
M
yD
88
+/
+  N
I
M
yD
88
-/-  N
I
M
yD
88
+/
+  I
M
yD
88
-/-  I
0.0
0.5
1.0
1.5
2.0
**
**
IF
N
-g
+
 I
L
-4
+
121 
 
        To validate the presence of cytokine co-expressers among the peripheral 
CD4
+
 T cell pool in infected MyD88
-/-
 mice, we carried out a similar analysis in a 
non-related mouse strain that was deficient in CD154 protein. These mice are 
hypersusceptible to Salmonella infection because of a defect in T-cell-dependent 
macrophage activation and antibody responses (al-Ramadi et al., 2006). These 
mice were infected with a dose of about 0.5 x 10
6
 CFUs/mouse, sacrificed three 
weeks later and splenic CD4
+
 T cells were purified and analyzed by intracellular 
staining following CD4
+
 T cell stimulation, as described earlier. A substantial 
percentage (17-18%) of stimulated CD4
+
 T cells was positive for IFN-γ as 
opposed to cells from non-infected mice that exhibited only 1.6% positivity. 
Importantly, however, there was no evidence of any IFN-γ/IL-10 or IFN-γ/IL-4 
co-expressers among the infected spleens in these mice (Fig. 35). This suggests 
that the observed phenomenon in MyD88
-/-
 mice is associated with the 
dysfunction of the adaptor molecule at the level of innate immune response to the 
intracellular pathogen and hence, possibly the induction of other compensatory 
pathways that lead to the expansion of these specialized CD4
+
 T cells.
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Fig. 35. No evidence for co-production of IFN-γ /IL-4 or IFN-γ /IL-10 by CD4+ T 
cells from Salmonella infected CD154
-/-
 (CD40L
-/-
) mice. CD40L
-/- 
mice were infected 
with 0.5 x 10
6
 CFUs/mouse of BRD509 and sacrificed 3 weeks later. The expression of 
IFN-γ, IL-10 and IL-4 in purified splenic CD4+ T cells was determined by intracellular 
cytokine staining following overnight stimulation with plate bound anti-CD3/CD28 
antibodies.  
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5. DISCUSSION 
        We and others have previously demonstrated the critical importance of the 
TLR-MyD88 pathway in defense against microbial infections (Sukhumavasi et al., 
2008); (Talbot et al., 2009); (Weiss et al., 2004); (Issac et al., 2013). In our 
laboratory, mice lacking the MyD88 signaling pathway were shown to be 
hypersusceptible even to low doses of an attenuated, double auxotrophic, strain of 
Salmonella enterica serovar Typhimurium (S. Typhimurium), as a result of 
defective clearance of the pathogen. This is mainly due to the delayed recruitment 
of inflammatory cells and defective production of inflammatory cytokines that are 
critical for controlling early phase of infection (Issac et al., 2013). In the case of 
the facultative intracellular pathogen, S. Typhimurium, susceptibility to infection 
was accompanied by the peculiar phenomenon of hypergammaglobulinemia (Issac 
et al., 2013). This study is aimed at defining the cellular and molecular parameters 
that predispose to dysregulated immunoglobulin synthesis and, by extension, 
autoantibody production.  
        In the present study, the aberrant antibody responses developed within the 
context of a strong CD4
+
 T cell-generated IFN- response combined with a 
background of Th2-biased immune responsiveness that was exhibited by MyD88
-/-
 
mice. Interestingly, small but significant levels of IFN-/IL-4 and IFN-/IL-10 co-
producing CD4
+
 T cells were uniquely observed in Salmonella-infected MyD88
-/-
 
mice.  The dysregulated antibody responses were largely driven by Salmonella 
infection in a time and dose-dependent fashion and culminated in production of 
antibodies reactive to several types of ubiquitous self-antigens. Given the defect in 
B lymphocyte central tolerance observed in infants born with a deficiency in 
MyD88 (Isnardi et al., 2008), it is plausible that a similar phenomenon exists in 
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MyD88-deficient mice, leading to the production of potentially self-reactive B cell 
clones. As a result of delayed clearance of bacteria, persistent Salmonella 
infection could lead to the activation of idle autoreactive B cells in MyD88
-/-
 mice. 
This could also lead to the expansion of distinct populations of IFN-γ+ T cells and 
extrafollicular CD4
+
 T helper cells that possibly activate aberrant B cell responses 
and autoantibody production. 
5.1. MyD88 signaling is crucial for early phase control of bacterial growth 
        The BRD509 strain of S.Typhimurium has a slow growth rate due to the 
inability to synthesize essential aromatic compounds. In the early phase of 
infection, the survival and growth of Salmonella in C57BL/6 mouse is determined 
by the induction of SPI-2 encoded virulence factors (Cirillo et al., 1998); (Pfeifer 
et al., 1999). The innate immune response that involves the bactericidal effector 
function as a result of activation of the host macrophages, plays a vital role in the 
control of the proliferation of the pathogen.  Although TLRs have a critical role in 
protection against bacterial infections, there is data that suggests that S. 
Typhimurium can exploit the TLR signaling in macrophages for enhanced 
intracellular replication and survival. One study demonstrated that treatment of 
macrophages with various TLR agonists, like LPS, poly (I:C), peptidoglycan or 
CpG, increased bacterial uptake and enhanced Salmonella survival (Wong et al., 
2009). In another study, Salmonella bacteria were shown to exploit recognition by 
TLR9 on macrophages to enhance their virulence. This was shown to be mediated 
through TLR-dependent acidification of SCV which in turn, upregulates several 
T3SS genes necessary for bacterial survival, replication and virulence (Arpaia et 
al., 2011a). In a third report, concomitant infection with an attenuated strain of 
Salmonella was found to aggravate infection with a virulent strain of Salmonella. 
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This is mediated by TLR4-induced production of IL-10 triggered by the 
attenuated bacteria which in turn, exacerbates infection by the virulent strain 
(Foster et al., 2008).         
       Neutrophils play a critical role as the first line of innate immune defense 
against Salmonella (Conlan, 1997). In response to Salmonella infection in the 
early phase, several anti-microbial defense mechanisms are activated, which 
mainly involves the recruitment of neutrophils and other phagocytic cells to the 
site of infection as well as induction of their microbicidal effector functions 
(O'Brien et al., 1980);  (Royle et al., 2003). TLRs promote the bactericidal activity 
of macrophages against Salmonella through increased cytotoxic activity and  
TNF-α production (Weiss et al., 2004). In our model, the delayed recruitment of 
inflammatory cells, consisting mainly of granulocytes, at the site of infection is 
apparent at 24 hours. Though we have not assessed the exact role of MyD88 in 
inflammatory cell recruitment, other studies have highlighted its critical function 
in chemokine expression that coordinate early phagocyte response (Bandow et al., 
2012) (Rydstrom and Wick, 2009). MyD88/TLR4-dependent chemokine 
expression of CCL2, CXCL9 and CXCL2 is crucial for neutrophil and monocyte 
recruitment following oral infection with Salmonella (Rydstrom and Wick, 2009). 
By 48 hours, the bacteria start to mobilize to the target organs in MyD88
+/+
 mice, 
leading to a further reduction in polymorphonuclear cells by 72 hours. In contrast, 
bacterial CFUs and neutrophil recruitment continue to expand in MyD88
-/-
 mice at 
72 hours post-infection in the peritoneal cavity. As early as 48 hours post-
infection, MyD88
-/-
 mice display defect in phagocytic cell recruitment and 
proinflammatory cytokine production, such as IL-6, IL-12 as well as antimicrobial 
effectors like nitric oxide (Fig. 3C-E) (Issac et al., 2013). These defects may well 
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contribute to MyD88
-/-
 mice being susceptible to infection. Even up to 10 days 
post-infection, the accumulation of these cells was more reduced in MyD88
-/- 
mice 
than TLR2/4
-/-
 mice (Seibert et al., 2010). Ko and colleagues (Ko et al., 2011) in 
their findings have shown accumulation of inflammatory myeloid cells at 4 weeks 
post oral administration of recombinant attenuated S. Typhimurium (RASV) strain 
with increased levels of inflammatory cytokines, resulting in systemic 
inflammation in MyD88
-/- 
mice. The substantial delay in the recruitment and 
activation of phagocytic cells in MyD88
-/-
 mice could be a major contributor to the 
increased host mortality observed in our study (Fig. 20, 21). Despite this delay, 
the fact that phagocytic cell infiltration occurs indicates the initiation of other 
signaling pathways as a substitute for MyD88. 
        TLR signaling has also proven to be critical in Gram-positive intracellular 
infections like L. monocytogenes where bacterial titers were higher in the organs 
of TLR2
-/-
 and MyD88
-/- 
mice than control mice. There is decreased activation of 
TLR-deficient macrophages and dendritic cells on L.monocytogenes infection 
leading to substantially reduced production of TNF-α, IL-12 p40 and nitric oxide 
(Torres et al., 2004). Studies with intracellular facultative Gram-negative bacterial 
infections of S. Typhimurium (Talbot et al., 2009) and Ehrilichia muris (Koh et 
al., 2010) in MyD88-deficient mice display enhanced bacterial numbers in the 
target organs and blood. Neutrophil recruitment is MyD88-dependent in early 
phase infections even with other intracellular pathogens (Sukhumavasi et al., 
2008); (Koh et al., 2010); (Lebeis et al., 2007). By 21 days post-infection with S. 
Typhimurium, the percentage of myeloid cells was substantially higher in infected 
MyD88
-/-
 spleens (Fig. 21A) which leads to lower percentages of lymphoid cells 
(Fig. 22B, 24B). The total splenic myeloid cells recovered were significantly 
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higher when compared to those of the wild-type infected mice. However we did 
not observe any dramatic changes in the absolute numbers of lymphocyte 
populations. In contrast, Ko and coworkers reported substantial increase in 
lymphoid and myeloid populations in MyD88
-/-
 spleens compared to those of 
wild-type mice at 4 weeks post oral infection with Salmonella (Ko et al., 2011). In 
addition to the increased myeloid cell numbers in the spleen of Salmonella 
infected MyD88
-/-
 mice, the increased spleen weights in these mice could be 
contributed by the enhanced erythropoiesis in the spleen to the growing 
Salmonella infection (Jackson et al., 2010). 
        The production of IL-12, IL-6 and nitric oxide by myeloid cells of mice 
lacking MyD88 at late stage of Salmonella infection suggests the induction of 
these cytokines in a MyD88-independent manner, possibly driven through TLR4-
triggered TRIF pathway. Yamamoto et al (2003) demonstrated that LPS-induced 
secretion of IL-6, IL-12 and TNF-α was abrogated in macrophages from TRIF-/- 
mice. Furthermore, proliferative responses of splenocytes to LPS were severely 
impaired in these mice (Yamamoto et al., 2003). IFN-α and IFN-β production 
through the TRIF mediated pathway leads to nitric oxide release in response to 
Salmonella LPS (Zughaier et al., 2005). Moreover TLR-independent intracellular 
PRRs, such as NLRs, are involved in the production of inflammatory cytokines 
and development of adaptive response to Gram-positive (Fritz et al., 2007) and 
Gram-negative bacteria (Geddes et al., 2010). Nod1 and Nod2 provide effective 
antibacterial inflammatory responses (IL-1β, keratinocyte derived chemokine) and 
induce generation of enteric Th17 responses to Salmonella infection (Geddes et 
al., 2010); (Geddes et al., 2011). Peptidoglycan recognition by Nod1 directs Th1, 
Th2 and Th17 responses (Fritz et al., 2007). Another MyD88 independent 
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mechanism is complement activation which on sensing LPS of Gram-negative 
bacteria generates anaphylatoxins that induce inflammatory responses (Winter et 
al., 2010). 
5.2. TLR signaling in IFN-γ production and T cell mediated immune response 
        Control of Salmonella infection requires strong T cell responses involving 
both CD4
+
 and CD8
+
 T lymphocytes (al-Ramadi et al., 2006); (Hess et al., 1996); 
(Mittrucker and Kaufmann, 2000). The CD4
+ 
Th1 response in Salmonella infected 
mice is characterized by inflammatory cytokine secretion, particularly IFN-γ (Pie 
et al., 1997); (Kaufmann, 1993); (Mastroeni, 2002). Deficiencies in IL-12 and IL-
12-dependent production of Th1 cytokines, such as IFN-γ and TNF-α, caused 
profound susceptibility to Salmonella infection in mice (Jouanguy et al., 1999); 
(Tite et al., 1991) and predisposition to Salmonellosis in humans (de Jong et al., 
1998); (Altare et al., 1998). During the early stage of infection, NK cells are the 
major source of IFN-γ which is necessary for macrophage activation and effective 
protection to Salmonella (Ramarathinam et al., 1993). In infected MyD88-
deficient mice, the IL-12 response was severely impaired in the acute phase 
between 2-48 hours of Salmonella infection (Fig. 3D) (Issac et al., 2013). Despite 
the observed defect in IL-12 production at 48 hours post-infection, comparable 
levels are detected at three weeks post-infection in wild-type and MyD88
-/-
 mice. 
The production of IL-12 also correlates with IFN-γ production. The Th1 
dependent induction of IFN-γ at three weeks post-infection was at substantially 
high levels, comparable to those of immunized MyD88
+/+
 mice (Fig. 34A). In 
experimental models of other intracellular pathogens, the early acute IFN-γ 
release from splenocytes was MyD88 dependent (Naiki et al., 2005) but the Th1-
induced cytokine response eventually developed with time in MyD88
-/-
 mice 
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(Sukhumavasi et al., 2008).  A robust Salmonella-specific T cell memory response 
developed in MyD88
-/- 
mice following infection with a sublethal dose of BRD509 
strain. However, memory T cells failed to provide effective protection to 
immunized MyD88
-/-
 mice as they remained susceptible to virulent challenge. The 
overall mortality was much higher when compared to the immunized wild-type 
mice. This lack of effective protection in the absence of MyD88 further highlights 
the critical role of phagocytes in the control of Salmonella bacterial proliferation 
(Issac et al., 2013). A recent study demonstrated that neutrophils are able to 
produce IFN-γ in response to intracellular pathogens, including Salmonella, in 
mice with TLR11-deficiency. In this report, IFN-γ production by neutrophils was 
regulated by TNF-α and IL-1β (Sturge et al., 2013). MyD88 is a crucial 
component of the signaling pathway of IL-1R and IL-18R. IL-1β and IL-18 are 
potent activators of the acute phase of anti-bacterial host defense (Adachi et al., 
1998a) through activation of NK cells (Chaix et al., 2008); (Raupach et al., 2006) 
and development of Th1 responses (Takeda et al., 1998). IL-18 was shown to be 
required for essential clearance of bacteria and to be involved in the secretion of 
IFN-γ by CD4+ T cells of Salmonella infected mice (Srinivasan et al., 2007). 
Despite the evidence of Th1 responses, the increased susceptibility of MyD88
-/-
 
mice to Salmonella infection could also be explained by the lack of IL-1β and    
IL-18 signaling as a result of the loss of MyD88.   
5.3. TLR signaling in B cell mediated adaptive immune response to infection 
        The role of TLRs in the induction of antibody responses is controversial. 
Antigen-specific antibody responses have been reported to depend on TLR 
activation on B cells (Chandrashekhar and Ruslan, 2005). However, there are 
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several other studies that have highlighted the importance of signaling through 
TLRs for the control of the pathogen but not for the induction of adaptive immune 
responses (Gavin et al., 2006); (Ko et al., 2009). B cells express most TLRs 
(Dasari et al., 2005); (Rawlings et al., 2012) and notably TLR engagement 
promotes B cell proliferation, survival and differentiation to long lived antibody 
secreting plasma cells (Gerondakis et al., 2007); (Gray et al., 2007); (Boeglin et 
al., 2011);(Ruprecht and Lanzavecchia, 2006). TLR4 promotes B lymphocyte 
maturation while TLR2 arrests the process (Hayashi et al., 2005). Some TLRs 
have also been suggested to have a role in the early stages of B cell development 
(Applequist et al., 2002). TLR signaling has proven to be essential for generation 
of antibody secreting plasma cells in both the spleen and bone marrow in MyD88
-
/-
 mice after influenza VLP vaccination (Kang et al., 2011). The expression of 
TLRs varies during B cell development and increased antibody production has 
been demonstrated on TLR activation of terminally differentiated plasma cells in 
humans. In our study, the loss of MyD88 did not affect B cell numbers in naïve 
mice (Fig. 22B) which is in agreement with other studies (Adachi et al., 1998b); 
(Kawai et al., 1999). In an experimental system utilizing mice with MyD88 
deficiency restricted to the B cell compartment (MyD88
B-/-
), Salmonella-
immunized animals possess fewer and smaller germinal centers (GCs) than those 
of wild-type mice, thus suggesting that GC B cell differentiation is also dependent 
on TLR signaling (Barr et al., 2009). Direct TLR-induced activation of human B 
cells also leads to expression of a large number of cytokines (Agrawal and Gupta, 
2011); (Jagannathan et al., 2009). On the other hand, at 4 weeks post oral 
administration of RASV, GC formation was increased in MyD88
-/-
 mice when 
compared to wild-type mice (Ko et al., 2011). Thus, B cell-specific loss of 
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MyD88 affects their activation in GCs, while total MyD88 deficiency seems to 
not adversely affect B cells in GCs, suggesting that MyD88 functions in different 
capacities depending on the cell type. 
        One of the main findings in our study is the observed phenomenon of 
hypergammaglobulinemia. Wild-type mice in response to Salmonella infection, 
typically exhibit humoral immune response skewed by Th1 type cytokines. 
Following infection with attenuated Salmonella, antibodies of IgG2c and IgG3 are 
the predominant isotypes being produced in C57BL/6 mice (al-Ramadi et al., 
2006); (Issac et al., 2013) or isotypes of IgG2a and IgG3 in BALB/C mice 
(Harrison et al., 1997). In addition to the cytokine-induced Ig isotype switching, 
interaction between TLR9 expressed on B cells and pathogen ligands has been 
shown to induce IgG2a class switching. Interaction of pathogen with ligands can 
directly activate B cells, possibly explaining as to why they generally induce 
strong IgG2a responses (Jegerlehner et al., 2007). In contrast to wild-type mice, 
MyD88
-/-
 mice irrespective of the route of Salmonella infection, in response to 
Salmonella infection developed aberrant humoral immune response with anti-
Salmonella antibodies of all isotypes being produced at high levels, establishing a 
state of hypergammaglobulinemia (Fig. 4). Infection with B. Burgdorferi bacteria 
induced IgM hypergammagobulinemia along with IgG1 and IgE activated 
responses in the absence of MyD88 (Woods et al., 2008). Interestingly, uninfected 
MyD88 deficient mice exhibited high levels of total IgG1 antibody subclass in 
their serum which were largely unchanged after infection (Fig. 7C). The clear 
dominance of Th2-biased adaptive immune response is confirmed by high levels 
of IL-4 in the MyD88
-/-
 mice. In hygienic conditions, the immune response is 
predisposed to a Th2 response which shifts to a Th1 response on exposure to a 
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pathogen. In the absence of MyD88 the Th2 profile remains intact. The 
predominant Th2 profile could be associated with the inability to respond to 
pathogens in the absence of TLR signaling. The lack of MyD88 undermines the 
exposure to pathogen naturally acquired through air or water, maintaining the de 
facto Th2 response. Moreover, the influence of these responses by commensal 
bacteria can be evaluated by continuous treatment with antibiotics from birth in 
both MyD88
+/+
 and MyD88
-/-
 mice for up to 8-12 weeks. Following this, CD4
+ 
T 
cells can be purified and levels of IL-4 can be determined. This will clarify any 
role of the commensals in driving the de facto Th2 responses. Several animal 
models of infection have highlighted the development of Th2 responses due to 
MyD88 deficiency (Chen et al., 2010); (Debus et al., 2003); (Liu et al., 2004); (Ko 
et al., 2009). Ko and colleagues reported that signaling through MyD88 is 
dispensable for the induction of LPS-specific B cell responses. Moreover they 
demonstrate decreased IgG2a:IgG1 antibody responses (Ko et al., 2009). 
Similarly, in another study, IgG1 response to T-cell dependent antigens took place 
independently of MyD88 signaling along with loss of IgG2c in mice with MyD88-
deficient B cells infected with Salmonella (Barr et al., 2009). Our data are 
consistent with these findings of a Th2 induced IgG immune response (Issac et al., 
2013). However these levels were inevident in MyD88
-/-
 mice that possessed 
reduced isotype switched IgG antibodies on immunization with influenza viral 
particles (VLP), as a result of defective secretion of antibodies from splenic B 
cells (Kang et al., 2011). Interestingly, DCs have been claimed to support Th2 cell 
development in the absence of TLR signaling (Kaisho et al., 2002). This was not 
the case in another study where MyD88 signaling in Gr-1
+
CD11b
+ 
myeloid cells 
facilitated Th2 polarized B cell responses in a polymicrobial sepsis model (Delano 
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et al., 2007). Overall, a controversial role of MyD88 signaling in controlling B 
cells responses is portrayed. 
        Even infection with cytokine expressing strains of attenuated Salmonella 
failed to influence the trend of dysregulated antibody titers following infection in 
MyD88
-/- 
mice (Fig. 17). Interestingly, this phenomenon of uncompromised 
antibody response was not observed in MyD88
-/-
 mice infected with other Gram-
negative bacteria like A. baumanii or E. coli or Gram-positive bacteria like GpB 
Streptococcus or even with heat-killed BRD509 (Fig. 15C-E, Fig. 15). Though an 
exaggerated humoral immune response was generated to Salmonella infection in 
the MyD88
-/-
 mouse strain, this failed to provide effective protection to control the 
bacterial growth, further underlining the crucial role of the innate immune cells in 
the early phase of infection. In certain infections like B. burgdorferi, the antibody 
response to the pathogen appeared to control the bacterial burden substantially in 
MyD88
-/-
 mice (Liu et al., 2004). The antibody responses mounted in the absence 
of MyD88 could be through compensatory alternative sensory pathways being 
activated in response to the pathogens. One such mechanism is through NLRs 
particularly Nod1 and Nod2 that potentiate the generation of antigen-specific 
adaptive immune responses to bacterial ligands. This involves antigen specific 
immunoglobulin production and induction of optimal T cell response of Th1 or 
Th2 pathway (Fritz et al., 2007); (Kobayashi et al., 2005). 
        Stimulation of purified CD4
+ 
T cells from spleen or lymph node after 
infection, produced prominent IFN-γ levels in wild-type mice and IL-4 levels in 
MyD88-deficient mice (Koh et al., 2010); (Muraille et al., 2003). These 
observations were conflicting in our study following Salmonella infection where 
we confirm the production of strong IFN-γ levels in MyD88-/- mice similar to 
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those in the wild-type mice (Fig. 31A). The increased presence of IFN-γ on 
infection contributed to increased expression of Sca-1 activation markers in the 
myeloid and lymphocyte populations in the spleen (Fig. 21B, 24A, 26A, 27A). 
Furthermore, an aberrant induction of IL-4 was also observed in MyD88
-/-
 mice 
after infection with attenuated Salmonella (Fig. 29A). These levels observed at the 
RNA level were further confirmed with intracellular FACS staining and cytokine 
levels obtained after ex vivo restimulation of CD4
+ 
T cells (Fig. 31B, 34B). The 
induction of increased amounts of both IFN-γ and IL-4 in MyD88-/- mice 
coincides with the presence of prominent levels of cytokine-driven antibody 
isotypes after infection with Salmonella. Interestingly, Neves and colleagues 
reported stronger NK and T cell responses to Salmonella in mice with B cell-
specific MyD88 deficiency (MyD88
B-/-
) than those in wild-type animals (Neves et 
al., 2010). The stronger anti-Salmonella response was correlated with reduced 
production of IL-10 by the activated B cells in MyD88
B-/-
 mice, demonstrating a 
potentially important regulatory role for B cell-specific IL-10 synthesis.     
5.4. Breakdown of self-tolerance as result of loss of MyD88 
        MyD88/IRAK deficiency in humans was first identified in 2003 (von 
Bernuth et al., 2012). The adaptor molecule is crucial for infancy survival and 
early adulthood. Similar to MyD88
-/-
 mice, patients deficient in MyD88/IRAK-4 
had increased susceptibility to infections with invasive pyogenic Gram-positive 
and Gram-negative bacteria  (von Bernuth et al., 2008); (von Bernuth et al., 2012). 
The signaling proteins are more crucial during childhood. With age, infections in 
patients that lack these signaling molecules are rarer, probably due to adaptive 
immune responses from B and T lymphocytes (Picard et al., 2010). MyD88 is 
vital for the negative selection of autoreactive immature B cells in the bone 
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marrow. MyD88 and IRAK-4 deficient patients exhibited increased ratios of 
autoreactive B cells and high frequency of HEp-2 reactive clones (Isnardi et al., 
2008). This strongly implies a disruption of the B cell activation pathway and a 
breakdown of central tolerance in the absence of MyD88 signaling. However, no 
ANA or other polyreactive antibodies were detectable in sera collected from these 
patients within 3 months after birth (Isnardi et al., 2008). This could suggest either 
of two possibilities; one that TLR7/9 signaling that enhances costimulatory signal 
on BCR recognition of immune complexes gets thwarted and second that certain 
infections can breakdown self-tolerance as a result of loss of MyD88. As 
explained earlier, various experimental models have proved that infections can 
lead to autoimmunity (Tardieu et al., 1984); (Wucherpfennig, 2001); (Fairweather 
et al., 2001). Our findings show B cell hyper activation in mice with defective 
MyD88 signaling caused an aberrant and dysfunctional humoral immune response 
of all isotypes against the Salmonella antigens with high affinity to autoantigens 
such as dsDNA, thyroglobulin and other nuclear antigens (Fig. 10, 11). These 
antibodies also formed immune complexes in the glomerular membrane of the 
kidney (Fig. 12). Similar findings have been reported by Ko et al (Ko et al., 2011). 
In our study, infection with other Gram-negative pathogens though harboured 
higher bacterial counts in the MyD88
-/-
 spleen, failed to mount any phenomenon 
of hypergammaglobulinemia with autoantibody production (Fig. 14). This 
suggests that specific properties of Salmonella organisms such as their mode of 
survival and replication in the intracellular compartments of the macrophages may 
be responsible for the observed auto reactivity in MyD88-deficient mice. The 
chronic infection of Salmonella in MyD88-deficient mice could probably disrupt 
the anergic state of the autoreactive B cells, leading to the observed production of 
136 
 
antibodies to nuclear antigens. In one study, administration of poly(I-C) 
highlighted the role of MyD88 independent signalling in the development of 
autoimmunity in lupus prone mice deficient in MyD88. This has been associated 
with increased levels of IFN-α jointly with IL-6 and IL-12 (Sadanaga et al., 2007) 
Contrary to this is the involvement of MyD88 in the pathogenesis of 
autoimmunity in various autoimmune mouse models. In MRL/lpr mice, MyD88 
signaling in B cells mainly contributed to ANA and RF formation (Teichmann et 
al., 2013). Loss of MyD88 in MRL/lpr mice reduced immunoglobulin serum 
levels and anti-dsDNA antibody titres with reduced inflammatory lesions thus 
improving the survival of the mice (Sadanaga et al., 2007). Viral and bacterial 
infections have been known to drive polyclonal B cell activation, 
hyperglobulinemia and possible reactivity to self-antigens from chronic infections 
(Soulas et al., 2005); (Jellison et al., 2007). This non-specific B cell activation can 
be through direct activation by B cell mitogens or peptide derived interaction with 
CD4
+ 
T cell irrespective of the specificity of BCR (Stevenson and Doherty, 1999); 
(Hunziker et al., 2003). Furthermore, MyD88 expression in RF B cells is required 
for their initial activation and expansion in responses to IgG2a anti-chromatin 
(Herlands et al., 2008). With the activation of autoreactive B cells in the primary 
step of autoimmunity, the role of TLR signals in mediating these responses has 
been comprehended. 
        As mentioned previously, elevated levels of BAFF have been associated with 
increased survival of autoreactive B cells in the periphery (Lesley et al., 2004);  
(Mackay et al., 2003); (Thien et al., 2004). Though BAFF has no role in the 
elimination of high affinity self-reactive B cells in the bone marrow, peripheral 
deletion of autoreactive B cells has been found to be rescued by increased 
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expression of BAFF protein and hence, permit their entry to forbidden 
microenvironments of the spleen. Furthermore, the rescued self-reactive B cells 
that partially expressed CD86 were adequate for its response to antigenic 
stimulation leading to autoantibody production (Thien et al., 2004). IFN-α has 
been well established in the pathogenesis of SLE (Ronnblom and Alm, 2001); 
(Barrat et al., 2005); (Pascual et al., 2003) and IFN-α/β has been known to 
upregulate the expression of BAFF in autoimmune mouse models (Jacob et al., 
2011) as well as in humans (Krumbholz et al., 2008); (Litinskiy et al., 2002); (Yao 
et al., 2009). Other than exercising MyD88 as the adaptor molecule, TLR-4 can 
signal through TRIF for the induction of Type1 IFN genes (Yamamoto et al., 
2003). Thus we suggest if this pathway could be triggered as a compensatory 
route in the absence of MyD88, due to enhanced bacterial burden. In our results, 
evaluation of BAFF expression revealed increased levels of the B cell activating 
factor being expressed as a result of loss of MyD88 in the myeloid cells of the 
spleen by 3 weeks post-infection in the mouse strain (Fig. 30A). Ko and 
colleagues in their findings have shown increased levels of expression of BAFF 
and APRIL in the spleen of MyD88
-/-
 mice at two days, following oral 
administration of RASV strain (Ko et al., 2009). In one study, the presence of 
undigested mammalian DNA has also been implicated in the activation of Type I 
IFN genes (Okabe et al., 2005). Nickerson and colleagues in their study of the role 
of TLR7/9 in regulating autoimmunity, observed dermatitis and 
hypergamaglobulinemia even in MyD88 deficient animals, further suggesting 
possible contributions of MyD88 independent components such as PRRs, that 
recognise nucleic acids like RIG-I or MDA or other nucleic acid sensory pathways 
(Nickerson et al., 2010). 
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        IL-17 has been known to be involved in the pathogenesis of various 
inflammatory autoimmune diseases (Zhu and A Qian, 2012), one of which is its 
synergistic effect with BAFF in promoting B cell survival in SLE (Doreau et al., 
2009). However, there was no apparent induction of IL-17 or its regulatory protein 
in MyD88 deficient mice, to chronic Salmonella infection in our observations 
(Fig. 29) excluding its role in the observed autoimmune response as a result of 
self-tolerance breakdown. Furthermore, the reduction in the expression of Foxp-3 
in CD4
+ 
T cells of infected MyD88
-/-
 mice when compared to MyD88
+/+
 mice 
suggests dependency of Tregs on MyD88 signaling in response to infection (Fig. 
29B). This further implies a decreased Treg mediated suppression of immune 
responses, particularly T cell expansion to infection. 
        A distinct population of B helper T cells first identified in tonsils (Breitfeld et 
al., 2000) is localized in the B cell zone of lymphoid organs and has been 
associated with various autoimmune diseases in humans (Simpson et al., 2009); 
(Ma and Deenick, 2013). IL-6 and IL-21 proinflammatory cytokines along with 
costimulatory molecule stimulation are involved in the differentiation of this 
specialized subset of T cells called TFH cells. PD-1 and CXCR5 are upregulated in 
TFH cells, the latter of which is crucial for its migration to the B cell follicle (Park 
et al., 2014). These cells are regulated by the transcription factor B cell 
lymphoma-6 (bcl-6) and secrete IL-4 and IL-21 that promotes B cell somatic 
hyper mutation, affinity maturation, Ig isotype switch and plasma cell 
differentiation. IL-21 directly acts on B cells in germinal centers (Zotos et al., 
2010) to regulate Bcl-6 expression for affinity maturation of B cells (Linterman et 
al., 2010). IL-21 deficient mice immunized with T-dependent antigen showed 
defect in affinity maturation of plasma cells and formed abnormal germinal 
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centers. The abnormal GC development however, was not associated with 
unaffected TFH cells suggesting mainly the prerequisite of IL-21 in GC reactions 
and not TFH cell development (Zotos et al., 2010). Although Tfh cell formation is 
IL-21 independent, the maintenance of this T cell subset is impaired in the 
absence of the cytokine (Linterman et al., 2010). TFH cells facilitate the survival 
and differentiation of self-reactive B cells, eventually leading to autoantibody 
production and organ damage (Zhang et al., 2013). The dysregulation of TFH and 
extrafollicular Th cells has been linked to chronic autoimmunity in several 
autoimmune murine models (Odegard et al., 2008); (Park et al., 2014). Despite the 
fact that Bcl-6 suppresses differentiation of other T helper cells, increased levels 
of IFN-γ have been reported to promote accumulation of TFH cells in sanroque 
mouse model (Lee et al., 2012). Three weeks after infection with attenuated 
Salmonella in MyD88
-/-
 mice, a significant expression of IL-21 was observed, but 
with no evidence of Bcl-6 in splenic CD4
+ 
T cells (Fig. 29). Lack of Bcl-6 
expression could possibly reflect a late stage of TFH cell differentiation (Ma and 
Deenick, 2013). One study has also shown a downregulation of Bcl-6 expression 
in some murine TFH cells (Kitano et al., 2011). The extrafollicular T cell zone in 
the spleen was found to be a region of spontaneous autoantigen responses. 
Extrafollicular T helper cells promote the formation of somatic mutated 
autoantibodies in MRL/lpr mice in the extrafollicular sites of B cell proliferation 
(Odegard et al., 2008). Low transcriptional levels of CXCR5 in the splenic CD4
+ 
T cells of MyD88
-/-
 mice (Fig. 29) suggest these to be extrafollicular T helper cells 
that contribute to antibody class switched isotypes and autoantibody production 
through IL-21 (Odegard et al., 2008). There was a dramatic reduction in the 
accumulation of B and T cells in the spleens of IL-21R
-/-
 MRL/lpr mice along 
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with decreased B cell activation and autoantibody production (Rankin et al., 
2012). In support of our findings of increased populations of CD11b
+
Gr-1
+
 
myeloid cells with enhanced activation in the spleens of MyD88
-/-
 mice following 
infection (Fig. 28A) (Fig. 21), are the results of Ko and colleagues (Ko et al., 
2011). They suggest that the increased infiltration, expansion and activation of 
myeloid cells in the spleen could modulate proliferation of TFH like cells that 
include TFH cells and extrafollicular helper T cells, resulting in hyper IgG 
responses in chronic Salmonella infection. Though IL-6 production from 
inflammatory myeloid cells was involved in TFH cell differentiation in MyD88
-/-
 
mice (Ko et al., 2011), in our results with intraperitoneal infection at day 21, the 
cytokine was produced at significantly high levels in both the wild-type and 
MyD88
-/-
 mice (Fig. 30). This suggests involvement of other candidate cytokines 
in TFH cell development. Alternatively, in a study with lupus mice the frequency 
of TFH cells as well as IFN-γ producing CD4
+ 
T cells were substantially reduced in 
MyD88 deficient B cell and DCs (Teichmann et al., 2013).  Expansion of IFN-γ 
secreting CD4
+
 T cells and IL-21 producing extrafollicular T helper cells is one 
important feature in MRL/lpr mice (Rankin et al., 2012); (Odegard et al., 2008). 
An intriguing observation in our results is the generation of a population of CD4
+ 
T cells on infection with Salmonella in MyD88
-/-
 mice that produce both IFN-γ 
and IL-4. These double positive cells were not observed in the infected spleens of 
wild-type mice and the non-infected MyD88
-/-
 mice (Fig. 33, 34C). A study with 
intramacrophage parasitic infection, recovered CD4
+ 
T cells that are capable of 
producing both IFN-γ and IL-4 to the infection in the draining lymph nodes 
(Reiner et al., 1994) which were later confirmed to be TFH cells (Reinhardt et al., 
2009).  In our study, TFH like cells seem to be generated as a result of persistent 
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infection of Salmonella. In one report, persistent viral infection was shown to 
induce the differentiation of Th cells to TFH cell responses (Fahey et al., 2011). In 
our study, the enhanced induction of IFN-γ was confirmed by the increased level 
of its master regulator, T bet. However, this was not the case with GATA-3 that 
was thought to regulate the observed IL-4 T cell responses (Fig. 29). Migration of 
T helper cells to the extra follicular sites and expression of CXCR4 are largely 
dependent on ICOS costimulation. ICOS
-/-
 MRL/lpr mice developed reduced class 
switched antibodies and autoantibody titers (Zeller et al., 2006); (Odegard et al., 
2008). The levels of expression of CXCR4, ICOS and PD-1 in the CD4
+
T cells 
are yet to be assessed through PCR and intracellular staining in order to obtain 
further understanding of the accumulation of TFH cells and extrafollicular T helper 
cells and their respective contribution to the hyper antibody responses. This 
further highlights therapeutic approaches of targeting T helper 1 (Th1) cells and 
TFH cells in treating antibody mediated diseases. 
        Infection with GIDIL2/GIDIFN leads to hyper IgG responses in MyD88
-/-
 
mice but failed to induce any significant autoantibody production, as observed 
with BRD509 infected MyD88
-/-
 mice (Fig. 17, 18). This could be related to the 
persistence and chronicity of infection with BRD509 in the defective mouse 
strain. The IFN-γ and IL-2 expressing strains of Salmonella are cleared more 
effectively in the wild-type mice (Al-Ojali et al., 2012a); (Al-Ojali et al., 2012b); 
(al-Ramadi et al., 2004); (al-Ramadi et al., 2002). IL-2 expression in the bacteria 
improves NK cell cytotoxicity and IFN-γ production and, hence, increases the 
synthesis of anti-Salmonella effector molecules such as NO (al-Ramadi et al., 
2003). On the other hand, several studies have also highlighted the role of IL-2 in 
enhancing the suppressive activity and expansion of Treg cells (de la Rosa et al., 
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2004); (Thornton et al., 2004). The delivery of IFN-γ by Salmonella strain could 
further promote Th1 cell mediated responses thereby downregulating TFH /Th2 
cell expansion and function.  
        During chronic infections, CD4
+ 
T cells that secrete both IFN-γ and IL-10 
have been identified which are absent during normal conditions. There is evidence 
indicating the suppressive role of these double positive cells in controlling 
immune responses through IL-10 with IFN-γ help (Flores-García et al., 2011); 
(Liu et al., 2009). These functionally distinct CD4
+ 
T cells identified in an 
infection with intracellular pathogen T. gondii display both Th1 effector function 
as well as regulatory activity. The IL-10
+
IFN-γ+ CD4+ T lymphocytes when 
cultured with the parasite infected IL-10 deficient macrophages were able to 
control the intracellular T. gondii proliferation, effectively highlighting its effector 
function. However, the IL-12 production from infected macrophages was 
significantly reduced in the presence of these double positive cells (Jankovic et al., 
2007). In one study involving a murine model of L. major, secretion of IL-10 by 
Th1 cells prevented the effective elimination of the pathogen contributing to 
chronic infection (Anderson et al., 2007). Conditions that drive a highly polarized 
Th1 response were found to induce the appearance of these apparent regulatory 
cells (Jankovic et al., 2007).  In our infection model, IL-10
+
IFN-γ+ CD4+ T cells 
were found to be induced only in MyD88
-/-
 mice after infection and not in wild-
type mice or MyD88
-/-
 uninfected mice (Fig. 32, 34B). Also, there was no 
evidence for IL-10
+
 or IL-4
+
 cells in CD154
-/-
 mice. The presence of a chronic 
Salmonella infection in MyD88
-/-
 mice due to their inability to effectively clear the 
infection could probably generate these double producer cells. These cells could 
also contribute to the prolonged persistence of the bacteria. We have only 
143 
 
observed the presence of this distinct population of cells but their regulatory role 
to the persistent infection is yet to be elucidated.  
        Overall, our data demonstrate the crucial role of MyD88 mediated TLR 
signaling in regulating immune response against S. Typhimurium and its 
importance in maintaining self-tolerance in B lymphocytes. 
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